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Aeromonas spp. are important biofilm-forming fish pathogens causing great economic loss in 
aquaculture. Bacterial cells within biofilms communicate with each other via the production 
of quorum sensing (QS) signalling molecules called acyl-homoserine lactones (AHLs), which 
influence biofilm development and production of virulence factors. QS together with efflux 
pumps, extracellular polymeric substances (EPS) and eDNA are associated with resistance of 
bacteria to antimicrobial agents. These mechanisms provide a target for different control 
strategies. The objectives of this study were to: (i) determine effective antimicrobial agents 
and exposure concentrations against aeromonad biofilms; (ii) ascertain whether Aeromonas 
spp. produce QS molecules or display efflux pump phenotypes, and (iii) investigate the effect 
of antimicrobial agents, lytic enzymes, efflux pump inhibitors and QS inhibitors on biofilm 
formation by Aeromonas spp. isolates.signalling MICs of azithromycin, ciprofloxacin, 
ceftazidime, and tetracycline ranged between 0.064-64 μg/ml. Gentamicin had the lowest 
MICs which ranged between 0.0048-32 μg/ml.The highest MBIC at which antimicrobial 
agents exhibited inhibition was 4096 μg/ml. Majority of the isolates displayed MIC levels 
ranging from 2-32 μg/ml, and thus a ≥ 128-fold increase was observed for MBICs. Of the 
sub-MIC, MIC and supra-MIC exposures tested, MIC exposure of biofilms was the most 
effective. Gentamicin MIC exposures inhibited initial attachment of 100% (28/28) of isolates 
tested, while azithromycin MIC exposure detached 82.1% (23/28) of isolates. Carbonyl 
cyanide 3-chlorophenylhydrazone completely inhibited efflux of cefpodoximeby 14.8% of 
isolates. However, 1-(1-naphthylmethyl)-piperazinewas more effective, decreasing adherence 
of 98.1% (53/54) of isolates and increasing detachment of 100% (54/54) of isolates. DNase I 
was more effective against the mature biofilm,where it increased biofilm detachment of 
64.8% of isolates. Of the 48 Aeromonas spp. and six Plesiomonas spp. isolates used, only a 
single isolate induced the production of violacein by the C. violaceum CV026 biosensor, 
while all isolates induced the utilization of X-gal to produce a visible blue colour with the 
A.tumefaciens A136 biosensor. Based on the reaction to the two biosensors, aeromonads 
appeared to produce long-chain acylhomoserine lactones. By blocking QS, S-adenosyl 
homoserinewas more effective in inhibiting both initial attachment (72.2% of isolates) and 
pre-formed biofilms (detached 74.1% of isolates). The investigated strategies are promising 
for Aeromonas spp. biofilm inhibition. Thesecould be explored aspotential therapeutic 
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Introduction and Literature Review 
1. Introduction 
Many bacteria reside in aquatic settlement and the majority of these are suggested to be 
pathogenic (Declerk et al., 2009). About 95% of the biomass is found in distribution water 
systems with 5% occurring only in the water phase (Declerk et al., 2009). In aquatic settings 
such as surface water or man-made treatment systems, bacteria survive and grow in limited 
amounts of nutrients (Vital et al., 2010). Within these aquatic settings water pathogens have 
been shown to exist as both planktonic cells and biofilms. This aids pathogens to survive in 
water since the biofilm is protected by the exopolysaccharide substance, which concentrates 
nutrients, prevents access of antimicrobial agents and prevents desiccation (Chmielewski and 
Frank, 2003).        
 Aeromonas spp. havea high tendency to form biofilmsand are suggested to be 
associated with the first stage of biofilm formation in aquatic environments (Dogruoz et al., 
2009). Aeromonad biofilms are considered as the major food and water-borne pathogens 
(Igbinosa et al., 2012). The source of infection for Aeromonas spp. isolates is contaminated 
fish and water, animal faeces and food handlers (Elhariry, 2011). Aeromonasspp. cause 
different kinds of diseases in humans but more importantly they havebeen found to be 
associated with diarrhea in children, elderly people and immune-compromised patients 
(Igbinosa et al. 2012). In addition aeromonads cause diseases such as cellulitis, septicaemia 
and wound infections in fish and other animals (Farmer et al., 2006). Therefore, control 
strategies that can eradicate biofilms formed by members of this species are required in order 
to reduce their infections in both humans and animals. 
 
1.1. Characterization of Aeromonas spp.  
Aeromonas spp. isolates are aquatic bacteria that are often associated with diseases in fish 
and other animals (Janda and Abbott, 2010). Fish industries often face great economic 
lossesassociated with Aeromonas spp.(Janda and Abbott, 2010), and these bacteria are 
alsoassociated with opportunistic infections in humans (Corral et al., 1990). Aeromonas spp. 
are Gram-negative, rod-shaped, non-spore forming facultative anaerobes, which normally 
possess a single polar flagellum (Farmer et al., 2006). They are oxidase-, catalase- and 








Members of this genus can be divided into the motile group that grow well at 35-37 
°C (cause diseases in humans) and the non-motile group that grow well at 22-25 °C (cause 
diseases in fish) (Janda and Abbott, 2010). Different Aeromonas species that are currently 
known include: Aeromonas hydrophila, A. hydrophila subsp. dhakensis, A. hydrophila subsp. 
ranae, A. hydrophila-like, A. salmonicida, A. salmonicida  subsp. achromogenes, A. 
salmonicida  subsp. salmonicida, A. salmonicida  subsp. masoucida, A.sobria, A. caviae  A. 
bestiarum, A. media, A.eucrenophila, A. veronii biovar veronii, A. veronii biovar sobria, A. 
schubertii, A. trota, A. tecta, A. aquariorum, A. bivalvium, A. sharmana, A. 
allosaccharophila, A. encheleia, A. papoffi, A. culcicola, A. simiae, A. jandae and A. 
molluscorum (Igbinosaet al., 2012).  
 
1.2.  Environmental and clinical importance of Aeromonas species 
Aeromonads are ubiquitous in aquatic environments (Nishikawa et al., 1994), which serve as 
their primary habitat (Farmer et al., 2006) and their presence in aquatic environments is now 
considered a threat to public health (Senderovich et al., 2008). They are found in high 
numbers in polluted flowing water (Farmer et al., 2006), raw sewage, treated sewage, 
activated sludge, and mud sinks. Water drainage systems and swimming pools also provide a 
suitable environment for the growth of Aeromonas spp. (Farmer et al., 2006). Aeromonas 
spp. cause diseases in different animals with A. hydrophila and A. salmonicida being the 
major etiological agents. A. salmonicida causes furunculosis in salmon, trout, cutthroat trout, 
rocky mountain white fish, and brown trout. A. hydrophila causes red leg and other diseases 
in fish, red sore diseases of bass, ulcer diseases of carp, cod, channel cat fish, centrachid fish 
and other diseases in other animals (Farmer et al., 2006).     
 Diseases that are caused by Aeromonas spp.in humans are extraintestinal infections, 
meningitis, bacteremia, wound infections (Farmer et al., 2006), cellulitis, peritonitis, and 
myonecrosis (Janda and Abbott, 2010). A. schubertii in humans is associated with blood 
infections, while A. sobria in humans is the most invasive in tissues. Aeromonas spp.utilizes 
adhesins, hemolysins and cytotonic enterotoxins as virulence factors to cause diseases in 
humans(Senderovich et al., 2008). The presence of extracellularenzymes such as proteases, 
lipases, and elastases, production of amonabactin, enterobactin, siderophores, α- and β-
haemolysins, thermo-stableand thermo-labile enterotoxins, invasins and adhesins, also plays a 







formation, which may be associated with their ability to persist and cause disease in diverse 
hosts (Parker and Shaw, 2011).  
 
1.3 Biofilm formation 
Bacteria transitionfrom planktonic cells to sessile cellswhere they live as a population of cells 
within a biofilm (Landini et al., 2010).A biofilm is a community of cells living together 
within the extracellular polymeric substances (EPS) attached to the surface (del Pozo and 
Patel, 2007). The EPS is composed of proteins, lipids, polysaccharides, extracellular DNA, 
phospholipids and humeric substances (Simoes et al., 2010). The matrix provides protection 
for the biofilm against harsh conditions prevents antimicrobial agents from penetrating within 
and is also responsible for attachment of the biofilm (Simoes et al., 2010). There are four 
stages involved in biofilm formation (Fig. 1.1), i.e., attachment, colonization, maturation and 
detachment (Behlau and Gilmore, 2008).  
 
 
Figure 1.1: Stages involved in biofilm formation.Firstly, the planktonic cells that are 
dispersed from the biofilm or cells from the environment attach to the surface. The cells then 
form micro-colonies, which is then followed by formation of the developing biofilm. Before 
the cells are dispersed the fully matured biofilm is formed (Behlau and Gilmore, 2008). 
 
The attachment stage occurs on rough and hydrophobic surfaces (Simoes et al., 2010). 












hydrophobic, Van der Waals and electrostatic forces (Kaplan, 2010). Irreversible interaction 
which follows reversible interaction, involves strong attachment of appendages (flagella, pili 
and fimbrae) to the surface area (Simoes et al., 2010). Cells that are attached to the surface 
multiply to form micro-colonies to which the secondary colonizers will attach (Simoes et al., 
2010).As the cell density increases, cells produce signalling molecules during a process 
called quorum sensing (QS). This process has been suggested to influence biofilm 
development (Cataldi et al., 2007). The last step of biofilm formation is dispersal of cells 
which occurseither by erosion, sloughing and seeding (Fig.1.1) (Kaplan, 2010). 
 
1.3.1. Evidence of biofilm formation by Aeromonas spp. 
Biofilm formation by Aeromonas spp. is a characteristic which they share with Vibrio and 
Yersinia species (Basson et al., 2008). Aeromonas spp. isolates have been shown to form 
biofilmson both synthetic and natural objects (Declerk et al., 2009). Aeromonads were also 
identified as the bacteria responsible for biofilm formation in potable and recycled water 
systems (Bomo et al., 2004).  Aeromonas species are found in water where they infect fish 
and if outside their host form biofilms to survive. Aeromonads have been shown to survive in 
conditions where nutrients are limited, however, nutrients increase the biomass and rate of 
biofilm development (Bomo et al., 2004). A. caviae was shown to form biofilms on the 
surface of glass flasks (Bechet and Blondeau, 2003), while A. hydrophila was shown to form 
biofilms in vitro when cultured on a polystyrene surface (Elhariry, 2011). Aeromonas spp. 
were shown to form both single and mixed biofilms (with Flavobacterium spp. isolates) 
within 24 and 48 hours (Basson et al., 2008).  Since Aeromonas spp. are mostly associated 
with surface colonization and biofilm formation in water distribution systems, food 
processing and the gastrointestinal tract for clinical strains, attachment is one of the most 
important aspects of pathogenicity (Santos et al., 2010). 
Flagella are useful for movement of cells towards the surface area and sufficient flow 
rates of water and nutrient concentrations enhance attachment of cells to surfaces (Simoes et 
al., 2010). Flagella are involved in the first step of biofilm formation (Kirov et al., 2004). 
Thedetailed mechanism of the involvement of flagella in biofilm formation is not well 
understood, however, they are important in colonization which is followed by biofilm 
formation (Wilhems et al., 2009). Bacteria can either have polar or lateral flagella, however, 
Gavin et al. (2002) suggested that the number of bacteria having both is increasing. Polar 







for swarming activity (Gavin et al. 2002). While polar flagella are produced on all culture 
conditions, lateral flagella are produced on solid media. Aeromonas spp. were observed to 
possess both types of flagella which are involved in biofilm formation (Gavin et al., 2002). 
Canals et al. (2007) observed that polar flagella are more important than lateral flagella in 
Aeromonas biofilm formation. Their study suggested that Aeromonas spp. isolates that were 
polar flagella-positive but lateral flagella negative had 62% reduction in biofilm formation. 
However, an A.hydrophila lateral flagella mutant could not form a biofilm until lateral 
flagella genes were inserted. Santos et al. (2010) observed that A. caviae possess both polar 
and lateral flagella which are involved with biofilm formation. Aeromonads are suggested to 
have type IV pili which are associated with autoaggregation of these bacterial cells. In 
addition to its involvement in biofilm formation, QS in Aeromonas spp. like other different 
species have been shown  to mediate communication (Lynch et al., 2002).     
 
1.4. Quorum sensing 
Quorum sensing (QS) is a mechanism employed by cells of either the same or different 
species to communicate with each other via production of signalling molecules. The 
produced signal molecules induce expression of the target genes, which then allows the 
bacteria to achieve different important functions (Cataldi et al., 2007). There are different 
signalling molecules produced by different bacterial species. The produced signalling 
molecules include: acyl homoserine lactones (AHLs), auto-inducer 2 (AI-2), 4-quinolones, 3-
hydroxypalmitic acid methyl ester, cis-11-methyl-2-dodecanoic acid and butyrolactone 
(Tarighi and Taheri, 2011). AHLs are QSsignalling molecules that are produced by Gram-
negative bacteria and are responsible for mediating communication between these bacteria. 
Gram-negative and Gram-positive bacteria also share a universal auto-inducer called auto-
inducer 2 (AI-2), which is a type of signalling molecule that functions as a common language 
between interspecies bacteria (Kozlova et al., 2008).The 4-quinolones are involved with 
controlling expression of virulence factors, biofilm development, iron transport system and 
C4-AHL production. A molecule called 3-hydroxypalmitic acid methyl ester, which is 
produced by converting fatty acid to methyl ester by methyl transferase, has also been shown 
to mediate cell-density dependent signals between Gram-negative bacteria (Tarighi and 
Taheri, 2011).Diffusible signal factor molecules, cis-11-methyl-2-dodecanoic acid and 
butyrolactone have been shown be involved in a cell-dependent signalling mechanism 







The two types of signal molecules involved in QS which have been most thoroughly 
studied are AHLs and AI-2, and for the purpose of the current study the focus will be on 
AHLs. The production of both AHLs and AI-2 is dependent on bacterial cell density. As the 
cell density of the bacteria increases (Fig. 1.2), the amount of signalling molecules also 
increases (Pan and Ren, 2009).The major function of AHLs is suggested to be inducing 
biofilm formation in different bacterial species (Lynch et al., 2002; Cataldi et al., 2007; 
Kozlova et al., 2008). AHLs with different lengths within a biofilm were suggested to be 
responsible for bio-fouling (Ponnusamy et al., 2009). AHL production is also associated with 
bioluminescence, antibiotic production, swarming motility and production of virulence 
factors in other bacterial species(Ponnusamy et al., 2009).  
 
 
Figure 1.2: The mechanism of quorum sensing.When the cell density of the population is 
low, the amount of signal produced is low and vice versa. The signals produced induce the 




1.4.1. Strategies used to extract, identify and characterize AHLs 
Different strategies have been used to identify AHL production. These include the use of 
biosensors, thin layer chromatography (TLC) and/or high performance liquid 
chromatography (HPLC) (Wang et al., 2010). The biosensors that are commonly used are 







detects short and medium AHLs (C-6, C-6-3-oxo, C-8, C8-3-oxo, C-4) and the latter detects a 
broad range of AHLs (all 3-oxo, C-6, C-8, C-10, C-12, C-14, C-6-3-hydroxy, C-8-3-hydroxy 
and C-10-3-hydroxy) (Steindler and Venturi, 2007).      
Detection of AHLs by C. violaceum CV026 is indicated by the production of a purple 
violacein pigment, while in A. tumefaciens A136 identification is indicated by the presence of 
blue color which appears after this bacterium utilizes 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (Steindler and Venturi, 2007). The C. violaceum CV026 reporter strain 
was constructed by inserting a transposon in the cviI AHL synthase gene (responsible for 
production of AHL) and the putative violacein repressor locus, so that this strain can only 
produce violacein against exogenous AHL. The A. tumefaciens A136 strain was constructed 
by introducing a mutation in the traI gene (responsible for the production of AHL), and the 
construct contains two plasmids, viz, pCF218 inserted with traR expressed from tetR vector 
promoter and pCF372, which is transcriptionally linked to lacZ. As a result, the reporter can 
utilize X-gal and produce a detectable blue color (Steindler and Venturi, 2007).    
 Biosensor assays do not give information on the exact structure of AHLs. TLC is 
commonly used to determine the type of AHLs produced by a certain bacterial species. 
Control AHLs with known migration characteristics are used for comparison with the 
unknown (Shaw et al., 1997). TLC chromatograms can also be overlaid with agar-containing 
biosensors which makes it easy to locate the migrating AHLs (Steindler and Venturi, 2007). 
Using TLC, Yersinia enterocolitica was shown to produce 3-oxo-hexanoyl homoserine 
lactone and hexanoyl homoserine lactone (Medina-Martínez et al., 2006). However, TLC 
cannot give structural information of the AHLs and hence HPLC is used (Wang et al, 2010).  
HPLC can also be used to purify AHLs before analysis (Steindler and Venturi, 2007). 
 
1.4.2. Acyl homoserine lactones 
Gram-negative bacteria produce AHLs as their major signal molecules (Estrela et al., 2009). 
Signals are specific so that QS occurs between Gram-negative bacteria of the same species, 
due to differences in the lengths and side chains of AHLs produced by different species 
(Cataldi et al., 2007). The side chains of AHLs that are produced by different species have N-
acyl chains with carbons that range from 4-14, and this resultsin production of diverse AHLs 
(Fig. 1.3). The signal diversity also results from the C-3 position on the side chain of AHLs 
which can either be substituted by 3-oxo, 3 hydroxyl, fully methylene group or have 







differences in AHLs of different species enables bacteria of the same species to communicate 
without confusion in a community where different bacterial species are found. 
Therefore,bacteria of the same species will only produce signals that are recognized by the 




Figure 1.3: Different types of AHLs that are produced by different bacterial species. The 
AHL structures represented are produced by Pseudomonas aeruginosa, Aeromonas 
salmonicida, Burkholderia cepacia, Vibrio fischeri, Agrobacterium tumefaciens, Rhizobium 
leguminosarum and Rhodopseudomonas palustris, respectively (Pan and Ren, 2009). 
  
 
AHLs produced by Gram-negative bacteria involved in QS aresuggested to be 
homologues of LuxI and LuxR of Vibrio fischeri (Taga and Bassler, 2003). LuxI-type 
proteins are involved in catalyzing the production of AHL. The produced AHLs diffuse out 
of the cells and accumulate around the biofilm until a sufficient number of cells is reached. 
Stimulated by the high densities of cell populations, concentrated AHLs diffuse into the cells 
where they bind to the LuxR-type proteins. Thereafter, the complex binds to lux boxes where 
they induce expression of specific genes (Fig. 1.4) (Steindler and Venturi, 2007). The AHLs 
bind to LuxR at the N-terminus of the transcriptional activator, and its C-terminus binds to 





















Figure 1.4: The LuxR and LuxI system mechanism. R proteins which are AHL cognate 
proteins are produced by luxR and luxI produces AHL synthetase, which catalyze the 
production of AHLs. AHLs then bind to their cognate genes via the N-terminus and induce 




LuxI-type proteins and the LuxR-type proteins are very specific in their activation 
(Taga and Bassler, 2003) and this specificity is important in preventing gene expression of 
other species (Taga and Bassler, 2003). The LuxI-type protein is specific when binding to its 
substrate, which is the acyl-acyl carrier protein on the homocysteine moiety of S-
adenosylmethionine and LuxR-type only binds to the AHL molecule that it recognizes as its 
cognate molecule. 
 
1.4.3. Auto-inducer 2 
AI-2is the signalling molecule responsible for cell-to-cell communication in both Gram-
negative and Gram-positive bacteria (Kozlova et al., 2008). The major function of these auto-
inducers was first described in Vibrio harveyi, where it is responsible for the production of 
light. In other bacterial species such as E. coli, V. cholerae, Clostridium perfringens, and 







virulence factors (Taga and Bassler, 2003).The structure of AI-2 is similar to the structure of 
the furanosyl-borate di-ester moleculeand this molecule, like AHLs,isderived fromS-
adenosyl-methionine.The LuxS protein convertsS-adenosyl-methionine to dihydroxy-2, 3-
pentanedione, which then undergoes cyclization to produce 2,4-dihydroxy-2-methylhydro-3-
furanone, which forms a diesterboric acid to form AI-2. Boyen et al. (2009) demonstrated 
that in V.harveyi, AI-2 binds to the LuxP protein after which the complex binds to LuxQ 
which possess both the sensor kinase domains and a response regulator domain. They 
suggested that in low concentration the repressor protein blocking the transcription of 
luciferase is activated after LuxQ phosphorylates LuxO, and this reaction is aided by LuxU 
(intermediary protein) (Fig. 1.5).  
 
 
Figure 1.5: AI-2 mediated signalling in V. harveyi. Transcription of target genes is achieved 
in high density and vice versa (Boyen et al., 2009). 
 
 
At high concentration LuxO is inactivated after AI-2 induces the phosphatase activity 
of LuxQ. The reaction then induces transcription of the luciferase operon in return (Fig. 1.5). 
The major function of AI-2 is mediating inter-species communication, and this is because 
bacterial species that cannot produce this molecule can, however, respond to its signal (Ryan 
and Dow, 2008). Ryan and Dow (2008) have suggested that P. aeruginosa does not produce 
AI-2 but it can detect it and express virulence genes. A luxS Caenorhabditis elegans mutant 
was observed to have attenuated virulence, while a luxS mutant Vibrio vulnificus showed a 
delayed time required for it to kill mice when compared to the wild type (Kozlova et al., 







different species, AI-2 is also associated with the activated methyl cycle (Tarighi and Taheri, 
2011).   
 
1.4.4. Quorum sensing in Aeromonas spp. isolates   
In Aeromonas spp. the genes responsible for QS are ahyRI and asaRI (Swift et al., 1997). The 
AhyRI and AsaRI QS system of Aeromonas spp. functions in a similar manner to the LuxI 
and LuxR systems. The gene that is responsible for production of AI-2 in A. hydrophila and 
Vibrio spp. is luxS. In the latter species, the receptors of the LuxS protein are recognized as 
LuxP and in the former species the receptors have not being identified (Kozlova et al., 2008). 
AHLs are suggested to be the major molecules responsible for signalling by Aeromonas spp. 
(Khajanchi et al., 2010). Swift et al. (1997) observed that A. hydrophila and A. salmonicida 
produce diffusible AHLs in which N-butyryl homoserine lactone (C-4 AHL) was the main 
signalling molecule. A. hydrophila isolates produce N-octanoylhomoserine lactone (C-8 
AHL), N-dodecanoylhomoserine lactone (C-12 AHL) and N-tetradecanoylhomoserine 
lactone (C-14 AHL), while A. salmonicida producesC-8 AHL, dodecanoylhomoserine 
lactone (C-12 AHL), N-tetradecanoylhomoserine lactone (C-14 AHL) and N-
decanoylhomoserine lactone (C-10 AHL) (Cataldi et al., 2007). Aeromonas spp. isolates 
obtained from patients with malaria were shown to produce C-4 AHL and N-
hexanoylhomoserine lactone C-6 AHL as the two major types of AHLs. A. hydrophila 
isolates were shown to produce both C-4 AHL and C-6 AHL, while A. sobria isolates only 
produced C-4AHL (Chan et al., 2011). A. hydrophila was shown to produce C-4 AHL, as the 
major AHL and A. caviae was shown to produce 3-oxo-C-6AHL (Medina-Martínez et al., 
2006). Aeromonas spp. isolates isolated from municipal activated sludge also produced C-4 
AHL and C-6 AHL (Morgan-Sagastume et al., 2005).     
 Aeromonas QS has been implicated in the production of virulence factors. C-4 AHL 
produced during QS by A. hydrophila was shown to be responsible for the production of 
extracellular protease (Kirke et al., 2004). Chan et al. (2011) also suggested that QS in 
Aeromonas spp. is associated with the production of virulence factors. The production of 
virulence factors such as hemolysins, cytotonic and cytotoxic enterotoxins, proteases, lipases, 
leucocidins, endotoxin, adhesions, and an S layer in Aeromonas spp. is associated with high 
cell density, showing that it is QS-mediated (Khajanchi et al., 2010). In addition to 
production of virulence factors, QS is involved in the development of a biofilm (Lynch et al., 







not form a mature biofilm when compared to the parent strain. Ponnusamy et al. (2010) 
observed that the production of auto-inducers is responsible for the formation of the three-
dimensional structure of a biofilm. Lynch et al. (2002) observed that C-4AHL or C-6AHL 
produced by a mutant strain of A. hydrophila was important in biofilm formation and for its 
development when compared with its wild type that is incapable of producing AHLs. In a 
study conducted by Khajanchi et al. (2009), similar results were obtained. Labbate et al. 
(2004) suggested that AHL production by aeromonads is important in the formation of 
microcolonies. AI-2 is also suggested to be responsible for production of virulence factors and 
biofilm formation in A. hydrophila (Khajanchi et al., 2010). AI-2 was shown to be 
responsible for the formation of well-defined biofilm structures of A. hydrophila, when 
compared with an AI-2 mutant strain that formed an altered biofilm (Kozlova et al., 2008).  
 
1.4.5. Association of auto-inducers with biofilm formation 
Auto-inducers that are produced by bacteria induce expression of target genes only when 
high cell density is reached and these molecules often have an effect on biofilm formation 
(Khajanchi et al., 2010). The mechanism by which AHL contributes to biofilm formation is 
not clear, however, interfering with their signals during QS results in reduction in biofilm 
formation (Morohoshi et al., 2008). This shows that AHLs are indeed associated with biofilm 
formation. Addition of exogenous AHLs to a bacterial species which is incapable of 
producing AHLs often also results in biofilm formation (McClean et al., 1997). AHLs are 
produced by diverse Gram-negative bacteria such as Serratia marcescens (Rice and Koh, 
2005), P. aeruginosa (Davies et al., 1998), Hafnia alvei (Viana et al., 2009) and Vibrio 
anguillarum (Morohoshiet al., 2008), which have been shown to form biofilm mediated by 
AHLs during QS.Nadell et al.(2008) suggested that even though QS is responsible for 
biofilm development, it is also responsible for the production of exopolymeric substance 
(EPS). QS controls when the polymers that makes up the EPS should be produced and when 
they should be repressed. This then influences biofilm formation when the cells are deprived 
of nutrients (Nadell et al., 2008). The EPS protects cells within the biofilm and also is 
responsible for attachment of cells to the substrate which initiates biofilm formation (Behlau 
and Gilmore, 2008). AHLs in biofilm formation of Gram-negative bacteria have been 
suggested to affect heterogeneity, architecture, stress resistance, maintenance and sloughing 
(Viana et al., 2009). While the influence of AHLs on biofilm formation is still a mystery, 







1.5. Biofilm resistance 
Biofilms cause problems in the paper, food, cosmetic and pharmaceutical industries (de 
Carvalho, 2007) as well as being linked to health-care associated infections (del Pozo and 
Patel, 2007). Biofilmcells are difficult to kill because of their increased resistance to 
antimicrobial agents(del Pozo and Patel, 2007). Biofilm formation by bacteria is suggested to 
be a major strategy to achieve pathogenicity and to develop resistance to antimicrobial agents 
(Landini et al., 2010). Biofilms are 10-1000 times more resistant to antimicrobial agents 
when compared to their planktonic counterparts (Mah and O’Toole, 2001). Biofilms adapt 
easily to environmental stress due to their existence as a population (Declerk et al., 2009). 
Severalmechanisms have been proposed (Fig. 1.6) that may contribute to biofilmcells being 
resistant to a wide range of antimicrobials (del Pozo and Patel, 2007). The antimicrobial 
agents may be prevented from entering beyond the surface layer of the biofilm, and these 
may be due to changes in the environment within the biofilm; growth inside the biofilm 
maychange in favor of the biofilm rendering the antimicrobial agents inactive; enzymes 
within the matrix of the biofilm may destroy the incoming antimicrobial agentsand biofilms 
also expressspecific genes associated withefflux pumps (del Pozo and Patel, 2007). Gene 
transfer also plays an important role in providing resistance, since a planktonic cell that is 
resistant to a specific antimicrobial agent may transfer resistance to other cells within a 
biofilm.QS is now also considered one of the major mechanisms associated with biofilm 
resistance to different antimicrobial agents (Molin and Tolker-Nielsen, 2003). 
 
 
Figure 1.6: Different aspects associated with biofilm resistance. The EPS is represented by 
yellow and the bacterial cells by blue circles. Quorum sensing, nutrient and oxygen 
concentration, induction of general stress response, change in profiles of outer membrane 








 Efflux pump activation is one of the major mechanisms employed by bacteria to 
confer resistance to different antimicrobial agents (Poole, 2001). Efflux pumps are proteins 
that are utilized by bacteria to pump out antimicrobial agents, and may either occur as a 
single or multi-component system (Kvist et al., 2008). A typical bacterial cell may have five 
or more of the different classes of efflux pumps(Fig. 1.7), i.e., the major facilitator (MF) 
super-family, the ATP-binding cassette (ABC) family, the resistance-nodulation-division 
(RND) family, the small multidrug resistance (SMR) family and the multidrug and toxic 
compound extrusion (MATE) family (Poole,2001). The RND class is suggested to be unique 
for Gram-negative bacteria. Pumping out of the drugs from the bacterial cell by the efflux 














Figure 1.7: Five different efflux pump classes of Gram-negative bacteria:the efflux pump 
multidrug and toxic compound extrusion (MATE) family, the major facilitator (MF) super-
family, the small multidrug resistance (SMR) family, resistance-nodulation-division (RND) 
family and the ATP-binding cassette (ABC) family (Piddock, 2006). 
 
 
QSin a biofilm is also important in resistance because signal molecules cause 
transcription of genes that allows the cells to survive longer in the presence of antimicrobial 
agents. Butler et al. (2010) observed that the high cell density alone of cells within a biofilm 
is enough to confer resistance at high concentrations of antimicrobial agents. This might be 







development of resistance. Also when the cell density is high, cells communicate viaQS 
confering resistance to the neighbor cell.  
Extracellular DNA (eDNA) is one of the major components of the EPS and this 
matrix inhibits the ability of antimicrobial agents to penetrate within the biofilm. eDNA is 
suggested to be involved in biofilm formation (Allesen-Holm et al., 2006), and it is more 
effective when it is intact with the EPS than when it is freely released by planktonic cells 
(Böckelmannet al., 2006). Even though biofilms are resistant to a wide variety of 
antimicrobial agents, many control strategies are being developed. 
 
1.6. Biofilm control strategies 
A number of strategies are being pursued in order to eradicate or prevent biofilm formation 
by diverse microorganisms. Use of enzymes, phages, antimicrobial molecules from microbial 
origin (Simoes et al., 2010), persister cell-destroying substances, phosphorylation inhibitors 
(benzalkonium chloride, chlorhexidine), electrical current, radio-frequency,electromagnetic 
fields, ultrasound in combination with antimicrobial agents (del Pozo and Patel, 2007), 
hydrophilic coatings and a combination of drugs (Francolini and Donelli, 2010) are the 
commonly used strategies to control biofilms. These agents can be used singly or in 
combination to inhibit biofilm formation depending on the biofilm under investigation. 
 
1.6.1. Use of antimicrobial agents 
The use of antimicrobial agents to treat bacterial pathogens has been the most commonly 
used method of controlling infections, including biofilm-associated ones. However, the major 
development of resistance to antimicrobial agents by bacteria is limiting their application in 
clinical, agricultural andindustrial fields (Francolini and Donelli, 2010). Biofilms are more 
resistant to antimicrobial agent than planktonic cells due to the presence of different 
resistance  mechanisms within a biofilm (Høibyet al., 2010).   
 Antimicrobial agentscan sometimes be effective when used alone, but they are more 
effective when used in combination as they provide a synergistic effect (Francolini and 
Donelli, 2010). Rifampicin killed strains of Staphylococcus aureus in a biofilm when used in 
combination with linezolid (Raad et al., 2007), while tobramycin and silver inhibited the 
growth of micro-organisms (Kim et al., 2009). Curtin and Cormican (2003) suggested that 
the resistance of bacteria to antimicrobial agents does not always mean that the agent has 







lowest effective concentration, i.e, minimum inhibitory concentrations (MIC), is then 
required. MICs are the lowest concentrations of antimicrobial agents that will inhibit the 
bacterial growth after overnight incubation (Andrews, 2001). Minimum bactericidal 
concentrations (MBCs) are used to determine the ability of antibiotics to inhibit the growth of 
bacteria within a specific time (Pankey and Sabath, 2004). MBCs are defined as the lowest 
concentration that inhibit growth of the bacteria in the initial inoculumof the subculture. 
When using antimicrobial agents, MIC and MBC valuesare used to determine the required 
concentration to control microbial growth. Tobramycin, ticarcillin-clavulanate, and 
ceftazidime at their MICs, were shown to be effective in inhibiting biofilm formed by 
P.aeruginosa (Francolini and Donelli, 2010). Clindamycin, daptomycin, linezolid, tigecycline 
and vancomycin were shown to be more effective against S. aureus biofilm than against 
planktonic cells (Perez-Giraldo et al., 2003).       
 In addition to the use of both MIC and MBC, the use of half the amount of the MIC is 
suggested to be effective. The effective concentration of antimicrobial agents should be 
above the MIC as suggested by Pompilio et al. (2010). However they further suggested that 
after a certain period of applying these antimicrobial agents, the concentration within a cell 
becomes lower than the MIC and is called sub-MIC. Sub-MICs do not kill the micro-
organisms, however, they change the chemical and physical cell-surface characteristics which 
affects the functionality and expression of some virulence factors, adhesion, biofilm 
formation, hydrophobicity and motility (Pompilioet al., 2010). Sub-MIC levels of 
roxithromycin and sansanmycin were observed to inhibit the generation of P. aeruginosa 
biofilms and proliferation of bacteria (Liet al., 2009). Moxifloxacin at its sub-MIC caused 
reduction in biofilm formation of Stenotrophomonas maltophilia (Pompilio et al., 2010). The 
sub-MIC of gentamicin was shown to be effective in inhibiting the growth of Salmonella 
typhimurium, when compared to ciprofloxacin and cefotaxime (Landini et al., 2010). Even 
though the sub-MICs are aimed at inhibiting biofilm formation, these concentrations have 
also been shown to enhance biofilm formation. Haddadin et al. (2009) observed that sub-
MICs of ciprofloxacin and roxithromycin inhibited S. aureus biofilm formation, while sub-
MICs of cefalexin increased biofilm formation. They suggested that since cefalexin is a cell 
wall synthesis inhibitor, its sub-MIC could have affected the cell surface of the bacteria 
which increased hydrophobicity leading to increased adherence.While the sub-MIC of 
vancomycin was observed to increase cell density of S. epidermidis, the MIC of this 







that this might be due to the thick staphylococcal walls in response to antimicrobial agents or 
it maybe because low concentrations might have affected expression of genes involved in 
biofilm formation. 
 
1.6.2. Use of efflux pump inhibitors 
Efflux pump inhibitors (EPIs) are substances that block the activity of the efflux pumps 
(Kvist et al., 2008). Efflux pump inhibitorsblock and deactivate the efflux pumps and when 
used in combination with antimicrobial agents they increase their activity since they will 
prevent antimicrobial agents from being pumped out (Kvist et al., 2008).In order for the EPIs 
to be effective, several factors should be taken into consideration such as: whether the 
resistance mediated by efflux pump is dominant, EPIs occur in multiples, and also that efflux 
might work together with other mechanisms responsible for resistance in the 
bacteria.Effective EPIs are the ones that will make the resistant bacteria susceptible, make the 
bacteria that acquired resistance from other bacteria susceptible and inhibit the strain that is 
transferring resistance to other strains (Lomovskaya and Watkins, 2001). EPIs can be used to 
restore the activity of the antimicrobial agents and to block biofilm formation (Kvist et al., 
2008).           
 There are different types of EPIs that can be used to inhibit biofilm formation (Kvist 
et al., 2008), however,the current study only focused on phenylalanine arginine β-
naphthylamide (PAβN), 1-(1-naphthylmethyl)-piperazine (NMP) and carbonyl cyanide 3-
chlorophenylhydrazone (CCCP). PAβN and NMP target the resistance-nodulation-cell 
division (RND) super-family, and CCCP targets the proton motive force. PAβN and NMP 
affect biofilms directly by binding directly to the target sites, while CCCP affects the energy 
level of the bacterial membrane.  Three efflux pump inhibitors, viz: thioridazine, 1-(1-
naphthylmethyl) piperazine (NMP) and phenyl-arginine-β-naphthylamide (PAβN) were used 
by Kvist et al. (2008) and inhibition of E. coli and Klebsiella spp. biofilms 
wereobtained.They also obtained inhibition of species not belonging to 
Enterobacteriaceaesuch as S. aureus and P. putida.PAβN and NMP are competitive 
inhibitors, which target the RND efflux pumps of Gram-negative bacteria (Kvist et al., 2008). 
PAβN and NMP were shown toinhibit the biofilm formed by V.cholerae (Kvist et al., 2008). 









1.6.3. Quorum sensing inhibitors 
QS induces expression of  virulence factors, pathogenesis (Hentzer et al., 2003) and biofilm 
formation (Asahi et al., 2010) in Gram-negative bacteria. It is thus likely that disruption of 
this process will inhibit production of virulence factors and biofilm development (Asahi et 
al., 2010). One strategy involves enzymes that degrade QS molecules by a process termed 
quorum quenching (Tarighi and Taheri, 2011).These enzymes include AHL-lactonases 
produced by Bacillus,Variovorax paradoxus, Pseudomonas spp., Comamonas 
spp.,Rhodococcus spp., and AHL-acyclase produced by Ralstonia spp. The other strategy 
includes the use of synthetic compounds and natural products from plants fungi, plants and 
algae (Kociolek, 2009). Quorum sensing inhibitors (QSIs) are compounds that inhibit cell-to-
cell communication within the bacteria population. These compounds can be used to control 
bacterial species that are infectious without affecting their growth (Hentzer et al., 2003). The 
QSI molecule that is considered the best candidate must have a low molecular mass and 
prevent expression of the genes that are controlled by QS. The compounds must be very 
specific for the QS regulator and should not have toxic effects to the bacteria and also the 
eukaryotic host (Rasmussen and Givskov, 2006). 
The three important target sites for QS inhibition are the signal generator (LuxI 
homologue), the signal molecule (AHL) and the receptor of the signal (Rasmussen and 
Givskov, 2006). Different compounds have different mechanisms and different efficaciesin 
inhibiting biofilm formation (Tarighi and Taheri, 2011). Phytochemicals are now recognized 
as one of the best QSI candidates (Hentzer et al., 2003). Rio red and Marsh white which are 
two types of compounds found in grapes were observed to inhibit AI-1 and AI-2 receptor 
systems in V.harveyi (Kociolek, 2009). Cinnamaldehyde inhibited the bioluminescence of V. 
harveyi by blocking AI-1 and also it inhibited AI-2 (Niu and Gilbert, 2004). Cinnamaldehyde 
was shown to inhibit the growth of different Pseudomonasspecies and E. coli (Niu and 
Gilbert, 2004). The mechanism of inhibition by cinnamaldehyde is not fully understood, 
however Niu and Gilbert (2004) hypothesized that to inhibit the growth of E. coli, 
cinnamaldehyde might have prevented these bacteria from reaching their substratum. 
Different concentrations of trans-cinnamaldehyde were used in the study by Amalaradjou et 
al. (2010), who obtained inhibition of uro-pathogenic E.coli with all concentrations when 
compared to the untreated isolates. Kociolek (2009) stated that cinnamaldehyde affects the 
mass of the biofilm and not the number of viable cells, and thus this inhibitor inhibits biofilm 







 Vanillin, which is a compound from vanilla beans and is used mostly in food 
industries as a flavoring agent, was shown to inhibit both short and long chain AHLs in A. 
hydrophila (Ponnusamy et al., 2009). Vanillin is suspected to interact with AHL receptors 
and interfere with binding of AHLs to their cognate receptors (Ponnusamy et al., 2009).
 Synthetic compounds mimic the QS signalling, however, unlike AI-1 and AI-2 these 
compounds block the signals rather than promoting it (Hentzer et al., 2003). Asahi et al. 
(2010) demonstrated that ten out of 17 AHL analogues that were made by replacing the AHL 
moiety with different amines and alcohols inhibited biofilm formation of Porphyromonas 
gingivalis. The analogs of S-adenosyl methionine are S-adenosylhomocysteine, S-
adenosylcysteine, and sinefungin, and these analogs inhibit synthesis of AHL, thus disrupting 
QS at its early stages (Hentzer and Givskov, 2003). Hentzer and Givskov(2003) observed that 
the use of S-adenosylmethionine analogs, which are compounds that act as amino group 
donors during formation of the homoserine lactone ring, were found to have inhibitory 
activity against P. aeruginosa. S-adenosylhomocysteine, sinefungin and butyryl-S-adenosyl 
methionine are suggested to have the ability to inhibit the production of AHLs in vitro but not 
in vivo. 
Halogenated furanones and usnic acid are the most commonly used inhibitors of 
Gram-negative bacteria (Francolini and Donelli, 2010). Hentzer et al. (2003) observed that 
halogenated furanones inhibited QS in P. aeruginosa, production of virulence factors and 
biofilm formation without interfering with its growth. Halogenated furanones act as 
competitive inhibitors by binding to regulatory protein and preventing AHLs from binding to 
the regulatory protein and thus disrupting QS (Landini et al., 2010). 4-hydroxy-2,5-dimethyl-
3(2H) furanonewas shown to inhibit the growth of A. hydrophila (Ponnusamy et al, 2010) 
and Hafnia alveiwhich is an opportunistic pathogen associated with noscomial infections and 
typically isolated from fish and meat (Viana et al., 2009). Raina et al. (2009) observed that 
(5Z)-4-bromo-5-bromomethylene-3-butylfuran-2(5H)-one inhibited swarming motility and 
biofilm formation in E. coli by interfering with AI-2. 
 
1.6.4. Use of matrix-degrading enzymes 
EPS of a biofilm is composed of proteins, polysaccharides, lipids and eDNA and these can be 
used as targets of degrading enzymes. When a biofilm forms, the cells first attach to the 
surface by weak interactions, followed by strong interactions which are followed by 







of the antimicrobial agents intothe biofilm (del Pozo and Patel, 2007). The need for enzymes 
that degrade the matrix and makes the cells within the biofilm accessible is necessary.
 Enzymes such as dispersin B (del Pozo and Patel, 2007; Francolini and Donelli, 2010; 
Simoes et al., 2010) and some other proteases and polysaccharides-hydrolyzing enzymes 
(Simoes et al., 2010) are used in controlling biofilms due to their ability to digest the 
extracellular matrix.Chaignon et al.(2007) observed that dispersin B degraded poly-N-
acetylglucosamine and reduced the biomass of S.epidermidis. Proteinase K and trypsin were 
also shown to reduce the biomass of S. epidermidis by degrading the peptide bonds.When 
serine protease, α-amylase and polysaccharidase were used to treat 16 different food bacterial 
species, serine protease was shown to be the mosteffective in removing biofilm formed by 
those species, followed by α-amylase (Lequette et al., 2010).  
 The presence of eDNA has been suggested to be responsible for biofilm formation in 
other bacterial species, however, for Aeromonasinformation is still limited. Evidence of the 
presence of eDNA was provided by Tetz and Tetz (2010) who observed a 30 kb eDNA in S. 
aureus and Böckelmann et al. (2006) who observed a 29 kb eDNA in an unspecified F8 
isolate (suspected to be Gammaproteobacterium or Rheinheimera baltica). eDNA 
interconnects the matrix component of cells within a biofilm (Allesen-Holmet al., 2006). The 
exact mechanism by which eDNA influences biofilm formation is not well understood. 
However, Tetz and Tetz (2010) observed that the shape of the biofilms treated with DNase I 
was different from the untreated biofilm. They also observed that biofilm cells that received 
DNase I treatment had formed a mesh-like structure containing increased area of cell free 
zones. Biofilms of P. aeruginosa were observed to be affected after the addition of DNase I 
(Allesen-Holm et al., 2006). Cleavage of extracellular DNA by DNase I through its 
exonuclease activity is the mechanism employed to reduce the biomass of a biofilm (Tetz et 
al., 2009). 
 
1.7. Rationale for the study 
It is estimated that approximately 99% of bacteria form biofilms to survive (de Carvalho, 
2007). Aeromonas spp. isolates are one of the major biofilm forming species in aquatic 
environments and are often associated with fish diseases and human (food and water-borne) 
infections. These bacteria have been identified in medical and industrial biofilms, resulting in 
their association with a wide variety of medical and industrial problems. Biofilm formation is 







antimicrobial therapy, protects against host defence mechanisms and also facilitates bacterial 
communication QS leading to the expression of virulence determinants. Understanding the 
effect of different biofilm inhibitors such as antimicrobial agents, lytic enzymes, 
phytochemicals and EPIs on biofilm formation by Aeromonas spp. isolates is critical as it 
could facilitate removal of these biofilms either clinically or in an aquaculture environment. 
These would then be solutions to limit infections caused by aeromonad biofilms in man or in 
fish.            
It is hypothesized that biofilm formation by Aeromonas spp. may be limited or 
completely eradicated with the use of antimicrobial agents, lytic enzymes, EPIsor QSIs. It is 
further hypothesized that Aeromonas spp. isolates from different sources communicate with 
each other by producing AHL signalling molecules, which may display diversity from other 
known  Aeromonas spp. 
 
1.8. Objectives 
The following objectives have been established: 
1.8.1. To investigate strategies to inhibit Aeromonas spp. biofilm formation 
  and QS; and 
1.8.2. To identify the ability of Aeromonas spp.isolates to communicate by 
  producing signalling molecules. 
 
1.9.Aims 
The following aims will be pursued:  
1.9.1. To determine the MIC of azithromycin, ciprofloxacin, 
 ceftazidime, gentamicin, and tetracyclineagainst Aeromonasspp; 
1.9.2. To identify the prevalence and diversity of efflux pumps in Aeromonas 
spp.isolates using the disk diffusion assay on Mueller-Hinton (MH) 
agar containing EPIs;  
1.9.3. To investigate the effect of EPIs [carbonyl cyanide 3-
chlorophenylhydrazone, phenylalanine arginine β-naphthylamide or 1-
(1-naphthylmethyl)-piperazine]on initial attachment and detachment 
using  microtiter plate assays; 
1.9.4.To determine the inhibition of adhesion or detachment from pre-formed 







1.9.4.1. Antimicrobial agents (tetracycline, azithromycin, ciprofloxacin, 
ceftazidime, gentamicin); 
1.9.4.2. Lytic enzymes (DNase I); 
1.9.4.3. QS inhibitors [4-hydroxy-2,5-dimethyl-3(2H) furanone and S-
  adenosylhomocysteine], and 
1.9.4.4. Phytochemicals (vanillin and cinnamaldehyde); 
1.9.5. To identify the expression of QS signalling molecules by Aeromonas 
 spp. isolates using biosensors:  
 1.9.5.1. C.violaceum CV026; and 
 1.9.5.2. A.tumefaciens A136. 
 
1.10. Questions to be answered 
A number of specific questions are relevant to this topic: 
1.10.1. Does exposure to varying concentrations of antimicrobial agents significantly 
  reduce  biofilm formation? 
1.10.2. Which antimicrobial agents are effective against aeromonad biofilms? 
1.10.3. Do Aeromonas spp. isolates demonstrate the efflux phenotype? 
1.10.4. Do antimicrobial agents, lytic enzymes, EPIs and QSIs inhibit or increase  
  bacterial adhesion and/or detachment from biofilms?  
1.10.5. What effect do the phytochemicals have on Aeromonas spp. biofilm formation 




















Characterization of biofilm-associated Aeromonas spp. resistance to antimicrobial 
agents and the effect of sub-MIC, MIC and supra-MIC antimicrobial agent exposures 
 
2.1. Introduction 
Biofilms are more resistant to antimicrobial agents compared to planktonic due to the 
activation of diverse resistance mechanisms that comes with cell density. They contain EPS, 
which inhibits penetration of antimicrobial agents within the biofilm. Resistance can also 
occur due to lack of oxygen and nutrients as well as accumulation of waste (Dhar and 
McKinney, 2007). Another major contributing mechanism is the presence of persister cells, 
which are a sub-population of cells that can withstand high doses of antimicrobial agents. 
Persister cells are responsible for the persistence of biofilms in the presence of certain types 
of antimicrobial agents (Gefen and Balaban, 2009). Keren et al. (2004) observed that P. 
aeruginosa which was tested for the formation of persister cells was not inhibited by 
ofloxacin throughout its growth phase. When the same test was perfomed with S. aureus it 
was observed that this species was not inhibited with ciprofloxacin and penicillin (Keren et 
al., 2004). Eventhough bacteria are resistant to antimicrobial agents, they remain the better 
candidates to treat infections due to ease of production and their affordability.   
 In order to determine the correct concentration of antimicrobial agents to use when 
treating infections, the MIC is used (Gould and MacKenzie, 2002). MIC helps to determine if 
the concentration of the antimicrobial agents should be reduced, increased or if it should 
remained unchanged. The correct MIC to use can vary between the types of drugs used or 
between bacterial species. The concentration below the MIC or the concentrations incapable 
of causing death but affecting the functionality of the cell are called sub-MICs and when 
these concentrations are doubled they are called supra-MIC. The sub-MIC is generally less 
effective when compared to the MIC and the supra-MIC.Supra-MIC is likely tobe more 
effective than sub-MIC and MICexposures. Sub-MIC affects different factors of bacteria such 
as morphology, virulence, ability to produce genetic variation (Couce and Blazquez, 2009), 
alteration of cell surface, inhibition of enzyme and toxin production and lastlysuppression of 
bacterial adhesion to host cells (Wojnicz and Jankowski, 2007). Høiby et al. (2010) suggested 
that sub-MICexposure of β-lactam induces biofilm formation of P. aeruginosa without 
affecting its growth. Landini et al. (2010) observed that MIC exposure of gentamicin was 







observed that the biofilm of Actinobacillus actinomycetemcomitans was resistant to 
ofloxacin, tetracycline minocycline, ampicillin, erythromycin and cefalexin at their MICs. 
The same drugs were more effective against the biofilm of A. actinomycetemcomitans at 
higher concentration than their MICs (Takahashi et al., 2007). This,therefore,suggests that the 
use of Minimum biofilm inhibitory concentrations (MBICs) is required, which usually is 
investigated for cells within the biofilm that are protected by EPS which provide resistance 
together with other resistance mechanisms (Reiter et al., 2013). This might explain why 
MBICs are usually higher than MICs which are determined against planktonic cells (Garcia-
Castillo et al., 2007).The following study aimed to compare the MICs of planktonic cells and 
MBICs of Aeromonas spp. biofilms.The study further determined the effect of of sub-MIC, 
MIC and supra-MIC exposures of five antimicrobial agents on initial attachment and biofilm 
detachment. 
 
2.2. Material and Methods 
2.2.1. Maintenance of bacterial cultures 
Forty-eight Aeromonas spp. isolates and six Plesiomonas shigelloidesisolates (Table 2.1) 
from catfish, koi-carp, tilapia and sea water were selected for study (Duma, 2012). The 
current study also included type strains (A. caviae ATCC 15468
T
 and A. hydrophila ATCC 
7966
T
). Isolates were maintained on tryptic soy agar (TSA) plates at 4 ºC and for long-term 
storage in TSB containing 20% glycerol at -70 ºC (Jacobs and Chenia, 2007).  
 
Table 2.1: List of study isolates, their respective species designation and source of 
isolation 
Isolate code Species name Source of isolates 
M2 A. hydrophila Catfish 
M5 A. hydrophila Catfish 
M6 A. hydrophila Catfish 
M13 A. hydrophila Catfish 
M14 A. hydrophila Tilapia 
M17 A. hydrophila Tilapia 
M50 A. hydrophila Catfish 
M51 A. hydrophila Catfish 
M52 A. hydrophila Tilapia 
M53 A. hydrophila Catfish 
M60 A. hydrophila Tilapia 
M62 A. hydrophila Tilapia 







M65 A. hydrophila Tilapia 
M86 A. hydrophila Koi-carp 
M94 A. hydrophila Koi-carp 
M95 A. hydrophila Koi-carp 
M22 A. culicicola Sea water 
M23 A. culicicola Sea water 
M25 A. culicicola Sea water 
M31 A. culicicola Sea water 
M32 A. culicicola Sea water 
M38 A. culicicola Sea water 
M39 A. culicicola Sea water 
M58 A. culicicola Tilapia 
M70 A. bestiarum Koi-carp 
M72 A. bestiarum Koi-carp 
M80 A. bestiarum Koi-carp 
M81 A. bestiarum Koi-carp 
M88 A. bestiarum Koi-carp 
M90 A. bestiarum Koi-carp 
M96 A. bestiarum Koi-carp 
M99 A. bestiarum Koi-carp 
M26 Aeromonas spp. 45 Sea water 
M34 Aeromonas spp. 45 Sea water 
M41 Aeromonas spp. Sea water 
M55 A. veronii Tilapia 
M57 A. veronii Tilapia 
M63 A. veronii Tilapia 
M18 A. caviae Tilapia 
M59 A. caviae Tilapia 
M68 A. caviae Koi-carp 
M76 A. salmonicida Koi-carp 
M77 A. salmonicida Koi-carp 
M8 A. allosaccharophila Tilapia 
M92 A. allosaccharophila Koi-carp 
M28 A. jandaei Sea water 
M49 A. sobria Tilapia 
M9 Plesiomonas shigelloides Catfish 
M45 Plesiomonas shigelloides Tilapia 
M46 Plesiomonas shigelloides Tilapia 
M47 Plesiomonas shigelloides Tilapia 
M66 Plesiomonas shigelloides Tilapia 
M67 Plesiomonas shigelloides Tilapia 
ATCC 15468
T
 A. caviae Type strain 
ATCC 7966
T









2.2.2. Determination of minimum inhibitory concentrations (MICs) using
  broth microdilution assays   
Twenty-eight Aeromonas spp. isolates (Table 2.1) as well as the type strains were selected 
based on their biochemical and physiological characteristics for the determination of MICs of 
planktonic cells for five antimicrobial agents. Five antimicrobial agents [azithromycin 
(AZM), ceftazidime (CAZ), ciprofloxacin (CIP), gentamicin (GN), and tetracycline (TET)] 
were tested against the isolates using thirteen concentrations: 0.008, 0.016, 0.064, 0.125, 0.5, 
1, 2, 4, 16, 32, 64, 128 and 256 μg/ml. MICs of the various planktonic cultures for each of the 
selected antimicrobial agents were determined using the broth microdilution assay (Andrews, 
2001). Two-fold serial dilutions of antimicrobial agents were prepared in Mueller-Hinton (M-
H) broth. Cultures were grown overnight in TSB, washed three times with sterile distilled 
water and diluted until they were equivalent to a 0.5 MacFarland standard (Andrews, 2001). 
Microtiter plate wells, each containing 100 μl of M-H broth medium with the required 
antimicrobial agent concentration, were inoculated with 10 μl of cell suspension and 
incubated at 30 ºC for 24 h without shaking. The negative control wells contained M-H broth 
only and the positive control wells contained the respective cell suspensions with no 
antimicrobial agents added. This was done in triplicate, on two separate occasions (Andrews, 
2001). TheMIC was the lowest concentration of antimicrobial agent, which inhibited visible 
growth of organism.  
 
2.2.3. Determination ofMBICs of biofilm cells 
Twenty-eight Aeromonas spp. isolates as well as the type strains were also used for the 
determination of MBICs of biofilm-forming isolatesfor five antimicrobial agents. Cultures 
were grown overnight in TSB, washed three times with sterile distilled water and diluted until 
they were equivalent to a 0.5 McFarland standard (Andrews, 2001).  
MBICs of cells were determined using a modified microtiter plate assay. Biofilms 
were formed at 30ºCfor 24 husing M-H broth. Once the biofilms had formed, planktonic cells 
were washed off and the wells were air-dried. Serial dilutions of antimicrobial agents 
(azithromycin, ciprofloxacin, ceftazidime, gentamicin, and tetracycline) were added to 100 μl 
of fresh M-H broth at the required antimicrobial agent concentrations and transferred to wells 
to determine MBICs of the biofilm cells. Wells, in triplicate, contained 0.008, 0.5, 12, 32, 
256, 1024, 2048, and 4096 μg/ml, respectively, of the antimicrobial agents to be tested. Plates 







onlyand the positive control wells contained the respective cell suspensions with no 
antimicrobial agents added.         
  Contents of each well wereaspirated, washed three times with 250 μl of sterile 
distilled water and the remaining cells were fixed with 200 μl of methanol for 15 min. After 
air-drying, wells were stained with 150 μl of 2% Hucker‘s crystal violet for 5 min. Excess 
crystal violet was removed by gently rinsing plates under running tap water. Dye bound to the 
adherent cells was resolubilized with 150 μl of 33% (v/v) glacial acetic acid and the optical 
density (OD) of each well was obtained at 595 nm using a Multiskan reader (Ascent F1, 
Thermolabsystems). Tests were done in triplicate, on two separate occasions and the results 
averaged. The cut-off OD (ODc) for the microtiter plate test was defined as three standard 
deviations above the mean OD of the negative control (Basson et al., 2008). MBICs were 
indicated by concentrations where the OD was ≤ 0.5. 
 
2.2.4. Effect of varying antimicrobial agent concentrations on biofilm 
 formation 
The effect of the sub-MIC, MIC and supra-MIC exposures of the five selected antimicrobial 
agents (azithromycin, ceftazidime, ciprofloxacin, gentamicinand tetracycline) on initial 
attachment and/or biofilm detachment was determined using a modified microtiter 
assay(Basson et al., 2008). MIC values were determined as described in section 2.2.3. Two 
treatments were investigated, i.e., exposure of cultures at the time of attachment and exposure 
after 24 h biofilm formation. Bacterial cultures were grown overnight at 30 ºC for 16 h, and 
microtiter plate assays were set up as described in section 2.2.3.  For the initial attachment 
assay, isolates were exposed to sub-MIC (0.5×MIC), MIC, and supra-MIC (2×MIC) amounts 
of antimicrobial agents at the time of inoculation.For the effect on mature biofilm, 24 h 
biofilms wereexposed to sub-MIC, MIC and supra-MICs of antimicrobial agent and 
incubated for a further 24 h.          
 Contents of each well were aspirated, washed three times with 250 µl of sterile 
distilled water and the remaining cells were fixed with 200 µl of methanol for 15 min. After 
air-drying, wells were stained with 150 µl of 2% Hucker’s crystal violet for 5 min. Excess 
crystal violet was removed by gently rinsing plates under running tap water. Dye bound to the 
adherent cells was resolubilized with 150 µl of 33% (v/v) glacial acetic acid, and the optical 
density (OD) of each was obtained at 595 nm using a Multiskan reader (Ascent F1, 







occasions and the results were averaged (Basson et al., 2008). Optical density (OD595 nm) in 
the presence of sub-MIC, MIC or supra-MIC of each antimicrobial agent was compared to 
that of control wells without antimicrobial agent exposure, to determine the effect of 
antimicrobial agent on adhesion or detachment.A measure of efficacy called Percentage 
biofilm reduction was calculated from the blank, control, and treated absorbance values (Pitts 
et al., 2003):  
Percentage reduction =[
(   )  (   )
   
]     , where B denotes the average absorbance per 
well for blank wells (no biofilm, no treatment), C denotes the average absorbance per well for 
control wells (biofilm, no treatment), and T denotes the average absorbance per well for 
treated wells (biofilm and treatment).  
 
2.2.5. Statistical analysis  
One-way repeated measures ANOVA and Student’s t-tests (SigmaStat) were used to examine 
the statistical significance of treated vs untreated assays for initial attachment and biofilm 
detachment assays. A p value of <0.05 was considered significant.  
 
2.3. Results 
2.3.1. Determinationof minimum inhibitory concentrations 
forAeromonasspp. And P. shigelloides isolates 
While theazithromycin MICs of Aeromonas spp. ranged from 0.5-64 μg/ml, the 
ceftazidimeMICs ranged from 0.064-128 μg/ml (Table 2.2). The ciprofloxacin MICs ranged 
from 0.064-12 μg/ml and the gentamicin MICs ranged from 0.0048-32 μg/ml (Table 2.2). 
The tetracycline MICs ranged from 6-32 μg/ml, with the majority of isolates displaying MICs 
of 12 and 32 μg/ml (Table 2.2). The majority of the isolates displayed MIC levels ranging 







Table 2.2: Minimum inhibitoryand minimum biofilm inhibitory concentrations of  Aeromonas spp. isolates 
























M2 A. hydrophila 12 4096 64 4096 12 4096 4 4096 32 4096 
M17 A. hydrophila 32 4096 12 > 4096 12 > 4096 4 > 4096 32 4096 
M51 A. hydrophila 0.5 4096 32 2048 4 4096 12 4096 12 2048 
M64 A. hydrophila 64 4096 0.064 > 4096 4 4096 32 4096 12 4096 
M94 A. hydrophila 2 4096 12 4096 2 4096 4 > 4096 32 4096 
M95 A. hydrophila 12 4096 32 4096 2 4096 2 4096 12 > 4096 
M70 A. bestiarum 64 4096 4 4096 4 4096 2 4096 12 4096 
M88 A. bestiarum 12 4096 1 4096 4 4096 2 4096 32 4096 
M90 A. bestiarum 2 1024 32 256 4 12 12 12 12 12 
M96 A. bestiarum 12 4096 12 4096 12 2048 2 2048 32 2048 
M23 A. culicicola 12 1024 64 2048 12 256 4 256 32 2048 
M31 A. culicicola 12 4096 12 1024 4 2048 12 4096 32 4096 
M38 A. culicicola 4 2048 64 256 12 256 4 2048 32 4096 
M58 A. culicicola 12 1024 32 2048 0.064 256 0.008 256 12 2048 
M55 A. veronii 12 4096 64 4096 4 4096 4 2048 32 4096 
M57 A. veronii 0.5 4096 32 4096 4 4096 2 > 4096 32 > 4096 
M63 A. veronii 64 4096 64 > 4096 12 4096 12 4096 32 4096 
M18 A. caviae 12 4096 32 4096 12 2048 12 2048 32 4096 
M59 A. caviae 12 2048 4 2048 1 4096 4 2048 32 4096 







M77 A. salmonicida 64 4096 12 4096 4 4096 2 4096 12 4096 
M41 Aeromonas spp. 12 1024 4 4096 4 > 4096 12 4096 12 2048 
M92 A. allosaccharophila 12 1024 32 4096 4 > 4096 32 4096 32 1024 
M28 A. jandaei 32 4096 32 4096 1 > 4096 4 4096 12 > 4096 
M49 A. sobria 12 4096 1 2048 4 4096 2 4096 6 4096 
M9 P. shigelloides 32 2048 4 2048 1 4096 12 2048 32 4096 
M46 P. shigelloides 12 2048 12 2048 12 1024 32 4096 32 1024 
M67 P. shigelloides 12 1024 32 4096 4 > 4096 1 4096 12 2048 







2.3.2. Determination of minimum biofilm inhibitory concentrations for
 Aeromonas and P. shigelloides spp. isolates 
The MBICs for AZM, CAZ, CIP, CN, and TET of selected isolates is summarised in Table 
2.2, together with the respective MICs.  The least effective concentration against isolate M2 
for azithromycin was 12 μg/ml as it induced biofilm formation (Fig. 2.1). However, from 
1024 to 4096 μg/ml, inhibition of biofilm was observed to increase as the concentration 
increased. With ceftazidime, 0.008 μg/ml was observed to be more effective than 0.5, 12 and 
32 μg/ml (Fig. 2.1). However, with an increase in concentration from 256 to 4096 μg/ml, 
ceftazidime inhibited biofilm formation. The least effective concentration for ciprofloxacin 
was 256 μg/ml and from 1024 to 4096 μg/ml it inhibited biofilm formation (Fig. 2.1). 
Gentamicin induced biofilmat 0.008 μg/ml and it was also less effective at 0.5 and 12 μg/ml. 
It was observed that gentamicin increased inhibition of biofilm formation as the concentration 
increased from 32 to 4096 μg/ml. Tetracycline induced biofilm formation at 0.5 μg/ml, 
however, it was observed that from 32 to 4096 μg/ml, tetracycline inhibited biofilm 
formation as the concentration increased (Fig. 2.1).       
 With isolate M17, it was observed that the most effective concentrations of 
azithromycin to inhibit biofilm formation were 32, 2048 and 4096, respectively (Fig. 2.2). 
The least effective concentration was 0.008 μg/ml. The efficiency of ceftazidme to inhibit 
biofilm formation was inconsistent, and 0.008 μg/ml was more effective than 0.5, 256 and 
1024 μg/ml in inhibiting biofilm formation, but less effective than 12, 2048 and 4096 μg/ml 
which were the most effectiveconcentrations (Fig. 2.2). With ciprofloxacin, 4096 μg/ml was 
more effective in inhibiting biofilm formation and 12 μg/ml followed by 0.008 μg/ml was 
less effective. Gentamicin induced biofilm formation at 0.008 μg/ml, and it was more 
effective in inhibiting biofilm formation as the concentration increased from 0.5 to 4096 
μg/ml. Tetracycline was more effective in inhibiting biofilm formation from 1024 to 4096 
μg/ml, while at 0.008, 12 and 256 μg/ml it was observed that tetracycline was less effective 
(Fig. 2.2).            
 It was observed that azithromycin induced biofilm of isolate M51 at 0.008 μg/ml (Fig. 
2.3). Inhibition of biofilm was observed to increase with the concentration starting from 32 to 
4096 μg/ml. Ceftazidime increased inhibition of biofilm as the concentration increased (0.008 
to 4096 μg/ml). It was observed that 0.008 μg/ml of ciprofloxacin was more effective in 
inhibiting biofilm of isolate M51than 0.5 and 12 μg/ml (Fig. 2.3). However, as the 







inhibiting biofilm formation. Gentamicin induced biofilm formation at 0.008 and 0.5 μg/ml. 
It was observed that from 12 to 4096 μg/m of gentamicin, biofilm inhibition increased with 
antimicrobial agents. Tetracycline was more effective in inhibiting biofilm formation as the 
concentration increased from 0.008 to 4096 μg/ml (Fig. 2.3).  
 For isolate M64, azithromycin was more effective at inhibiting the biofilm as the 
concentration increased (0.008-4096 μg/ml) (Fig. 2.4). With ceftazidime, 0.008 μg/ml and 12 
μg/ml were less effective and inhibition of biofilm formation was observed from 256 to 4096 
μg/ml. At 0.008 and 0.5 μg/ml of ciprofloxacin, induction of biofilm formation was observed. 
Inhibition of biofilm formation with ciprofloxacin was shown to be more effective as the 
concentration increased from 32 to 4096 μg/ml (Fig. 2.4). Gentamicin inhibited biofilm 
formation of M64 as the concentration increased from 256 to 4096 μg/ml. The concentrations 
of gentamicin that induced biofilm formation were 0.008 and 12 μg/ml. Tetracycline induced 
biofilm formation of M64 at 0.5μg/ml and it was more effective at 4096 μg/ml (Fig. 2.4).  
All antimicrobial agents were effective against biofilm of isolate M94 (Fig. 2.5). For 
azithromycin, 0.008 and 0.5 μg/ml were less effective compared to other concentrations. The 
most effective concentration to inhibit biofilm formation was 4096 μg/ml. Ceftazidime and 
tetracycline behaved in a similar manner, and from 0.008 to 32 μg/ml inhibition of biofilm 
was observed (Fig. 2.5). However,at 256 μg/ml the antimicrobial agents became less effective 
compared to 32 μg/ml and from 1024 to 4096 μg/ml these two antimicrobial agents increased 
inhibition of biofilm formation (Fig. 2.5). For ciprofloxacin, the less effective concentrations 
were 0.5 μg/ml, followed by12 μg/ml. It was observed that the most effectiveconcentration of 
ciprofloxacin was 4096 μg/ml. Gentamicin was more effective in inhibiting biofilm formation 
as the concentration increased (0.008 to 4096 μg/ml) (Fig. 2.5).   
 Azithromycin and tetracycline induced biofilm formation of isolate M95 at 0.008 and 
0.5 μg/ml, ceftazidime and ciprofloxacin induced biofilm formation at 0.008 and 0.5 μg/ml, 
respectively (Fig. 2.6). Tetracycline also induced biofilm formation at 12 μg/ml. From 32 to 
2048 μg/ml all antimicrobial agents were effective and more effective at 4096 μg/ml in 
inhibiting biofilm formation (Fig. 2.6).       
 With azithromycin it was observed that only 0.008 μg/ml was the least effective 
concentration, while other concentrations were effective in inhibiting biofilm formation of A. 
hydrophila ATCC 7966
T
 (Fig. 2.7). The most effectiveconcentration of azithromycin was 
2048 μg/ml. Ceftazidime was least effective against A. hydrophila ATCC 7966
T
 at 0.008, 







Ciprofloxacin induced biofilm formation at 0.5 μg/ml (Fig. 2.7). All other concentrations 
were observed to be less effective when compared to 4096 μg/ml which was the most 
effective concentration. Gentamicin induced biofilm formation of this isolate at 0.008 μg/ml, 
which was followed by 0.5 and 12 μg/mlwhich were also less effective. Gentamicin increased 
inhibition of biofilm formation as the concentration increased from 32 to 4096 μg/ml. The 
least effective concentration of tetracycline was 12 μg/ml followed by 256 μg/ml, and the 








Figure 2.1: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 









































Figure 2.2: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 








































Figure 2.3: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 













































Figure 2.4: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 









































Figure 2.5: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 












































Figure 2.6: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila 












































Figure 2.7: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. hydrophila  
isolate ATCC 7966
T 










































It was observed that 0.5 μg/ml of azithromycin was less effective than 0.008 μg/ml in 
inhibiting isolate M18 biofilm and from 12 to 4096 μg/ml biofilm inhibition increased with 
increasing concentrations (Fig. 2.8). With ceftazidime, inhibition of biofilm increased with 
concentrations from 0.008 to 12 μg/ml. However, 32 μg/ml was less effective than 12 and 0.5 
μg/ml and from 256 to 4096 μg/ml inhibition of biofilm was more effective as the 
concentration increased (Fig. 2.8). Ciprofloxacin and gentamicin exposures increased biofilm 
inhibition as the concentration increased from 0.008 to 4096 μg/ml. With tetracycline, it was 
observed that 0.5 and 12 μg/ml were less effective followed by 0.008 μg/ml, and from 32 to 
4096 μg/ml this antimicrobial agent inhibited biofilm formation as the concentration 
increased (Fig. 2.8).         
 Azithromycin, ceftazidime and tetracycline were more effective in inhibiting biofilm 
formation of isolate M59 as the concentration increased from 0.008 to 4096 μg/ml, with the 
exception to tetracycline where 0.008 μg/ml induced biofilm formation (Fig. 2.9). With 
gentamicin it was observed that from 0.008 to 12 μg/ml inhibition of isolate M59 biofilm was 
obtained as the concentration increased, and 32 μg/ml was less effective than 12 μg/ml. 
However, from 256 to 4096 μg/ml biofilm inhibition increased as the concentration of the 
antimicrobial agents increased (Fig. 2.9).      
 Azithromycin induced biofilm formation of A.caviae ATCC 15468
T
 at 0.008 and 0.5 
μg/ml (Fig. 2.10). Other concentrations that were less effective in inhibiting biofilm 
formation of A.caviae ATCC 15468
T
 included 12, 256 and 1024μg/ml, respectively. It was 
observed that azithromycin was effective and more effective at 32 μg/ml, than at 2048 and 
4096 μg/ml. Ceftazidime induced biofilm formation of this isolate at 0.5 μg/ml (Fig. 2.10). It 
was observed that from 12 to 1024 μg/ml, ceftazidime was more effective in inhibiting 
biofilm as the concentration increased and from 1024 to 4096 it was vice versa. Ciprofloxacin 
was less effective at 0.008 and 0.5 μg/ml, respectively. This antimicrobial agent was effective 
at 12 to 4096 μg/ml, however, it was most effective at 1024 μg/ml (Fig. 2.10). Gentamicin 
was less effective at 0.008 and 0.5 μg/ml, however it was effective at 12 to 4096 μg/ml and 
most effective at 256 μg/ml. Tetracycline induced biofilm formation at 0.008 and 1024 
μg/ml. Tetracycline was also less effective at inhibiting biofilm formation of this isolate at 
0.5, 12 and 32 μg/ml. This antimicrobial agent was effective at 256 and 2048 μg/ml and most 









Figure 2.8: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. caviae isolate 











































Figure 2.9: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. caviae isolate 













































Figure 2.10: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. caviae 
ATCC 15468
T  












































Azithromycin, ceftazidime, ciprofloxacin and gentamicin induced biofilm formation of 
isolate M70 at 0.008 μg/ml (Fig. 2.11). However, with azithromycin from 0.5 to 4096 μg/ml, 
inhibition of biofilm formation was observed as the concentration increased. With 
ceftazidime, 12 μg/ml was more effective when compared to 0.5 and 32 μg/ml but less 
effective than 256 μg/ml, where ceftazidime was more effective in inhibiting biofilm 
formation(Fig. 2.11). Ciprofloxacin was observed to be more effective in inhibiting biofilm 
as the concentration increased from 0.5 to 4096 μg/ml. Gentamicin increased biofilm 
inhibition as the concentration increased from 0.5 to 12 μg/ml, with the exception of 256 
μg/ml which was the least effective. With tetracycline, 0.5 μg/ml was less effective compared 
to 0.008 μg/ml, and from 12 to 4096 μg/ml, this antimicrobial agent increased biofilm 
inhibition with the concentration (Fig. 2.11).      
 With isolate M88, it was observed that azithromycin, ceftazidime andciprofloxacin 
induced biofilm formation at 0.008 μg/ml, and only ciprofloxacin induced biofilm formation 
at 0.5 μg/ml (Fig. 2.12). With azithromycin it was observed that 32 μg/ml was more effective 
than 0.5, 12, 256 and 1024 μg/ml, but less effective than 2048 and 4096 μg/ml which were 
more effective concentration  in inhibiting biofilm formation, respectively (Fig. 2.12). It was 
observed that while 0.5 μg/mlof ceftazidime was less effective, from 12 to 4096 μg/ml this 
antimicrobial agent decreased biofilm formation. With gentamicin0.5 μg/mlwas less effective 
than 0.008 μg/ml, which was more effective than 12 μg/ml (Fig. 2.12). However,from32 to 
4096 μg/ml, biofilm inhibition increased as the concentrations of the antimicrobial agent 
increased. With tetracycline, it was observed that from 0.008 μg/ml to 4096 μg/ml inhibition 
of biofilm increased, except at 256 μg/ml, where tetracycline was less effective than 32 μg/ml 
(Fig. 2.12).           
 The efficiacy of antimicrobial agents against isolate M90 was inconsistent, with 
azithromycin, at 0.5 μg/ml being the less effective concentration and 32 μg/ml being the most 
effective concentration (Fig. 2.13). For ceftazidime, 32 μg/ml followed by 0.5 and 2048 
μg/ml were less effective in inhibiting biofilm formation. The most effectiveconcentration for 
ceftazidime was 4096 μg/ml(Fig. 2.13). With ciprofloxacin, the most effectiveconcentration 
to inhibit biofilm formation was 12 μg/ml, the least effective concentrations were 0.008 and 
0.5 μg/ml, respectively. From 256 to 4096 μg/ml, ciprofloxacin became less effective as the 
concentration increased (Fig. 2.13). The most effective concentrations of gentamicin ranged 
between 12 to 256 μg/m, with 32 μg/ml being the most effective concentration to inhibit 







effective compared to lower concentrations. Tetracycline induced biofilm formation at 0.5 
μg/ml, followed by0.008 μg/ml, which was also less effective. The most effective 
concentration of tetracycline to inhibit biofilm formation was 12 μg/ml(Fig. 2.13).  
 It was observed that 0.008 μg/ml of azithromycin induced biofilm formation of isolate 
M96 (Fig. 2.14). However from 0.5 to 1024 μg/ml the azithromycin was effective in 
inhibiting biofilm formation. At 2048 μg/ml this antimicrobial agent became less effective 
compared to lower concentrations, and 4096 μg/ml was the most effective concentration to 
inhibit isolateM96 biofilm formation (Fig. 2.14).  The efficiency of ceftazidime was 
inconsistent and the least effective concentration to inhibit biofilm formation was 0.008 
μg/ml. From 256 to 4096 μg/ml, ceftazidime was more effective in inhibiting biofilm 
formation (Fig. 2.14). With ciprofloxacin, 0.008 μg/ml induced biofilm formation, however, 
from 0.5 to 4096 μg/ml this antimicrobial agent was more effective in inhibiting biofilm 
formation of isolate M96 (Fig. 2.14). It was observed that 0.008 μg/ml of gentamicin also 
induced biofilm formation, and from 0.5 to 32 μg/ml inhibition of biofilm was achieved. At 
256 μg/ml gentamicin became less effective than 12 and 32 μg/ml, and from 1024 to 4096 
μg/ml this antimicrobial agent was more effective in inhibiting biofilm formation. 
















Figure 2.11: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. bestiarum 








































Figure 2.12: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. bestiarum 









































Figure 2.13: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. bestiarum 











































Figure 2.14: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. bestiarum 
















































Azithromycin, ceftazidime and tetracycline induced biofilm formation of isolate M23 at 
0.008 μg/ml (Fig. 2.15). Azithromycin was effective at 0.5 and 12 μg/ml, however, from 32 
to 4096 μg/ml inhibition of biofilm formation increased. With azithromycin it was observed 
that the most effective concentration was 4096 μg/ml, and the least effective concentration 
was 1024 μg/ml (Fig. 2.15). Ciprofloxacin and gentamicin were effective at inhibiting 
biofilm formation as the concentration increased from 0.008 to 4096 μg/ml. Tetracycline was 
effective in inhibiting biofilm formation as the concentration increased from 0.5 to 4096 
μg/ml (Fig. 2.15).         
 Azithromycin, ciprofloxacin, gentamicin and tetracycline induced biofilm formation 
of isolate M31 at 0.008 μg/ml (Fig. 2.16). Azithromycin, ceftazidime, gentamicin and 
tetracycline were more effective in inhibiting biofilm as the concentration increased from 32 
to 4096 μg/ml. The same trend was observed with ciprofloxacin with the exception of 12 
μg/ml, which was more effective than 32-1024 μg/ml (Fig. 2.16).    
 With isolate M38, all five antimicrobial agents induced biofilm formation at 0.008 
and 0.5 μg/ml, and only gentamicin induced biofilm formation at 12 μg/ml (Fig. 2.17). 
Biofilm inhibition was observed with all five antimicrobial agents from 256 to 4096 μg/ml, 
with the most effective inhibitionat2048 to 4096 μg/ml (Fig. 2.17).    
 Azithromycin, ceftazidime and tetracyclinewereobserved to induce biofilm formation 
of isolate M58 at 0.008 μg/ml (Fig. 2.18). However, azithromycin was more effective at 
inhibiting biofilm formation as the concentrations increased from 0.5 to 4096 μg/ml. With 
ceftazidime it was observed that 256 μg/ml was least effective concentration and from 1024 
to 4096 μg/ml, ceftazidime was more effective in inhibiting biofilm formation (Fig. 2.18). 
With ciprofloxacin 0.008, 0.5, 12 and 32 μg/ml were less effective and from 256 to 4096 
μg/ml the antimicrobial agent was more effective. With tetracycline, 0.5 μg/ml was more 
effective than 12 μg/ml, however, it was observed that from 32 μg/ml to 4096 μg/ml, this 













Figure 2.15: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. culicicola 













































Figure 2.16: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. culicicola 









































Figure 2.17: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. culicicola 







































Figure 2.18: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. culicicola 















































Azithromycin induced biofilm formation of isolate M55 at 0.5 and 12 μg/ml and became 
effective at 32 to 2048 μg/ml and mosteffective at 4096 μg/ml (Fig. 2.19). Ceftazidime 
induced biofilm formation from 0.5 to 256 μg/ml and was effective at inhibiting biofilm 
formation of isolate M55 at 1024 and 2048 μg/ml (Fig. 2.19). This antimicrobial agent was 
most effective at 4096 μg/ml. Ciprofloxacin induced biofilm formation at 12 and 256 μg/ml, 
these concentrations were followed by 0.008, 0.5, 1024 and 32 μg/ml which were less 
effective. Ciprofloxacin was more effective at 2048 and 4096 μg/ml(Fig. 2.19). Gentamicin 
induced biofilm formation of isolate M55 at 0.5 and 12 μg/ml. At 12 and 32 μg/ml, 
gentamicin was also observed to be less effective (Fig. 2.19). However, increased biofilm 
inhibition was showed as the concentration increased from 256 to 4096 μg/ml. Tetracycline 
induced biofilm at 0.5 μg/ml,and was followed by 0.008 which was also less effective. 
However, from 12 to 4096 μg/ml, tetracycline inhibited biofilm formation as the 
concentration increased (Fig. 2.19).         
 Biofilm formation of isolate M57 was induced by azithromycin at 0.008 μg/ml and 
from 0.5 to 4096 μg/ml it increased biofilm inhibition with the exception of 1024 μg/ml 
which was less effective compared to lower concentrations (Fig. 2.20). With ceftazidime, 
0.008 μg/ml was less effective in inhibiting biofilm formation of isolate M57 compared to 
other concentrations. At 12 μg/ml, ceftazidime was more effective than other concentrations 
with the exception of 4096 μg/ml which was the most effective concentration (Fig. 2.20). The 
least effective concentration of ciprofloxacin to inhibit biofilm formation by isolate M57 was 
32 μg/ml, followed by 0.008 and 0.5 μg/ml. The remaining concentrations were effective 
with 4096 μg/ml being the most effectiveconcentration. Gentamicin was less effective at 0.5 
μg/ml, followed by 0.008 and 32 μg/ml, respectively (Fig. 2.20). Gentamicin was more 
effective at inhibiting biofilm formation as the concentration increased from 256 to 4096 
μg/ml. Tetracycline induced biofilm formation of isolate M57 at 0.008 and 0.5 μg/ml, while 
from 12 to 4096 μg/ml it increased inhibition of biofilm formation (Fig. 2.20).   
 Azithromycin was less effective at 0.008 μg/ml ininhibiting biofilm formation by 
isolate M63, however, from 0.5 to 4096 μg/ml it was observed to be effective (Fig. 2.21). The 
most effective concentration of this antimicrobial agent was 4096 μg/ml. With ceftazidime, 
0.5 μg/ml induced biofilm formation, and was followed by 0.008, 12 and 1024 which were 
also less effective compared to other concentrations. The most effective concentration of 
ceftazidime was 4096 μg/ml (Fig. 2.21). It was observed that ciprofloxacin was more 







μg/ml which was less effective than 32 μg/ml. Gentamicin induced biofilm formation at 0.5 
μg/ml, and 12 and 1024 μg/ml were less effective (Fig. 2.21). Gentamicin was observed to be 
effective at 32, 256, 2048 μg/ml and most effective at 4096 μg/ml. Tetracycline was less 
effective at 0.008 μg/ml, effective from 0.5 to 2048 μg/ml and most effective at 4096 μg/ml 









Figure 2.19: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. veronii 










































Figure 2.20: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. veronii 













































Figure 2.21: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. veronii 











































Azithromycin, ceftazidime and tetracycline were more effective in inhibiting biofilm 
formation of isolate M76 as the concentration increased from 0.008 to 4096 μg/ml (Fig. 
2.22).  Ciprofloxacin induced biofilm formation at 0.008 μg/ml and from 0.5 to 4096 μg/ml it 
increased inhibition of biofilm formation (Fig. 2.22).Gentamicin induced biofilm formation at 
0.008 and 0.5 μg/ml and from 12 to 4096 μg/ml it was more effective inhibiting biofilm 
formation (Fig. 2.22).        
 Azithromycin was most effective at inhibiting biofilm of isolate M77 as the 
concentration increased from 0.008 to 4096 μg/ml, with the exception of 32 μg/ml,which was 
less effective than 12 μg/ml (Fig. 2.23). The same trend was observed for ceftazidime, 
however, with ciprofloxacin, 1024 and 2048 μg/ml were less effective than 256 μg/ml. The 
most effectiveconcentration of ciprofloxacin to inhibit biofilm formation by isolate M77 was 
4096 μg/ml, followed by 256 and 0.5 μg/ml, respectively (Fig.2.23). The least effective 
concentration was 0.008 μg/ml. Gentamicin was more effective at inhibiting biofilm as the 
concentration increased from 0.008 to 4096 μg/ml except with 12 μg/ml which was less 
effective than 0.5 μg/ml. Tetracycline induced biofilm formation at 0.008 μg/ml and was 









Figure 2.22: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. salmonicida 












































Figure 2.23: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. salmonicida 











































Azithromycin induced biofilm formation of isolate M92 at 12 and 32 μg/ml, and at 
0.008 and 0.5 μg/ml this antimicrobial agent was also observed to be less effective (Fig. 
2.24). Azithromycin was effective from 256 to 4096 μg/ml and more effective at 1024 μg/ml. 
Ceftazidime induced biofilm formation at 0.008, 0.5 and 12 μg/ml. From 1024 to 4096 μg/ml, 
this antimicrobial agent increased inhibition of biofilm formation (Fig. 2.24). Ciprofloxacin 
induced biofilm formation at 0.5, 12 and 256 μg/ml, and 32 μg/ml as well as 1024 μg/ml were 
less effective in inhibiting biofilm formation. This antimicrobial agent was more effective at 
0.008, 2048 μg/ml and most effective at 4096 μg/ml (Fig. 2.24). Gentamicin induced biofilm 
formation at 12 μg/ml and 0.008, 1024 and 2048 μg/ml were less effective, respectively. 
Gentamicin was most effective at 4096 μg/ml. Tetracycline induced biofilm formation at 
0.008 μg/ml and 32 μg/ml. At 0.5 and 12 μg/ml, tetracycline was less effective in inhibiting 
biofilm formation by isolate M92. Tetracycline was effective at 256 and 2046 μg/ml, and 










Figure 2.24: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. 










































Azithromycin was more effective inhibiting biofilm formation of isolate M41 from 
0.008 to 4096 μg/ml as the concentration increased with the exception of 2048 μg/ml, which 
was less effective than 32, 256 and 1024 μg/ml (Fig. 2.25). Ceftazidime induced biofilm 
formation at 0.008 and from 0.5 to 4096 μg/ml it was more effective in inhibiting biofilm 
formation (Fig. 2.25). It was observed that 0.008 and 12 μg/ml of ciprofloxacin were less 
effective in inhibiting biofilm formation of M41 and the most effective concentration was 
256 μg/ml (Fig. 2.25). Tetracycline induced biofilm formation at 0.008 μg/ml, and from 0.5 
to 32 μg/ml the efficiency of this antimicrobial agent was more or less the same. However, 










Figure 2.25: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against unspecified 










































Azithromycin and ceftazidime induced biofilm formation of isolate M49 at 0.008 
μg/ml (Fig. 2.26). However, they were both effective in inhibiting biofilm formation as the 
concentration increased from 0.5 to 4096 μg/ml. Ciprofloxacin displayed inhibition of 
biofilm formationfrom 0.008 to 256 μg/ml (Fig. 2.26). Ciprofloxacin increased inhibition of 
biofilm formation as the concentration increased from 1024 to 4096 μg/ml. Gentamicin was 
more effective in inhibiting biofilm formation of isolate M49 as the concentration increased 
from 0.008 to 4096 μg/ml (Fig. 2.26). The least effective concentration for tetracycline was 
0.008, 0.5 and 256 μg/ml, and the most effectiveinhibition was observed from 1024 to 4096 











Figure 2.26: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. sobria 









































Azithromycin was more effective in inhibiting biofilm formation of isolate M28 as the 
concentration increased from 0.008 to 4096 μg/ml (Fig. 2.27). Ceftazidime induced biofilm 
formation at 0.008 and from 0.5 to 4096 μg/ml it increased inhibition of biofilm formation. 
Ciprofloxacin induced biofilm formation at 0.008 and 0.5 μg/ml, and from 12 to 4096 μg/ml 
it was more effective at inhibiting biofilm formation (Fig. 2.27). Gentamicin was more 
effective in inhibiting biofilm formation as the concentration increased from 0.008 to 4096 
μg/ml. Tetracycline induced biofilm formation at 0.008 and 0.5 μg/ml, and it was more 
effective in inhibiting biofilm formation as the concentration increased from 12 to 4096 










Figure 2.27: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against A. jandaei 










































Azithromycin and ceftazidime were more effective in inhibiting isolate M9 biofilm formation 
as the concentration increased from 0.008 to 4096 μg/ml (Fig. 2.28). With ciprofloxacin, 
0.008 μg/ml was less effective against isolate M9 biofilm, followed by 0.5, 12 and 32 μg/ml, 
respectively (Fig. 2.28). Ciprofloxacin was effective at 256 to 2048 μg/ml and more effective 
at 4096 μg/ml. Gentamicin was more effective in inhibiting biofilm formation as the 
concentration increased from 0.008 to 4096 μg/ml, with the exception of 12 μg/ml which was 
more effective than 32 μg/ml. Tetracycline induced biofilm formation at 0.008 μg/ml and 
became more effective in inhibiting biofilm formation as the concentrations increased from 
0.5 to 4096 μg/ml (Fig. 2.28).         
 All five antimicrobial agents induced biofilm formation of isolates M46 at 0.008 
μg/ml (Fig. 2.29). However, from 0.5 to 4096 μg/ml, all antimicrobial agents were more 
effective in inhibiting biofilm formation (Fig. 2.29).     
 Azithromycin induced biofilm formation of M67 at 12 and 32 μg/ml, and it was also 
observed to be less effective at 0.008 and 0.5 μg/ml (Fig. 2.30). Azithromycin was more 
effective at 256 to 4096 μg/ml, and the most effectiveconcentration was 1024 μg/ml. 
Ceftazidime induced biofilm formation at 0.008, 0.5 and 12 μg/ml, and it was also less 
effective at 256 and 32 μg/ml. Ceftazidime was more effective in inhibiting biofilm formation 
of isolateM67 as the concentration increased from 1024 to 4096 μg/ml (Fig. 2.30). 
Ciprofloxacin induced biofilm formation at 0.5, 12 and 256 μg/ml. At 32 and 1024 μg/ml, 
ciprofloxacin was also observed to be less effective. The most effective concentration of 
ciprofloxacin were 0.008, 2048 and 4096 μg/ml (Fig. 2.30). Gentamicin induced biofilm 
formation at 12 μg/ml, and 0.008, 1024 and 2048 μg/ml were also less effective, respectively. 
The most effectiveconcentration of gentamicin to inhibit biofilm formation was 4096 μg/ml. 
Tetracycline induced biofilm formation at 0.008 and 32 μg/ml. Tetracycline was effective at 
256 to 2048 μg/ml and more effective 4096 μg/ml (Fig. 2.30).    
 Based on the responses of selected isolates to the varying concentrations of 
antimicrobial agents (Figs. 2.1-2.30), 4096 μg/ml appeared to be the most effective for 
biofilm inhibition. There was a ≥128-fold increase in MBICs (4096 μg/ml) compared to the 










Figure 2.28: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against P. shigelloides 














































Figure 2.29: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against P. shigelloides 








































Figure 2.30: Effect of increasing concentrations of azithromycin, ceftazidime, ciprofloxacin, gentamicin and tetracycline against P. shigelloides 










































2.3.3. Effect of varying antimicrobial agent concentrations on biofilm 
 formation 
The effect of varying concentrations of AZM, CAZ, CIP, GN and TET (sub-MIC, MIC and 
supra-MIC) on both initial attachment and detachment was assessed for 25 Aeromonas spp. 
isolates and three P. shigelloides. In the initial attachment assays, sub-MIC, MIC and supra-
MIC exposure to azithromycin reduced biofilm formation of all isolates, except for isolate 
M94 where sub- and supra-MIC exposure of azithromycin induced biofilm formation (Fig. 
2.31). Sub-MIC, MIC and supra MIC exposure to azithromycin treatments were statistically 
significant (p < 0.001).   
MIC exposure of isolates to ceftazidime induced biofilm formation of isolate M64 and 
reduced biofilm formation of all the remaining isolates (Fig. 2.32). While the sub- and supra-
MIC exposuresto ceftazidime induced biofilm formation of isolate M30, only sub-MIC 
exposure to ceftazidime induced biofilm formation of A. hydrophila ATCC 7966
T
 (Fig. 2.32). 
The effect of sub-MIC, MIC and supra MIC exposure to ceftazidime treatments were 
statistically significant (p < 0.001).         
Exposure to sub-MIC of ciprofloxacin induced biofilm formation of isolates M2, M95 
and M90 and exposure to all concentrations (sub-MIC, MIC and supra-MIC) induced biofilm 
formation of isolates M57, M88 and M96, with the remaining isolates these concentrations 
reduced biofilm formation (Fig. 2.33). Sub-MIC and MIC exposure to ciprofloxacin induced 
biofilm formation of A. hydrophila ATCC 7966
T 
and A. caviae ATCC 15468
T 
(Fig. 2.33). 
Sub-MIC (p = 0.006), MIC (p < 0.001) and supra MIC (p < 0.001) exposure to ciprofloxacin 
treatments were statistically significant.       
 Sub-MIC exposure to gentamicin induced biofilm formation of isolates M2, M23, 
M31, M55 and M57and reduced biofilm formation all other isolates (Fig. 2.34). While the 
Supra-MIC exposure to gentamicin induced biofilm formation of isolate M2 and reduced 
biofilm formation of the remaining isolates, gentamicin MIC exposures reduced biofilm 
formation of all isolates (Fig. 2.34). Sub-MIC, MIC and supra MIC exposure to gentamicin 
treatments were statistically significant (p < 0.001).      
 Sub-MIC exposure to tetracycline induced biofilm formation of isolates M38, M55, 
M31, M96, M94 and A. caviae ATCC15468
T
 and exposure to MIC induced biofilm 
formation of isolates M17 and M90, while for the remaining isolates sub-MIC, MIC and 
supra-MICexposures reduced biofilm formation (Fig. 2.35). Sub-MIC, MIC and supra MIC 








Figure 2.31: Effect of sub-MIC, MIC and supra-MIC exposures of azithromycin (AZM) on initial attachment of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.32: Effect of sub-MIC, MIC and supra-MIC exposures of ceftazidime (CAZ) on initial attachment of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.33: Effect of sub-MIC, MIC and supra-MIC exposures of ciprofloxacin (CIP) on initial attachment of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.34: Effect of sub-MIC, MIC and supra-MIC exposures of gentamicin (GN) on initial attachment of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.35: Effect of sub-MIC, MIC and supra-MIC exposures of tetracycline (TET) on initial attachment of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Sub-MIC, MIC and supra-MIC exposures of azithromycin inhibited initial attachment of 85.7% 
(24/28), 89.3% (25/28) and 89.3% (25/28) of isolates, respectively (Table 2.3). With sub-MIC, MIC and 
supra-MIC exposures of ceftazidime, it was observed that attachment of 92.9% (26/28), 82.1% (23/28) and 
96.4% (27/28) of isolates, respectively, was inhibited (Table 2.3). While sub-MIC exposures of 
ciprofloxacin inhibited attachment of 75% (21/28) of isolates, MIC exposures inhibited attachment of 92.9% 
(26/28) of isolates, and supra-MIC exposures inhibited attachment of 89.5% (25/28) of isolates (Table 2.3).  
Sub-MIC, MIC and supra-MIC exposures of gentamicin inhibited attachment of 82.1% (23/28), 100% 
(28/28) and 96.4% (27/28) of isolates, respectively (Table 2.3). With tetracycline sub-MIC, MIC and supra-
MIC exposures inhibited attachment of 75% (21/28), 89.3% (25/28) and 96.4% (27/54) of isolates, 
respectively (Table 2.3). The MIC exposure of gentamicin was observed to be more effective in inhibiting 







Table 2.3: Effect of antimicrobial agents on initial attachment of Aeromonas and Plesiomonas spp. isolates 
Antimicrobial 
agents 





































































0 10.7 (3/28) 3.6 (1/28) 3.6 (1/28) 







In the detachment assays, sub-MIC exposure to azithromycin induced biofilm 
maturationof isolates M23, M46, M41, M55, M57, M70, M49, M94 and M77while the 
biofilms of the remaining isolates were reduced (Fig. 2.36). Supra-MIC exposure to 
azithromycin induced biofilm maturation of isolates M2,M23, M55, M57, M63, M70, M90 
and M95promoted biofilm detachment of the remaining isolates (Fig. 2.36). Sub-MIC and 
MIC exposure to azithromycin induced biofilm maturation of isolate M70 and sub-MIC and 
supra-MIC exposures induced biofilm maturation of isolates M55 and M23. The exposure to 
all concentrations (sub-MIC, MIC and supra-MIC) only induced biofilm maturation of isolate 
M57 (Fig. 2.36). Sub-MIC exposure to azithromycin treatments were statistically 
insignificant (p = 0.122). MIC and supra MIC exposure to azithromycin treatments was 
statistically significant (p < 0.001, p = 0.029).      
 Sub-MIC exposure to sub-MIC of ceftazidime induced biofilm maturation by isolates 
M2, M17, M76, and M95 and promoted biofilm detachment of the remaining isolates (Fig. 
2.37). While MIC exposure to ceftazidime induced biofilm maturationby isolates M18, M23, 
M28, M41, M55, M57 and M92, exposure to supra-MIC induced biofilm maturationof 
isolates M2, M23, M9, M92, M55 and M57. With the remaining isolates, these 
concentrations promoted biofilm detachment (Fig. 2.37). Sub-MIC (p = 0.003) and supra 
MIC (p = 0.031) exposure to ceftazidime treatments were statistically significantand MIC 
exposure to ceftazidime treatments were not statistically significant (p = 0.440).   
 Sub-MIC exposure to ciprofloxacin induced biofilm maturation by isolates M17, 
M23, M41, M46, M55, M57, M59, M63, M95 and M96 and A. caviae ATCC 15468
T
 (Fig. 
2.38). MIC exposure to ciprofloxacin induced biofilm maturation of isolates M2, M23, M55, 
M57, M59 andM64, and A. caviae ATCC 15468
T
 as did supra-MIC exposure induced biofilm 
maturation of isolate M63 (Fig. 2.38). These concentrations induced the biofilm maturation 
of the remaining isolates (Fig. 2.38). Sub-MIC exposure to ciprofloxacin treatments were not 
statistically significant (p = 0.989), while MIC (p = 0.007) and supra-MIC (p<0.001) 
exposures to ciprofloxacin treatments were statistically significant.       
 While sub MIC exposure to gentamicin induced maturation of isolates M23, M55 and 
M95MIC exposure induced biofilm maturation of isolate M67, and supra-MIC exposure 
induced biofilm maturation of isolates M17, M23, M63, M94, and M90 (Fig. 2.39). However, 
sub-MIC, MIC and supra-MIC exposure to gentamicin promoted biofilm detachment of the 
remaining isolates (Fig. 2.39). Sub-MIC and MIC exposure to gentamicin treatments were 







not statistically significant (p = 0.086).        
 Sub-MIC and supra-MIC exposure to tetracycline induced biofilm maturation of 
isolate M95, and exposure to MIC and supra-MIC induced biofilm maturation of isolate M88, 
while exposure to all antimicrobial agents induced biofilm maturation of isolates M23 and 
M55 (Fig. 2.40). While exposure to MIC of tetracycline induced biofilm maturation of isolate 
M2, exposure to supra-MIC induced biofilm maturation of isolates M41, M46,M59, M57, 
M77 and M92 (Fig. 2.40). These concentrations promoted biofilm detachment of the 
remaining isolates (Fig. 2.40). Sub-MIC, MIC and supra-MIC exposure to tetracycline 











Figure 2.36: Effect of sub-MIC, MIC and supra-MIC exposures of azithromycin (AZM) on pre-formed biofilms of Aeromonas spp. isolates using microtiter 
plate assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. 
veronii (M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei 





































Figure 2.37: Effect of sub-MIC, MIC and supra-MIC exposures of ceftazidime (CAZ) on pre-formed biofilms of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.38: Effect of sub-MIC, MIC and supra-MIC exposures of ciprofloxacin (CIP) on pre-formed biofilms of Aeromonas spp. isolates using microtiter 
plate assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. 
veronii (M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei 




































Figure 2.39: Effect of sub-MIC, MIC and supra-MIC exposures of gentamicin (GN) on pre-formed biofilms of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 





































Figure 2.40: Effect of sub-MIC, MIC and supra-MIC exposures of tetracycline (TET) on pre-formed biofilms of Aeromonas spp. isolates using microtiter plate 
assays.A. hydrophila (M2, M17, M51, M64, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M88, M90, M96); A. culicicola (M23, M31, M38, M58); A. veronii 
(M55, M57, M63); A. caviae (M18, M59, ATCC 15468
T
); A. salmonicida (M76, M77); Aeromonas spp. (M41); A. allosaccharophila (M92); A. jandaei (M28); 




































In the detachment assays, it was observed that sub-MIC, MIC and supra-MIC 
exposures of azithromycin increased detachment of 60.7% (17/28), 82.1% (23/28) and 71.4% 
(20/28) of isolates, respectively (Table 2.4). Sub-MIC, MIC and supra-MIC of ceftazidime 
increased detachment of 67.9% (19/28), 64.3% (18/28) and 67.9% (19/28), respectively 
(Table 2.4). It was observed that with sub-MIC exposures of ciprofloxacin, detachment was 
increased for only 35.7% (10/28) of isolates. MIC and supra-MIC of gentamicin exposures 
increased detachment of 60.7% (17/28) and 71.4% (20/28) of isolates, respectively (Table 
2.4).  Both sub-MIC and MIC exposures of gentamicin increased detachment of 57% (16/28) 
of isolates, respectively, and supra-MIC increased detachment of 60.7% (17/54) of isolates 
(Table 2.4). Sub-MIC, MIC and supra-MIC exposures of tetracycline increased detachment 
of 46.4% (13/28), 60.7 (17/28) and 57% (16/28) of isolates, respectively (Table 2.4). With the 
pre-formed biofilm assays, azithromycin was more effective when compared to other 




















Table 2.4: Effect of antimicrobial agents on detachment of Aeromonas spp. and Plesiomonas spp. isolates 
Antimicrobial 
agents 














































































































2.3.4. Determination of percent biofilm reduction 
When determining the percent reduction, the negative value represents induction of biofilm 
formation and the positive values represent reduction of biofilm formation. After calculating 
the percent reduction, it was observed that sub-MIC, MIC and supra-MIC exposures of 
azithromycin inhibited initial attachment of 92.8% (26/28), 96.4% (27/28) and 92.9% 
(26/28)of isolates, respectively (Table 2.5). Percent reduction for azithromycin sub-MIC 
exposure ranged from 1.5 to 100.3% and percent induction was 12 and 13.2%(Table 2.5). For 
MIC exposure, percent reduction ranged from 2 to 109.5% and percent induction was -4.2%. 
For supra-MIC exposure, percent reduction ranged from 8.6 to 110.5% and percent induction 
ranged from 6.4 to 50.8% (Table 2.5). Sub-MIC, MIC and supra-MIC exposures of 
ceftazidime inhibited initial attachment of 96.4% (27/28), 82.1% (23/28) and 100% (28/28) 
of isolates, respectively. Percent reduction for ceftazidime sub-MIC exposure ranged from 4 
to 103.6% and percent induction was 34.3% (Table 2.5). For MIC exposure, percent 
reduction ranged from 5 to 102.1% and percent induction ranged from 4.2 to 34.3% (Table 
2.5). For supra-MIC exposure, percent reduction ranged from 10.4 to 101.5%. With 
ciprofloxacin, sub-MIC, MIC and supra-MIC exposures inhibited initial attachment of 75% 
(21/28), 96.4% (27/28) and 96.4% (27/28) of isolates (Table 2.5). Percent reduction for 
ciprofloxacin sub-MIC exposure ranged from 6.1 to 103.8% and percent induction ranged 
from 4.9 to 264.3% (Table 2.5). For MIC exposure, percent reduction ranged from 0.9 to 
117.3% and percent induction was 111.9%. For supra-MIC exposure, percent reduction 
ranged from 5.4 to 121.1% and percent induction was12.8 and 98.9% (Table 2.5). Sub-MIC, 
MIC and supra-MIC exposures of gentamicin inhibited adhesion of 82.1% (23/28), 100% 
(28/28) and 96.4% (27/28) of isolates. Percent reduction for gentamicin sub-MIC exposure 
ranged from 16.8 to 104.1% and percent induction ranged from 3.9 to 79.6% (Table 2.5). For 
MIC exposure, percent reduction ranged from 0.8 to 111.3% and percent induction was -
3.4%. For supra-MIC exposure, percent reduction ranged from 6.9 to 120.6% and percent 
induction was 16.2% (Table 2.5). Adhesion of 75% (21/28), 89.2% (25) and 57.1% (16/28) of 
isolates was inhibited with sub-MIC, MIC and supra-MIC exposures of tetracycline, 
respectively (Table 2.5). Percent reduction for tetracycline sub-MIC exposure ranged from 
5.7 to 97.5% and percent induction ranged from1.4 and 54.9% (Table 2.5). For MIC 
exposure, percent reduction ranged from 18.1 to 89.9% and percent induction ranged from 








Table 2.5: Percent reduction of sub-MIC, MIC and supra-MIC exposures to azithromycin (AZM), ceftazidime (CAZ), ciprofloxacin 
(CIP), gentamicin (GN), and tetracycline (TET) on initial attachment of Aeromonas spp. isolates 
Species 
designation 
Isolates % Reduction 



















A. hydrophila M2 43.5 40.6 66.7 52 9.3 42.2 -51.9 36.2 96.8 -72.8 49.5 -66.2 19.3 69.5 55.5 
M17 76.2 79.6 100.4 96.2 -23.8 37.1 92.9 104.7 101.4 100.6 71.6 95.4 48.5 -17.3 99.5 
M51 69.3 87.3 60 78.9 23.3 72.9 90.7 97.9 101 97.5 101.1 99.7 97.5 71.4 77.1 
M64 96.4 99 99.3 46.4 -33.8 65.3 96.9 96.9 97.1 101.3 102.6 97.8 90.2 45.1 51.1 
M94 -13.2 7.2 -50.8 95.7 93.8 95.5 25.5 99.2 5.4 16.8 101.2 91.2 -8.2 80.6 75.1 





14.1 39.6 68.6 16.7 10.6 22.4 -9.5 50.8 -12.8 -21.3 0.8 18.8 5.7 20 49.8 
A. bestiarum M70 59.2 103.3 100.1 103.6 102.1 101.5 24 104.2 108.1 103.1 107 99.5 27.6 44.1 83.8 
M88 100.3 109.5 110.5 41.2 99.5 93.5 -133.6 18.8 7.1 106.3 111.3 104.3 25.7 57.3 52.1 
M90 -12 96 45.2 72.3 69.3 57.9 -111.3 117.3 121.1 70.1 113.8 120.6 7 -74.1 1 
M96 16.3 52.7 61.4 96.1 88.7 99.5 -74.6 96.1 100.5 92 84.7 92.4 -28.4 -4.4 13.4 
A. culicicola M23 75.7 84.9 57.6 73.4 5.4 49.9 29.4 62.3 65.3 -3.9 62.8 41.9 52.3 75.1 65.3 
M31 20.5 2 36.5 82.4 69.5 84 -4.9 21.4 62.7 -22 62.5 70.3 -37 20 67.6 
M38 6.4 -4.2 -6.4 -34.3 -34.3 23.3 22.2 81.1 95.2 27 53 99.5 -14 18.1 17.6 







*Percent reduction=Percentage reduction =   ((   )   (   )) (   )       , where B=average absorbance per well for blank wells, C=average 
absorbance per well for control wells, T=average absorbance per well for treated wells(Pitts et al., 2003),#AZM = azithromycin, #CAZ = ceftazidime, #CIP = 
#ciprofloxacin, #GN =gentamicin, #TET =tetracycline.^MIC = Minimum inhibitory concentration, ^sub-MIC = 0.5×MIC, ^supra-MIC = 2×MIC 
A. veronii M55 27.3 57.4 -9.8 14.4 96.2 84.9 89.7 95.3 106.4 -18.6 109.6 106.2 -54.9 53.8 59.4 
M57 11.6 25.5 8.6 75.8 58.7 11 -264.3 -
111.9 
-98.9 -79.6 108.5 107.8 -4 64.4 63 
M63 59.3 98.1 90.6 97.8 100.3 96.4 85.7 104.5 103.1 105.5 103.9 102 81.2 78.4 87.7 
A. caviae M18 49.1 88.1 81 88 82.5 100.5 97.1 101.9 100.4 70.7 98.5 98.3 63.2 65.7 78.6 





3.7 21.7 38.7 4.2 5 18.7 12.2 0.9 6.2 -58.6 -3.4 6.9 -32.5 18.4 48.6 
A. salmonicida M76 66.8 79.7 53.7 12.9 -31.2 43.3 19.3 96 100.3 95.5 95.6 97.2 20.5 75.4 84.5 
M77 17.5 64.8 100 97.7 85 98.7 97.4 66.4 93.5 94.2 101.3 100.9 59.9 75.5 68.1 
Aeromonas 
spp. 




M92 90.6 102.8 86.9 99.8 98.5 99.3 103.8 101 88.5 93.8 99.8 102 96.8 96.2 86.8 
A. jandae M28 73.3 69 75.9 91.5 86.9 92.5 78.1 93.3 90.2 80 98 99.2 57.6 62.5 51.2 
A. sobria M49 41.3 84.1 80 57.6 60.2 62.2 5.5 61.9 104 77.5 53.5 99 75 73.3 73.6 
P. shigelloides M9 88.4 91.7 87.2 81.6 72.8 54.2 95.7 98.7 99.4 100.6 97.3 99.5 52.7 81.3 77.5 
M46 80.7 76.1 68.5 98.1 98.2 98.9 101.2 95.2 100.7 101.8 100.3 102.9 79.3 89.9 95.6 







In the pre-formed biofilm assays, sub-MIC, MIC and supra-MIC exposures of 
azithromycin detached biofilm of 64.2% (18/28), 89.2% (25/28) and 78.6% (22/28) of 
isolates (Table 2.6). Percent reduction for azithromycin sub-MIC exposure ranged from 3 to 
89.8% and percent induction ranged from 1.6 and 161.3% (Table 2.6). For MIC exposure, 
percent reduction ranged from 5.1 to 103.8% and percent induction ranged from -0.9 to -
329.6% (Table 2.6). For supra-MIC exposure, percent reduction ranged from 2 to 99% and 
percent induction ranged from 7.9 to 232.3%. Sub-MIC, MIC and supra-MIC of ceftazidime 
exposures detached biofilm of 67.9% (19/28), 71.4% (20/28) and 75% (21/28) of 
isolate(Table 2.6). Percent reduction for ceftazidime sub-MIC exposure ranged from 12.9 to 
103.5% and percent induction ranged from 4.9 and 110.5% (Table 2.6). For MIC exposure, 
percent reduction ranged from 1.7 to 98.7% and percent induction ranged from -10.3 to -
390% (Table 2.6). For supra-MIC exposure, percent reduction ranged from 5.2 to 100.5% and 
percent induction ranged from 6 to 138.2% (Table 2.6). It was observed that ciprofloxacin 
sub-MIC, MIC and supra-MIC exposures detached biofilm of 57.1% (16/28), 78.6% (22/28) 
and 89.3% (25/28) of isolates. Percent reduction for ciprofloxacin sub-MIC exposure ranged 
from 2.3 to 75.2% and percent induction ranged from 0.8 and 144.6% (Table 2.6). For MIC 
exposure, percent reduction ranged from 0.5 to 83.5% and percent induction ranged from 3.1 
to 53.6%. For supra-MIC exposure, percent reduction ranged from 1 to 94.7% and percent 
induction ranged from 2.6 to 17.5% (Table 2.6). Sub-MIC, MIC and supra-MIC exposures of 
gentamicin inhibited attachment of 67.9% (19/28), 75% (21/28) and 67.9% (19/28) 
respectively (Table 2.6). Percent reduction for gentamicin sub-MIC exposure ranged from 1 
to 56.2% and percent induction ranged from 1.7 and 79.1% (Table 2.6). For MIC exposure, 
percent reduction ranged from 6.9 to 91.5% and percent induction ranged from -0.3 to -96.9% 
(Table 2.6). For supra-MIC exposure, percent reduction ranged from 0.8 to 101.8% and 
percent induction ranged from 9 to 191.3%. Sub-MIC, MIC and supra-MIC exposure of 
tetracycline detached biofilm of 60.7% (17/28), 67.9% (19/28) and 57.1% (16/28) of 
isolates(Table 2.6). Percent reduction for tetracycline sub-MIC exposure ranged from 3.8 to 
87.9% and percent induction ranged from 5.5 and 108.1% (Table 2.6). For MIC exposure, 
percent reduction ranged from 9.2 to 92.8% and percent induction ranged from 8.6 to 88.4%. 
For supra-MIC exposure, percent reduction ranged from 7 to 74.9% and percent induction 









Table 2.6: Percent reduction of sub-MIC, MIC and supra-MIC exposures to azithromycin (AZM), ceftazidime (CAZ), ciprofloxacin 
(CIP), gentamicin (GN), and tetracycline (TET) of pre-formed biofilm of  Aeromonas spp. isolates 
Species 
designation 
Isolates % Reduction 





















A. hydrophila M2 16.2 25.1 -97.6 -6.1 23.3 -57.9 4.2 -22.7 67.2 9.4 -4.1 14.5 55.3 -86.2 7 
 M17 63.6 84.9 40.5 -33.9 52.5 54.7 -100.2 3.3 5.8 29.7 -16.6 -47.9 4.9 31.5 74.9 
 M51 41 40.8 12.4 80 46.4 71.7 27.4 0.5 49.8 24 31.2 32.1 -5.5 67.6 36.4 
 M64 21.4 56.7 3.1 28 -11.6 15.2 23.9 -21.6 10 -26.9 9.4 -19.4 -15.8 -18.3 -32.9 
 M94 -52.4 68.1 51.6 36 1.7 43.4 1.9 22.5 15.3 41.5 -96.9 -191.3 -37 23.7 -56 
 M95 68.9 64.8 -23.9 -29.7 7.5 30.8 -47.2 17.2 40.3 -11.1 34.8 43.2 -55.8 -76.1 29.8 
 ATCC 7966
T
 6.4 53.3 10.4 41.1 70.6 43.6 53.5 17.4 32.3 56.2 69.3 74 35.7 46.5 50.2 
A. bestiarum M70 -148.2 -329.6 -8.3 -29.6 6.1 16.4 15.8 40.5 70.7 52.3 42.5 52.9 54 58.6 44.9 
 M88 65.7 27.4 59.3 22.6 55.9 48.7 -7.8 45.8 -4 43.8 49.4 -9 -16.4 -8.6 -117.2 
 M90 31.5 36.9 -16.9 38.4 49.7 63.1 51.7 40.8 55.2 -28 -17.1 -97.3 -47.3 28.8 -55.5 
 M96 40.6 32.8 51.1 34.6 26.3 33.7 -1.3 53.3 55.6 52.6 53.9 27.6 36.7 38.1 27.3 
A. culicicola M23 -10.4 -0.9 -16.5 -25.2 -10.3 -60 -1.6 -35.7 5 -53.8 -0.3 -37.3 4.9 -34.7 -59.2 
 M31 49.5 54.1 34.1 77.4 57.5 88.1 43.4 44.9 83.4 -11.4 48.4 42.8 47.1 59.4 38.3 
 M38 77.8 42.3 79.3 45.2 60 76.3 -2.7 68 32.4 1.7 77 65.2 38.5 90.4 41.1 
 M58 89.8 103.8 99 73.7 78.2 67.3 90.2 83.5 94.7 92.5 91.5 91.1 87.9 92.8 98.3 
A. veronii M55 -21.5 5.1 -40.1 -4.9 -98.8 -34.4 -35.9 -53.6 24 -18.3 20.3 23.1 3.8 -41.5 -18.3 








 M63 10.1 43.1 -7.9 -2.8 42.1 -6 -55.5 55.5 -17.5 28.8 6.9 -74.9 -35.1 31 55.7 
A. caviae M18 -1.6 70.3 43.8 45.4 -13 5.2 -0.8 51.6 82.4 15.7 58.3 51.5 33.8 35.4 40.2 
 M59 39 15.4 32.1 12.9 38.3 34.6 -8.5 -3.1 32.6 29.1 31.8 0.8 55.6 15 -0.5 
 ATCC 15468
T
 40.4 43 46.6 40.4 43 46.6 -11.5 -3.2 24 27.2 44.5 17 26.4 21.1 19.2 
A. salmonicida M76 73.2 49.7 36.6 -5.9 39.7 53.5 2.3 24.4 68.3 35.4 55.9 46.6 -6.4 -7.5 11.7 
 M77 -34.5 11.2 62.6 78 85.7 78.1 42.7 35.8 32.1 1 53.7 49.7 66.4 62.5 -31.8 
Aeromonas spp. M41 -156.4 17.1 43.8 40.7 -139.9 25.7 -32.3 22.3 1 -13.8 -34 -20.3 -69.1 10.4 -50.1 
A. 
allosacharophila 
M92 3 41.7 2 46.2 -65.4 -103.5 6.2 18.7 -2.6 41.7 63.3 50.4 -8.5 -18.3 -83 
A. jandae M28 47.5 50.5 58.9 41.2 -115.1 38.1 2.6 40.7 38.1 27.1 -0.8 33.1 21.4 28.1 21.9 
A. sobria M49 -16.3 2.9 61.8 103.5 98.7 100.5 75.2 5 55.3 78.8 88.4 101.8 63.9 75.7 67.5 
P. shigelloides M9 62.8 59 44.4 26.3 9.3 -37.1 38.1 32.2 58.4 -1.7 22.9 54.4 21 41.2 53.9 
 M46 -11.1 20.1 49.3 51.2 21.7 48.3 -12.4 80.6 46.9 68.3 50.7 2.8 36.3 9.2 -21.1 
 M67 60.1 56 63.3 53.2 68.4 74.7 9.6 49.5 3.6 32.5 -53.9 59.7 64.1 53.3 36 
*Percent reduction=Percentage reduction =   ((   )   (   )) (   )       , where B=average absorbance per well for blank wells, C=average 
absorbance per well for control wells, T=average absorbance per well for treated wells(Pitts et al., 2003),#AZM = azithromycin, #CAZ = ceftazidime, #CIP = 












Aeromonas spp. are suggested to contribute to severe economic loss in aquaculture since 
members of this genus cause disease in fish. Members of this genus have also been shown to 
cause disease in humans. Aeromonads are resistant to a wide variety of antimicrobial agents and 
their ability to form biofilm makes it difficult to eradicate them since biofilm cells are more 
resistant to antimicrobial agents compared to their planktonic counterparts (Presterl et al., 2009). 
The current study aimed atcomparing the MICs and MBICs of biofilm-associated Aeromonas 
spp. isolates. The effect of varying antimicrobial agent concentrations on biofilm formation was 
also determined.          
 The MICs forazithromycin ranged from 0.5-64 μg/ml and the MIC for ceftazidime and 
ciprofloxacin ranged from 0.064-64 μg/ml, while the MICs for gentamicin ranged from 0.0048-
32 μg/ml, and the MIC for tetracycline ranged from 6-32 μg/ml. The observed MIC trend 
forazithromycin, ceftazidime ciprofloxacin was similar to that observed by Ramalivhana et al. 
(2009) where MIC of gentamicin, amikacin, isepamicin and netilmicin ranged from 1-64 μg/ml. 
High MIC levels were observed for tetracycline, azithromycin and ceftazidime. The high 
frequency of tetracycline resistance in Aeromonas spp. isolates has been reported by Jacobs and 
Chenia (2007). A. allosaccharophila was shown to be susceptible to ciprofloxacin at the MIC of 
greater than 1 mg/l (Picao et al., 2008). Castro-Escarpulli et al. (2003) reported that 44.1% of 
Aeromonas spp. isolates that were isolated from frozen fish were resistant to tetracycline. The 
lowest MIC in the current study was obtained with gentamicin. Aeromonas spp. isolates from a 
waste water treatment plant were susceptible to gentamicin (Igbinosa and Okoh, 2012). 
Aeromonas spp. isolates from India (Igbinosa et al, 2012), Piaractus mesopotamicus and 
Oreochromis niloticus (Belem-Costa and Cyrino, 2006) were also shown to be susceptible to 
gentamicin. Antimicrobial agents used in the present study (azithromycin, ciprofloxacin, 
ceftazidime, gentamicin, and tetracycline) were ineffective against the majority of Aeromonas 
spp. isolates as the MBICs ranged from 12μg/ml to ≥ 4096 μg/ml. The results obtained indicated 
that the effectiveness of the antimicrobial agents is not class-specific but concentration-
dependent. The MBICs were~128-foldhigher compared to the MICs of antimicrobial agents 
(Table 2.2). Similar results were obtained by Sandoe et al. (2006) who observed that 






ampicillin, vancomycin and linezolid, respectively, while the MIC of the same antimicrobial 
agents was 4 mg/l.  The MBIC of bacitracin, vancomycin, gentamicin, rimfampin, nitrofurazone 
and enrofloxacin against S.epidermidis biofilm was observed to be 4096 μg/ml, while the MIC of 
the same antimicrobial agents was 512 μg/ml (Pettit et al., 2005).      
 Sub-inhibitory antimicrobial concentrations are lower than the MICs and have been 
suggested to be important in determining the resistance of bacteria to antimicrobial agents. This 
is due to the ability of these concentrations to affect cell functions without killing the cell (Dynes 
et al., 2009). In the current study, sub-MIC, MIC and supra-MIC of antimicrobial agents were 
effective in inhibiting initial attachment and detaching biofilm isolates. Percent reduction, 
whichmeasures the efficacy of treatments (Pitts et al., 2003), was used to confirm if sub-MIC, 
MIC and supra-MIC exposures indeed reduced the adhesion of the isolates on polystyrene 
surface. During initial attachment the biofilm is not fully matured, and the absence of the 
extracellular polymeric substances during this stage increases the susceptibility of the cells to 
antimicrobial agents (Takahashi et al., 2007). Among the sub-MICs exposures of all five 
antimicrobial agents tested, sub-MIC exposures of ceftazidime was the highest in the initial 
attachment and pre-formed biofilm and it inhibited attachment and detached 92.9% (26/28) and 
67% (19/28) isolates, respectively. Sub-MICs exposures to ceftazidime are suggested to be 
capable of inhibiting QS in P. aeruginosa (Høiby et al., 2010). Pompilio et al. (2010) observed 
that moxifloxacin sub-MIC exposures affect cellular functions reducing cell hydrophobicity and 
biofilm formation of St.maltophilia. Even though the sub-MIC of ceftazidime was more 
effective, however, sub-MICs of all antimicrobial agents were more effective in inhibiting inital 
attachment as it has been observed by similar studies. Sub-MIC exposures of cefazolin, 
vancomycin and dicloxacillin were shown to inhibit initial attachment of S.epidermidis (Cerca et 
al. 2005). Cerca et al. (2005) suggested that sub-MIC exposures inhibit initial attachment of cells 
on surfaces which as a result prevents biofilm formation. Sub-MIC exposures of gentamicin and 
ciprofloxacin (0.5×MIC) were shown to reduce biofilm formation by Salmonella typhimurium 
(Majtan et al., 2007). Sub-MIC of gemifloxacin was shown to affect adhesiveness, 
hydrophobicity, haemagglutination and swarming of both E. coli and S. aureus at 1/32MIC and 
1/8 MIC respectively (Dal Sasso et al., 2003). Sub-MICs were also observed to be associated 






aureustosub-MICs of cefalexin was observed to induce biofilm formation (Haddadin et al., 
2009). Cargill and Upton (2009) observed that sub-MIC of vancomycin increased cell density of 
S. epidermidis. Exposure to sub-MIC of cefotaxime was observed to induce biofilm formation of 
S. typhimurium (Majtan et al., 2007). All the above-mentioned studies suggested that induction 
of biofilm formation by sub-MIC might be due to inability of these concentrations to penetrate 
within the biofilm.      
 MIC testing is the most preferable method to measure the activity of the antimicrobial 
agents (Lim and Yun, 2001). However, the addition of higher doses of antimicrobial agents to 
the MIC is suggested to be effective in suppressing the growth of bacteria for a longer period and 
this is called supra-MIC (Cars and Odenbok-Toraqrist, 1993). MIC exposure using gentamicin 
was most effective in inhibiting initial attachment compared to MIC exposure of other 
antimicrobial agents and it inhibited 100% (28/28) of isolates, the MIC of azithromycin detached 
82.1% (23/28) of isolates. The supra-MICs exposures of azithromycin and ciprofloxacin were 
more effective in the pre-formed biofilm assay as they both detached 71.4% (20/28) of isolates. 
The supra-MIC exposures of ceftazidime, gentamicin and tetracycline were more effective 
against initial attachment with all three antimicrobial agents inhibiting 96.4% (27/28) of the 
isolates. Both ceftazidime and ciprofloxacin have been shown to reduce the biofilm formation by 
Burkholderia cepacia (Peeters et al., 2009). Tetracycline was observed to reduce biofilm 
formation of S.epidermidis when used in combination with vancomycin. Liaqat et al. (2009) 
observed that 5×MIC of tetracycline reduced biofilm formation by Klebsiella spp., P. 
aeruginosa, Achromobacter spp. K.pneumoniae, and Bacillus pumilis. Supra-MIC exposure of 
gentamicin was observed to be effective in inhibiting E. coli biofilm alone and to be more 
effective when it was used in combination with ultrasound (Carmen et al., 2005). Non-typeable 
Haemophilus influenzaewas observed to be resistant to the MIC of azithromycin, however, sub-
MIC exposure of azithromycin reduced biofilm formation of the same strain (Starner et al., 
2008). The MIC exposure of ciprofloxacin against K. pneumoniaewas observed to be 0.18 
mg/ml, however 10× the concentration was observed to be more effective in reducing the biofilm 
formation (Anderl et al., 2002). The most effective concentration among the different 
concentrations (sub-MIC, MIC and supra-MIC) used was the MIC. MIC exposures of gentamicin 






detached biofilms of 82.1% (23/28) of isolates. However, all five antimicrobial agents were more 
effective in the intial attachment assays and this might be due to the absence of resistance 


































Identification of efflux pump-associated antimicrobial resistance and determination of the 
effect of efflux pump inhibitors and DNase I on Aeromonas spp. biofilm formation 
3.1. Introduction 
Aeromonas spp. has been shown to form biofilms in different aquatic environments, where they 
infect fish and cause different infections (Bomo et al., 2004). Biofilms are also associated with 
different diseases in humans, and the innate resistance to antimicrobial agentsmakes it hard to 
treat infections caused by these bacterial species (Alcaide et al., 2010). The increase in resistance 
to antimicrobial agents by bacteria is caused by different mechanisms, of which the presence of 
efflux pumps is one of the main mechanisms. The resistance-nodulation-cell division (RND) is 
the major type of efflux pump observed in Gram-negative bacteria, where it provides resistance 
to different classes of antimicrobial agents. These efflux pumps have been identified in common 
bacterial species such as E. coli, K.pneumoniae, Enterobacter spp.,and P.aeruginosa(Lupo et al., 
2012). Hernould et al. (2008)observedthat A. hydrophila possessedan AheABC pump belonging 
toRND system by blocking it with phenylalanine arginine β-naphthylamide (PAβN), an efflux 
pump inhibitor.  They also observed that cefuroxime, cefoperazone, erythromycin, lincomycin, 
pristinamycin, minocycline, trimethoprim, fusidic acid and rifampin are the substrates of the 
AheABC system. Amoxicillin, carbenicillin, ciprofloxacin, enrofloxacin, erythromycin, 
kanamycin, minocycline, oxytetracycline, streptomycin, sulphamethoxazole, tetracycline, and 
trimethoprim were also observed to be the substrates of the AheABC system in A. 
hydrophila(Lukkana et al., 2011).aheA encodes a membrane fusion protein, and aheB for inner 
membrane transporter, while aheC encodes an outer membrane protein (Hernould et al., 2008).
 Since the resistance of biofilms to antimicrobial agents is increasing, the use of efflux 
pump inhibitors has been shown to be the most promising strategy (Kvist et al., 2008). By 
blocking the efflux pumps, EPIs inhibit them from pumping antimicrobial agents out. Efflux 
pump inhibitors can either be used directly to inhibit biofilm formation or to increase 
susceptibility of the bacteria to certain antimicrobial agents (Pagès and Amaral, 2009). Two 
commonly used efflux pump inhibitors, PAβN or 1-(1-naphthylmethyl)-piperazine (NMP) have 






the RND pumps reduced biofilm formation (Bina et al., 2009) and also decreased bacterial 
pathogenicity since RND pumps have been suggested to be involved with pathogenicity in some 
Gram-negative bacteria species (Blair and Piddock, 2009).      
 The application of PAβN and NMP against Aeromonas spp. is still limited, however, 
various studies are providing evidence of their effectiveness against other bacterial species. Both 
PAβN and NMPincreasedsusceptibilityof V.cholerae to Triton X-100, deoxycholate, cholate and 
erythromycin and PAβN was more effective than NMP (Bina et al., 2009). Increased activity of 
levofloxacin against E. coli was observed only when it was used with either PAβN and NMP 
(Pagès and Amaral, 2009). Hannula and Hanninen (2008) observed that PAβN increased 
susceptibility of Campylobacter jejuni and Campylobacter coli to erythromycin and rifampicin. 
While these inhibitors affected the pathogenicity of P. aeruginosaby reducing its invasiveness 
(Hirakata et al., 2009), Kvist et al. (2008) observed that they inhibited biofilm formation by E. 
coli. CCCP which affects the bacteria indirectly by inhibiting the energy required by the efflux 
pump to function has also been identified as one of the best EPI candidates (Ramón-Garcíaet al., 
2006). CCCP was shown to increase the susceptibility of tetracycline by inhibiting the energy 
required by the Tap protein (efflux pump) of Mycobacterium fortuitum (Ramón-García et al., 
2006).         
The use of DNase I hasalso been shown to be an effective strategy to inhibit biofilm 
formation. DNase I digests extracellular DNA (eDNA) via its exonuclease activity and 
disruptsthe extracellular matrix which then affects biofilm formation (Tetz and Tetz, 2010). The 
presence of eDNA in the extracellular matrix makes it a better target because its digestion will 
inhibit biofilm formation since it is important in the adhesion of biofilm (Das et al., 2010) and 
biofilm development (Qin et al., 2007). Biofilm formation of S. aureus was reduced after 
digesting eDNA with DNase (Tetz and Tetz, 2010). Tetz et al. (2009) observed that digestion of 
eDNA by DNase I reduced the biomass of E. coli biofilm.     
 Therefore, this chapter aimed at identifying efflux pump-associated antimicrobial 
resistance and detecting the effect of different EPIs on initial attachment and biofilm detachment 
by Aeromonas spp. Furthermore, the effect of DNase I on attachment and biofilmdetachment on 







3.2. Materials and Methods 
3.2.1. Identification of efflux pump-associated antimicrobial resistance 
To determine the presence of the efflux mechanism in Aeromonas spp. isolates, Mueller-Hinton 
(M-H) agar plates were prepared with or without efflux pump inhibitors CCCP, PAβN or NMP 
(Sigma, SA)] (Magnet et al., 2001; Shi et al., 2005). The final concentration of the efflux 
inhibitors in the M-H agar was 20 µg/ml. M-H agar with or without efflux inhibitors were 
inoculated with standardized cell suspensions equivalent to a 0.5 McFarland standard and 
amikacin (AK30), ampicillin (AMP10), azithromycin (AZM15), cefpodoximine (CPD10), 
chloramphenicol (C30),  ciprofloxacin (CIP5), enrofloxacin (Baytril-ENR5), erythromycin 
(E15),  gentamicin (CN10), nalidixic acid (NA30), norfloxacin (NOR10), ofloxacin (OFX5), 
streptomycin (S10), sulphamethoxazole (RL25), tetracycline (TE30) and trimethoprim 
(W1.25)discs (Oxoid, Basington, UK) were placed onto the inoculated plates. Plates were then 
incubated at 30 °C for 24 h. Inhibition zone diameters were measured and the resistance or 
susceptibility profiles of the isolates were determined in the presence/absence of the efflux pump 
inhibitor. If the efflux pumps were present and active in isolates, zone diameters on the efflux 
inhibitor-containing plates were greater than corresponding zone diameters on plates without the 
inhibitor (Magnet et al., 2001). A difference of ≥ 5 mm between a plate without EPI and a plate 
with EPI was considered a inhibition-positive result. Resistance, susceptibility and intermediate 
susceptibility to antimicrobial agents were established according to CLSI criteria (CLSI, 2007). 
 
3.2.2. Effect of efflux pump inhibitors on biofilm formation 
EPIs (CCCP, PAβN or NMP)were used to determine their effect on initial attachment and pre-
formed biofilm using modified microtiter assays (Basson et al., 2008). 
Aeromonas spp. isolates including A. hydrophila ATCC 7966
T 
and A. caviae ATCC 
15468
T
, were grown overnight in TSB, washed three times with sterile distilled water and the 
turbidity of the cell suspensions was adjusted to that equivalent to a 0.5 McFarland standard. The 
first assay investigated the effect of EPIs on initial attachment of cells. EPIsto a final 
concentration of20 µg/mlwere added to 90 µl TSB and 10 µl of cell suspension and incubated for 
24 h at 30 ºC with agitation. For the effect on mature biofilm, 24 h biofilms were exposed to 






controlscontainedonly TSB broth and positive controls contained the respective cell suspensions 
only with no EPIs added. Staining and determination of OD values was done as described 
previously in section 2.2.4, according to Basson et al. (2008). The OD595 nmof the control wells 
without EPIs were compared to wells with EPIs to determine their effect on biofilm formation. 
All experiments were done in triplicate, on two separate occasions. Percentage reduction was 
calculated as described in section 2.2.4. 
 
3.2.3. Effect of DNase I on initial attachment and biofilm detachment 
Bovine DNase I (Sigma) was added prior to initial attachment and to pre-formed biofilm to 
determine if Aeromonas spp. isolates use eDNA as an adhesin to attach to the surface or to 
maintain their biofilm structure, respectively.  Sixteen hour-old cultures were used to prepare cell 
suspensions which were standardized equivalent to a 0.5 McFarland standard (Basson et al., 
2008).  For initial attachment assays, bovine DNase I (Sigma) was added to 90 µl TSB and 10 µl 
of cell suspension, at a final concentration of 1 mg/ml (Izano et al., 2009) and microtitre plates 
were incubated for 24 h at 30 ˚C with agitation (Basson et al., 2008).   
For pre-formed biofilm detachment assays, 24 h biofilms were established following 
addition of 90 µl TSB and 10 µl of standardized cell suspension to microtitre plate wells, which 
were incubated at 30 ºC for 24 h.  After a 24 h incubation period, microtitre plates were washed 
three times with sterile deionised water and allowed to air-dry.  Following the addition of 90 µl 
TSB and DNase I (to a final concentration of 1 mg/ml), microtitre plates wereincubated for a 
further 24 h with agitation at 30˚C.  
For both initial attachment and biofilm detachment assays, the negative controls 
contained TSB broth only and positive controls contained respective cell suspensions with no 
DNase I added. Staining and determination of OD values was done as previously described in 
section 2.2.4, according to Basson et al. (2008). All assays were done in triplicate on two 







3.2.4. Statistical analysis  
One-way repeated measures ANOVA and Student’s t-tests (SigmaStat) were used to examine the 
statistical significance of treated vs untreated assays for initial attachment and biofilm 
detachment assays. A p value of <0.05 was considered significant. 
 
3.3. Results 
3.3.1. Identification of efflux pump-associated antimicrobial resistance 
When antimicrobial susceptibility was examined in the absence of EPIs, 100% (54/54) of 
isolatesdisplayed susceptibility to OFX5 (Table 3.1).Susceptibility of 98.1% (53/54) of isolates 
to NOR10, CIP5 and AK30, respectively was also observed. While 96.3% (52/54), 81.5% 
(44/54), and 79.6% (43/54) of isolates displayed susceptibility to CN10, NA30 and ENR5, 
respectively, 70.4% (38/54)) of isolates displayed susceptibility to both cefpodoxime (CPD10) 
and C30 (Table 3.1). Susceptibility to AZM15 was observed for 50% (27/54) isolates and 
withthe remaining antimicrobial agentsa small number of isolates (<50%) were susceptible 
(Table 3.1). Isolates were more resistant to W1.25 and RL25.With the former, it was observed 
that100% (54/54) of isolates displayed resistance and with the latter, 98.1% (53/54) of isolates 
displayed resistance (Table 3.1). With AMP10 or TE30, 94.4% (51/54) of isolates displayed 
resistance, while with erythromycin 90.7% (49/54) of isolates were resistant (Table 3.1). 
In order to determine the efflux phenotypes of isolates, zone diameters on EPI-containing 
plates were compared to control plates without EPIs. When zone differences of ≥5 mm were 
observed, the R, I, S criteria of the isolates was assessed. Changes noted included: resistant 
(R→R), partial inhibition (R→I), complete inhibition (R→S), intermediate susceptibility to 
susceptibility (I→S) and susceptibility (S→S). R→R and S→S indicate that although the zone 
diameter difference was ≥5 mm; there however, was no change in the phenotype. Therefore, the 










Table 3.1: Susceptibility of 48 Aeromonas spp. and six P. shigelloidesisolates to 16 
antimicrobial agents. 
Antimicrobial agents %Susceptibility %Intermediate 
susceptibility 
% Resistance 
Ampicillin (AMP10) 1.9 (1/54) 3.7 (2/54) 94.4 (51/54) 
Cefpodoxime (CPD10) 70.4 (38/54) 5.6 (3/54) 24.1 (13/54) 
Chloromphenicol (C30) 70.4 (38/54) 20.4 (11/54) 9.3 (5/54) 
Trimethoprim (W1.25) 0 0 100 (54/54) 
Sulphamethoxazole (RL25) 1.9 (1/54) 0 98.1 (53/54) 
Norfloxacin (NOR10) 98.1 (53/54) 0 1.9 (1/54) 
Enrofloxacin (ENR5) 79.6 (43/54) 20.4 (11/54) 0 
Ofloxacin (OFX5) 100 (54/54) 0 0 
Ciprofloxacin (CIP5) 98.1 (53/54) 0 1.9 (1/54) 
Nalidixic acid (NA30) 81.5 (44/54) 7.4 (4/54) 11.1 (6/54) 
Tetracycline (TE30) 1.9 (1/54) 3.7 (2/54) 94.4 (51/54) 
Gentamicin (CN10) 96.3 (52/54) 1.9 (1/54) 1.9 (1/54) 
Streptomycin (S10) 98.1 (53/54) 1.9 (1/54) 0 
Amikacin (AK30) 98.1 (53/54) 0 1.9 (1/54) 
Azithromycin (AZM15) 50 (27/54) 38.9 (21/54) 11.1 (6/54) 
Erythromycin (E15) 1.9 (1/54) 7.4 (4/54) 90.7 (49/54) 
 
 
With CCCP, varying levels of efflux pump inhibition was observed when it was used in 
combination with 11 of the 16 antimicrobial agents tested (Table 3.2). Partial inhibition of the 
efflux pump of a single isolate was observed when CCCP was used in combination with 
ampicillin, cefpodoxime, sulphamethoxazole, ciprofloxacin and tetracycline. Complete inhibition 






chloramphenicol, trimethoprim, nalidixic acid, amikacin and azithromycin. Complete inhibition 
of the efflux pump was obtained for 14.8% (8/54) of isolates when CCCP was used with 
cefpodoxime. Finally, intermediate susceptibility to complete inhibition was observed when 
CCCP was used in combination with cefpodixime, chloromphenicol, enrofloxacin, nalidixic acid 
and azithromycin. It was observed that 13% (7/54) of isolates changed from intermediate 
susceptibility to complete susceptibility when CCCP was used with chloromphenicol.   
  
Table 3.2: Alteration in susceptibility of 48 Aeromonas spp. and six P. shigelloidesto 16 











Ampicillin (AMP10) 29.6 
(16/54) 
1.9 (1/54) 0 0 0 
Cefpodoxime (CPD10) 1.9 (1/54) 1.9 (1/54) 14.8 (8/54) 1.9 (1/54) 1.9 (1/54) 
Chloromphenicol (C30) 0 0 5.6 (3/54) 13 (7/54) 7.4 (4/54) 
Trimethoprim (W1.25) 0 0 1.9 (1/54) 0 0 
Sulphamethoxazole 
(RL25) 
0 1.9 (1/54) 0 0 0 
Norfloxacin (NOR10) 0 0 0 0 25.9 (14/54) 
Enrofloxacin (ENR5) 0 0 0 3.7 (2/54) 9.3 (5/54) 
Ofloxacin (OFX5) 0 0 0 0 5.6 (3/54) 
Ciprofloxacin (CIP5) 0 1.9 (1/54) 0 0 22.2 (12/54) 
Nalidixic acid (NA30) 0 0 3.7 (2/54) 1.9 (1/54) 11.1 (6/54) 
Tetracycline (TE30) 22.2 
(12/54) 
1.9 (1/54) 0 0 0 
Gentamicin (CN10) 0 0 0 0 9.3 (5/54) 
Streptomycin (S10) 0 0 0 0 7.4 (4/54) 
Amikacin (AK30) 0 0 1.9 (1/54) 0 1.9 (1/54) 
Azithromycin (AZM15) 0 0 1.9 (1/54) 1.9 (1/54) 0 
Erythromycin (E15) 9.3 (5/54) 0 0 0 1.9 (1/54) 
*R→R=resistant to resistant, *R→I=resistant to intermediate, *R→S=resistant to susceptible, *I→S=intermediate 
to susceptible, *S→S=susceptible to susceptible 
 
 
NMP increased susceptibility of isolates to six different antimicrobial agents (Table 3.3). 
Partial inhibition of efflux pump was observed forcefpodoxime and erythromycin, in the 
presence of NMP (Table 3.3). Complete inhibition of efflux pump activity was observed when 
NMP was used in combination with cefpodoxime, nalidixic acid, and amikacin.Complete 






5.6% (3/54) of isolates, which had intermediate susceptibility to chloromphenicol, became 
completely susceptible when NMP was used. 
 
Table 3.3: Alteration in susceptibility of 48 Aeromonas spp. and six P. shigelloides to 16 











Ampicillin (AMP10) 14.8 (8/54) 0 0 0 0 
Cefpodoxime (CPD10) 5.6 (3/54) 3.7 (2/54) 7.4 (4/54) 0 1.9 (1/54) 
Chloromphenicol (C30) 1.9 (1/54) 0 0 5.6 (3/54) 1.9 (1/54) 
Trimethoprim (W1.25) 0 0 0 0 0 
Sulphamethoxazole 
(RL25) 
0 0 0 0 0 
Norfloxacin (NOR10) 0 0 0 0 13 (7/54) 
Enrofloxacin (ENR5) 0 0 0 0 1.9 (1/54) 
Ofloxacin (OFX5) 0 0 0 0 1.9 (1/54) 
Ciprofloxacin (CIP5) 0 0 0 0 1.9 (1/54) 
Nalidixic acid (NA30) 0 0 3.7 (2/54) 1.9 (1/54) 0 
Tetracycline (TE30) 3.7 (2/54) 0 0 0 0 
Gentamicin (CN10) 0 0 0 0 1.9 (1/54) 
Streptomycin (S10) 0 0 0 1.9 (1/54) 3.7 (2/54) 
Amikacin (AK30) 0 0 1.9 (1/54) 0 0 
Azithromycin (AZM15) 0 0 0 0 0 
Erythromycin (E15) 1.9 (1/54) 1.9 (1/54) 0 0 0 
*R → R = resistant to resistant, *R → I = resistant to intermediate, *R → S = resistant to susceptible, *I → S = 
intermediate to susceptible, *S → S = susceptible to susceptible 
 
 
PAβN increased susceptibility to 10 different antimicrobial agents (Table 3.4). Partial 
inhibition was obtained when PAβN was used in combination with cefpodoxime and 
erythromycin. PAβN in combination with erythromycin resulted in partial efflux pump inhibition 
for 7.4% (4/54) of isolates, unlike thePAβN-cefpodoximecombination in which partial inhibition 
was obtained for a single isolate only. PAβN resulted in complete efflux pump inhibition when 
used in combination with ampicillin, cefpodoxime, choloramphenicol, nalidixc acid, tetracycline, 
amikacin, azithromycinand erythromycin. Complete inhibition of the efflux pump was obtained 






9.3% (5/54) of isolates that were intermediate susceptible became complete susceptible when 
PAβN was used with either chloromphenicol or azithromycin, respectively. 
 
 
Table 3.4: Alteration in susceptibility of 48 Aeromonas spp. and six P. shigelloides to 16 











Ampicillin (AMP10) 9.3 (5/54) 0 1.9 (1/54) 0 0 
Cefpodoxime (CPD10) 3.7 (2/54) 1.9 (1/54) 5.6 (3/54) 0 0 
Chloromphenicol (C30) 0 0 3.7 (2/54) 9.3 (5/54) 5.6 (3/54) 
Trimethoprim (W1.25) 0 0 0 0 0 
Sulphamethoxazole 
(RL25) 
0 0 0 0 0 
Norfloxacin (NOR10) 0 0 0 0 9.3 (5/54) 
Enrofloxacin (ENR5) 0 0 0 1.9 (1/54) 3.7 (2/54) 
Ofloxacin (OFX5) 0 0 0 0 0 
Ciprofloxacin (CIP5) 0 0 0 0 7.4 (4/54) 
Nalidixic acid (NA30) 0 0 3.7 (2/54) 3.7 (2/54) 0 
Tetracycline (TE30) 11.1 (6/54) 0 1.9 (1/54) 0 0 
Gentamicin (CN10) 0 0 0 0 0 
Streptomycin (S10) 0 0 0 1.9 (1/54) 1.9 (1/54) 
Amikacin (AK30) 0 0 1.9 (1/54) 0 0 
Azithromycin (AZM15) 0 0 3.7 (2/54) 9.3 (5/54) 1.9 (1/54) 
Erythromycin (E15) 7.4 (4/54) 7.4 (4/54) 1.9 (1/54) 0 0 
*R → R = resistant to resistant, *R → I = resistant to intermediate, *R → S = resistant to susceptible, *I → S = 
intermediate to susceptible, *S → S = susceptible to susceptible. 
 
The antimicrobial agent that was observed to be effluxed the most by all EPIs was 
cefpodoxime (displayed greatest levels of complete inhibition with EPIs than any of the other 
antimicrobial agents tested).Alterations in susceptibility for isolates M65, M80 and M90 were 
observed with CCCP and NMP and with CCCP and PAβN, alterations in susceptibility 
wereobserved for isolates M2, M8, M18, M23 and M80. Alterations in susceptibility with PAβN 
and NMP were observed forisolates M50, M26 and M51. Isolates for which alterations in 
susceptibility were observed with all three EPIs (CCCP, NMP and PAβN) included: isolates 







3.3.2. Effect of EPIs on initial attachment of Aeromonas andPlesiomonas spp. 
 isolates 
CCCPinhibited attachment of92.6% (50/54) of isolates and increased attachment ofisolates M23, 
M41 as well asA.hydrophila ATCC 7966
T
and A. caviae ATCC 15468
T
(Fig. 3.1).It was observed 
that NMP inhibited attachment of 98.1% (53/54) of isolates and increased attachment of a single 





 type strains (Fig. 3.2). The least effective inhibitor was PAβN, which 
decreased adherence of 61.1% (33/54) of isolates (Fig.3.3).PAβN increased attachment of 
isolates M8, M26, M22, M41, M50, M57, M58, M59, M60, M62, M63, M64, M66, M68, M86, 
M90, M92, M94,A. hydrophila ATCC 7966
T
andA. caviae ATCC 15468
T
(Fig. 3.3). Inhibition 
decreased in the following order: NMP>CCCP>PAβN (Figs 3.1-3.3, Table 3.5). Treatments of 









Figure 3.1: Effect of 20 µg/ml carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on initial attachment of Aeromonas and Plesiomonas spp. isolates using 
microtiter plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. 
bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); 
A.caviae  (M18, M59, M68, ATCC15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. 











Figure 3.2: Effect of 20 µg/ml 1-(1-naphthylmethyl)-piperazine (NMP) on initial attachment of Aeromonas and Plesiomonas spp. isolates using microtiter 
plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, 
M72, M80, M81, M88, M90, M96, M99,); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, 
M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. sobria (M49); 










Figure 3.3: Effect of 20 µg/ml phenylalanine arginine β-naphthylamide (PAβN) on initial attachment of Aeromonas and Plesiomonas spp. isolates using 
microtiter plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. 
bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. 






The most effective EPI in initial attachment was NMP (Table 3.5).  NMP inhibited 
attachment of 98.1% of isolates. CCCP inhibited attachment of 92.6% of isolates whilst 
PAβNwas the least effective (Table 3.5).  
 
Table 3.5: Effect of CCCP, NMP and PAβNon initial attachment and pre-formed biofilm of 
Aeromonas spp. and Plesiomonas spp. isolates 
*EPIs=efflux pump inhibitors, 
#





PAβN=phenylalanine arginine β-naphthylamide. 
 
3.3.2.1. Species-specific effect of EPIs on initialattachment 
NMP inhibited attachment of 100% of isolates in all the species except A. hydrophila where it 
was observed to inhibit 94.1% (16/17) of the isolates (Table 3.6). CCCP was observed to inhibit 
attachment of 100% of A. hydrophila and A. caviaeisolates (Table 3.6). PAβN inhibited 
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Table 3.6: Species-specific effect of EPIs on initial attachment  







A. hydrophila (n=17) 100 (17/17) 94 (16/17) 64.7  (11/17) 
A. culicicola (n=8) 87.5 (7/8) 100 (8/8) 62.5 (5/8) 
A. bestiarum (n=8) 87.5 (7/8) 100 (8/8) 75 (6/8) 
Aeromonas spp. (n=3) 66.7 (2/3) 100 (3/3) 33.3 (1/3) 
A. caviae (n=3) 100 (3/3) 100 (3/3) 33.3 (1/3) 
A. veronii (n=3) 66.7 (2/3) 100 (3/3) 33.3 (1/3) 
A. allosaccharophila (n=2) 100 (2/2) 100 (2/2) 0 
A. salmonicida (n=2) 100 (2/2) 100 (2/2) 100 (2/2) 
A. jandaei (n=1) 100 (1/1) 100 (1/1) 100 (1/1) 
A. sobria (n=1) 100 (1/1) 100 (1/1) 100 (1/1) 
P. shigelloides (n=6) 83.3(5/6) 100 (6/6) 83.3 (5/6) 
*CCCP=carbonyl cyanide 3-chlorophenylhydrazone, *NMP=1-(1-naphthylmethyl)-piperazine, 
*PAβN=phenylalanine arginine β-naphthylamide. 
 
3.3.3. Effect of EPIs on pre-formed biofilm of Aeromonas and Plesiomonas 
 spp. isolates 
CCCP increased detachment of 85.2% (46/54) of the isolates including the type strains, and 
increased attachment of isolates M22, M26, M63 and M99(Fig. 3.4). This EPI demonstrated no 
effect on isolates M22, M65, M90 and M95 (Fig. 3.4). NMP increased detachment of 100% of 
the isolates, and unlike in the initial attachment assays, NMP also increased detachment of 
A.hydrophila ATCC 7966
T
 and A. caviaeATCC 15468
T
 (Fig. 3.5). While PAβN increased 
detachment of 90.7% (46/54) of isolates and increased attachment of isolate M17, it was had no 
effect on isolates M13, M63, M94 and M95 (Fig. 3.5). With A.hydrophila ATCC 7966
T
 and A. 
caviaeATCC 15468
T
, PAβN increased detachment of both strains (Fig. 3.6). An increase in 
biofilm detachment was observed in the following order: NMP > PAβN > CCCP (Figs. 3.4-3.6, 







Figure 3.4: Effect of 20 µg/ml carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates using 
microtiter plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. 
bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. 






Figure 3.5: Effect of 20 µg/ml 1-(1-naphthylmethyl)-piperazine (NMP) on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates using microtiter 
plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, 
M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, 
M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. sobria (M49); 








Figure 3.6: Effect of 20 µg/ml phenylalanine arginine β-naphthylamide (PAβN) on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates using 
microtiter plate assays. A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. 
bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. 








NMP was also the most effective EPI in the pre-formed biofilm assays and it detached 
100% of isolates (Table 3.5). PAβN was the second best EPI, and it detached 90.7% of isolates, 
whilst CCCP was the least effective (Table 3.5).  
 
3.3.3.1. Species-specific effect of EPIs on pre-formed biofilm 
NMP detached100% of the isolates in all 11 species that were investigated (Table 3.7). PAβN 
detached 100% of A. culicicola, A. bestiarum, unspecified Aeromonas spp. and A. caviae isolates 
(Table 3.7). All three EPIs increased detachment in 100% isolates of P. shigelloides (Table 3.7). 
 
Table 3.7: Species-specific effect of EPIson pre-formed biofilm  






A. hydrophila (n=17) 88.2 (15/17) 100 (17/17) 70.6 (12/17) 
A. culicicola (n=8) 87.5 (7/8) 100 (8/8) 100 (8/8) 
A. bestiarum (n=8) 62.5 (5/8) 100 (8/8) 100 (8/8) 
Aeromonas spp. (n=3) 33.3 (1/3) 100 (3/3) 100 (3/3) 
A. caviae (n=3) 66.7 (2/3) 100 (3/3) 100 (3/3) 
A. veronii (n=3) 66.7 (2/3) 100 (3/3) 66.7 (2/3) 
A. allosaccharophila (n=2) 100 (2/2) 100 (2/2) 100 (2/2) 
A. salmonicida (n=2) 50 (1/2) 100 (2/2) 100 (2/2) 
A. jandaei (n=1) 100 (1/1) 100 (1/1) 100 (1/1) 
A. sobria (n=1) 100 (1/1) 100 (1/1) 100 (1/1) 
P. shigelloides (n=6) 100 (6/6) 100 (6/6) 100 (6/6) 
*CCCP=carbonyl cyanide 3-chlorophenylhydrazone, *NMP=1-(1-naphthylmethyl)-piperazine, 
*PAβN=phenylalanine arginine β-naphthylamide. 
 
 
3.3.4. Determination of percent reduction 
When determining the percent reduction, following EPI exposure, the negative value represents 
inductionof biofilm formation and the positive values represent reductionof biofilm formation. 
The percent reduction as shown in Table 3.8indicates that CCCP reduced biofilms of 92% 
(50/54) of isolates at the time of inoculation.For CCCP, percent reduction ranged from 6.7 to 
119.7% and percent induction ranged from 1.3 to 907.5%. PAβN and NMP reduced biofilm 






time of inoculation (Table 3.8).For PAβN percentreduction ranged from 3.5 to 536.2% and 
percentinduction ranged from 7.0 to 457.4%. While the percent reduction for NMP ranged from 
30.3 to 109.4%, percent induction ranged from 58.3 to 214.5% (Table 3.8).   
 In the pre-formed assays it was observed that CCCP reduced biofilm formation of 85.2% 
(46/54) of isolates (Table 3.8). The percent reduction for CCCP ranged from 12 to 101.8% and 
percent induction ranged from 4.9 to 53.4%.Biofilms of 98.1% (53/54) and 100% (54/54) of 
isolates were reduced by PAβN and NMP, respectively (Table 3.8). For PAβN, percent reduction 
ranged from 0.2 to 122.8% and percent induction ranged from 1.1 to 44%. For NMP, the percent 
reduction ranged from 47.9% to 109.7% and no induction was observed. 
 
Table 3.8: Percent reduction of EPIs on initial attachment and pre-formed biofilm of 
Aeromonas spp.and P. shigelloides isolates 
Species designation Isolates %  Reduction 













A. hydrophila  M2 99.7 96.1 99.2 91.2 103.1 99.7 
 M5 102.9 83.7 97.1 68.5 84.9 94.1 
 M6 101.7 3.5 102.3 83.6 94.7 98.4 
 M13 96.3 24.5 95.8 100.3 4.3 87.5 
 M14 53.4 28.6 72.8 17.8 83 74.1 
 M17 98.2 17.8 73.3 101.8 -44.4 78.4 
 M50 101.7 -67 96.1 63.1 89.5 98.2 
 M51 93.6 29.2 85.9 93.4 10.6 57 
 M52 94.9 20.8 88 52.2 65.3 94.3 
 M53 75.5 98.5 97.5 95.7 95.5 99.4 
 M60 91.2 -57.5 65.8 83.5 48.1 80.9 
 M62 104.4 56.9 104.6 67.4 88.3 88.7 
 M64 100.2 -15.1 94.4 37 35.6 96 
 M65 101.1 55 99.6 -4.9 71.7 109.7 
 M86 100.1 -23.4 95.3 61.5 99.5 92.2 
 M94 118 -457.4 -58.3 85.4 4.1 74.3 





119.7 19.5 109.4 69.6 103.9 93.8 
A. bestiarum M70 54.5 76.5 82.8 95.1 82.1 82.8 
 M72 86.3 80.4 100.3 40.5 64.1 74.5 






 M81 92.8 58.2 77.8 68.8 75.3 82.7 
 M88 -2.8 57.3 33.3 69.4 74.5 76.4 
 M90 90.2 -83.8 75.4 2.6 102.1 89.6 
 M96 97.2 5.7 98.3 -12.9 35.5 56 
 M99 91.8 66.5 86.1 -21.5 47.6 86.8 
A. culicicola M22 92.7 -42.3 100.1 40.9 15.9 75 
 M23 -9.9 8.7 88.8 100.9 65.5 97.7 
 M25 84.3 93.8 95.7 57.9 68.4 82.8 
 M31 31.2 92.5 91.4 34.4 72.6 83.7 
 M32 77.1 29.9 94.2 27.9 77.8 70.2 
 M38 18.2 20 94.5 94.6 21.7 91.4 
 M39 73.8 5.3 74.9 18.8 62.8 47.9 
 M58 103.5 -87 48.8 61 33.2 97.8 
Aeromonas spp. M26 95.4 -7 65 69.7 109.8 87.2 
 M34 101.4 40.8 98.4 62.7 90.5 100.9 
 M41 -103.2 -31.4 37.8 62.7 78.3 76.7 
A. caviae M18 87.2 25.3 78.7 64.6 92.8 84.3 
 M59 69.6 -45.1 89.9 12.4 89.5 75.4 





-907.5 536.2 -214.5 50.6 104.9 62.1 
A. veronii M55 76.1 101.5 82.7 30.9 95.7 85.4 
 M57 6.7 -32.2 72.3 67.3 93 85.3 
 M63 86.5 -69.8 56.3 -53.4 -1.1 49.2 
A. allosaccharophila M8 105.5 -65.7 100.1 61.6 82.9 92 
 M92 98 -32.8 84.2 34 91.8 76.5 
A. salmonicida M76 95.6 99.4 71.3 51.3 29.2 88.2 
 M77 65.1 10.8 81.1 -29.7 62.2 84.3 
A. jandaei M28 51.6 104.4 91.8 78 101.1 79.1 
A. sobria M49 57.4 92.7 95.3 21 99.5 78.5 
P. shigelloides M9 37.1 28 76.1 46.2 92.1 88.2 
 M45 85.3 -8.4 30.3 -53.2 122.8 71.9 
 M46 82.4 45.3 87.2 93.2 67.6 88 
 M47 80.4 10.8 90.8 39.1 68.2 60.1 
 M66 100.5 68.3 101 82.2 87 100.2 
 M67 -1.3 -19.6 71 88.4 60.1 93.8 
*Percent reduction=Percentage reduction =   ((   )   (   )) (   )       , where B=average absorbance 
per well for blank wells, C=average absorbance per well for control wells, T=average absorbance per well for 
treated wells(Pitts et al., 2003),  
#
CCCP = carbonyl cyanide 3-chlorophenylhydrazone, 
#
NMP = 1-(1-naphthylmethyl)-piperazine, 
#
PAβN = 








3.3.5. Effect of DNase I on initial attachment and biofilm detachment 
DNase I significantly inhibited attachment of 59.2% (32/54) of isolates (p= 0.004). It was 
observed that in a pre-formed biofilm assays, DNase I significantly increased detachment of 
64.8% (35/54) of isolates (p < 0.001). In the initial attachment assays, DNase I increased 
attachment of isolates M8, M17, M25, M26, M39, M41, M45, M50, M58, M59, M60, M63, 
M64, M66, M68, M90, M94, M99, as well as A. hydrophila ATCC 7966
T
 and A. caviae ATCC 
15468
T
 type strains. Forisolates M9, M18 and M62,DNase I had no effect on their initial 
attachment (Fig. 3.7).          
 DNase I was more effective in detaching biofilms than in inhibiting attachment of 
isolates. DNase I was observed to increase attachment of isolates M5, M13, M17, M22, M26, 
M34, M88, M90, M92, M94 and M96 in the pre-formed biofilm assays (Fig. 3.8). It had no 
effect on isolates M25, M32, M46, M51, M50, M65, M95 and M99. DNase I effectively 
inhibited biofilm formation of isolates M17, M94, M90 and M26 in both initial attachment and 
pre-formed biofilm assays. With A. hydrophila ATCC 7966
T 
and A. caviae ATCC 15468
T
, 






Figure 3.7: Effect of 1 mg/ml DNase I on initial attachment of Aeromonas and Plesiomonas spp. isolates using microtiter plate assays.A. hydrophila (M2, M5, 
M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M72, M80, M81, M88, M90, M96, 
M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii 
(M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. sobria (M49); Plesiomonas shigelloides (M9, M45, M46, 







Figure 3.8: Effect of 1mg/mlDNase I on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates using microtiter plate assays.A. hydrophila (M2, M5, 
M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M72, M80, M81, M88, M90, M96, 
M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii 
(M55, M57, M63); A. allosaccharophila (M8, M92); A. salmonicida (M76, M77); A. jandaei (M28); A. sobria (M49); Plesiomonas shigelloides (M9, M45, M46, 






3.3.6. Species-specific effect of DNase I on biofilm formation 
The species-specific effect of DNase I in both initial attachment and pre-formed assays is given 
in Table 3.9. DNase I increased detachment of 100% of A. caviae and A. veroniiisolates in the 
pre-formed biofilm assays (Table 3.9). While DNase I in the initial attachment assay did not 
inhibit any of the A. caviae isolates, it inhibited 66.7% (2/3) of A. veronii isolates (Table 3.9). 
DNase I inhibited 58.8% (10/17) and 53% (9/17) of A. hydrophila isolates in both initial 
attachment and pre-formed biofilm asssays (Table 3.9). With A. culicicola, DNase I inhibited 
62.5% (5/8) of isolates in the initial attachment assays and detached 75% (6/8) of isolates. 
 








Initial attachment  
 
Preformed biofilm 
A. hydrophila (n=17) 58.8 (10/17) 53 (9/17) 
A. culicicola (n=8) 62.5 (5/8) 75 (6/8) 
A. bestiarum (n=8) 75 (6/8) 50 (4/8) 
Aeromonas spp. (n=3) 33.3 (1/3) 33.3 (1/3) 
A. caviae (n=3) 0 100 (3/3) 
A. veronii (n=3) 66.7 (2/3) 100 (3/3) 
A. allosaccharophila (n=2) 50 (1/2) 50 (1/2) 
A. salmonicida (n=2) 100 (2/2) 100 (2/2) 
A. jandaei (n=1) 100 (1/1) 100 (1/1) 
A. sobria (n=1) 100 (1/1) 100 (1/1) 






3.3.7. Determination of percent reduction following DNase I treatment 
After determining the percent reduction, it was observed that DNase I reduced biofilms of 64.8% 
(35/54) of isolates at the time of inoculation (Table 3.10). In the initial attachment assays, 
percent reduction ranged from 1.3 to 1644.5% and percent induction ranged from 4.5 to 334.8%. 
In the pre-formed biofilm assays, DNase I reduced biofilms of 66.7% (63/54) of isolates (Table 
3.10). It was observed that percent reduction ranged from 4.3 to 88.9% and percent induction 
ranged from 0.2 to 114.4%. 
 
Table 3.10: Percent reduction of DNase I on initial attachment and pre-formed biofilm of 
Aeromonasspp.andP. shigelloides isolates 
Species designation  Isolates % Reduction   
  Initial attachment Pre-formed biofilm 
A. hydrophila M2 73.4 27.5 
 M5 78.9 -30.9 
 M6 66.3 39.3 
 M13 7.4 -48.3 
 M14 7.3 49.6 
 M17 -64.2 -29.4 
 M50 -42.7 18.7 
 M51 14.8 -10 
 M52 -34.6 88.9 
 M53 15.5 76.5 
 M60 -184.7 68.8 
 M62 86.6 88.9 
 M64 -4.7 17.6 
 M65 -4.5 -13.4 
 M86 105.7 31.5 
 M94 -334.8 -39.8 
 M95 34.5 4.3 
 ATCC 7966
T
 13.8 73.1 
A. bestiarum M70 56.1 73.3 
 M72 38.9 53.4 
 M80 5.2 -114.4 
 M81 52 85.8 
 M90 -167.4 -25.8 
 M96 18.7 -23.3 






A. culicicola M22 15.4 -23.4 
 M23 13 60 
 M25 -48.1 -0.8 
 M31 63.7 55.3 
 M32 21.6 -0.2 
 M38 55.8 54.2 
 M39 -23.6 10.8 
 M58 -68.9 62.7 
Aeromonas spp. M26 2.7 53.6 
 M34 38.9 22.1 
 M41 -45.2 61.1 
A. caviae M18 1.3 16.9 
 M59 -19.9 26.3 
 M68 -5.6 43.5 
 ATCC 15468
T
 1644.5 62.6 
A. veronii M55 58.5 61.3 
 M57 9.5 37.8 
 M63 -113.4 29.1 
A. allosaccharophila M8 -84.6 16 
 M92 102.4 -38.5 
A. salmonicida M76 20.8 76.3 
 M77 18.3 19.6 
A. jandaei M28 56.7 65.2 
A. sobria M49 64.9 -2.6 
P. shigelloides M9 9.2 34.8 
 M45 -21.2 -62.2 
 M46 6.3 -3.1 
 M47 15.6 15.7 
 M66 29 66.9 
 M67 -47.8 70.3 
 M88 59.9 -32.4 
*Percent reduction=Percentage reduction =   ((   )   (   )) (   )       , where B=average absorbance 
per well for blank wells, C=average absorbance per well for control wells, T=average absorbance per well for 











Aeromonas spp. isolates have been suggested to be rapidly developing resistance mechanisms 
against different antimicrobial agentsdue to their widespread use (Igbinosa et al., 2012). The 
presence of EPIs restores the activity of antimicrobial agents by blocking the efflux pumps from 
pumping them out of the cell (Kvist et al., 2008). This study used EPIs in combination with 
antimicrobial agents to identify efflux pump-associated antimicrobial resistance in Aeromonas 
spp and closely related P. shigelloides species. It was observed that Aeromonas spp. isolates in 
the present study were more susceptible to quinolones (ofloxacin, norfloxacin and ciprofloxacin) 
and aminoglycosides (amikacin and gentamicin). In contrast to the results obtained in the current 
study, Aeromonas spp. (A. media and A. punctata subsp. punctata) were observed to be highly 
resistant to quinolones which was due to mutations in type II topoisomerase genes (Cattoir et al., 
2008). However, Blasco et al. (2008) observed that Aeromonas spp. isolates isolated from water 
reservoirs and cooling systems were moderately susceptible to quinolones. Aeromonas spp. 
isolates together with V. cholerae and P. shigelloides isolated from Cambe Stream were 
observed to be susceptible to norfloxacin (Gibotti et al., 2000). The isolates were more resistant 
to metabolic inhibitors (trimethoprim and sulphamethoxazole), penicillins (ampicillin) and 
tetracyclines (tetracycline). Ribeiro et al. (2010) suggested that eventhough Aeromonas spp. are 
resistant to penicillins, they are also resistant to aminoglycosides. Thus, Aeromonas spp. isolates 
showed resistance to amikacin and gentamicin (aminoglycosides) together with ampicillin and 
trimethopim–sulphamethoxazole (Gibotti et al., 2000). In agreement with this study, Aeromonas 
spp. isolates isolated from shrimp hatcheries and ponds were shown to be highly resistant to 
ampicillin (Vaseeharan et al., 2005). Aeromonas and Plesiomonas spp. from tilapia in Trinidad 
were highly resistant to ampicillin, followed by trimethoprim-sulphamethoxazole (Newaj-Fyzul 
et al., 2008). Pérez-Valdespino et al. (2009) reported that Aeromonas spp. isolates from human 
stool samples from case of diarrhoea in Mexico were highly resistant to tetracycline and 
trimethoprim-sulphamethoxazole. A. salmonicida was also suggested to be more resistant to 
tetracycline and trimethoprim-sulphamethoxazole (Bello-Lopez et al., 2009).    
 While CCCP inhibited efflux of 11 antimicrobial agents, NMP and PAβN inhibited efflux 
of 6 and 10 antimicrobial agents, respectively (Tables 3.2 - 3.4). The efflux of cefpodoximein 






the inhibitor was effective, the isolates would be resistant in the absence and susceptible in the 
presence of the inhibitor. CCCP blocks the energy required by efflux pumps in order to function 
(Kvist et al., 2008). Thus, inhibiting the efflux pumps indirectly by depriving them of energy 
provides a promising control strategy. NMP followed CCCP and it completely inhibited efflux of 
cefpodoxime in 7.4% of isolates, while the least effective, PAβN completely inhibited efflux of 
cefpodoximein 5.6% of isolates. NMP and PAβN are the substrates of RND pumps and act as 
competitive inhibitor of antimicrobial agents, as a result they have been shown to increase 
susceptibility to different antimicrobial agents (Bina et al., 2009). The action of these EPIs is 
limited to certain classes of antibiotics (Bina et al., 2009). The effectiveness of EPIs has also 
been suggested to be dependent on their mechanisms (Pannek et al., 2006). Bina et al. (2009) 
compared the RND-deficient strain of V. cholerae and test isolates to see if the NMP and PAβN 
were effective. They observed that NMP and PAβN reduced the MICs of deoxycholate, cholate 
and erythromycin. PAβN when combined with either levofloxacin  (Marquez, 2007; Pagès and 
Amaral, 2009) or fluoroqinolone was shown to increase the susceptibility of P.aeruginosa (Pages 
and Amaral, 2009). PAβN increased the susceptibility of Acinetobacter baumannii to 
clarithromycin, rifampicin or linezolid (Pannek et al., 2006) which correlates with finding of the 
current study, although different antimicrobial agents were investigated.   
 NMP was most effective in preventing initial attachment and reducing biofilm formation 
by Aeromonas species isolates. NMP decreased initial adherence of 98.1% of isolates and 
increased biofilm detachment of 100% of isolates, respectively. This suggests that it is possible 
to eradicate biofilm formed by Aeromonas spp. and P. shigelloides isolates by blocking the RND 
pumps, which is a target of both NMP and PAβN. It is not clear why PAβN was only effective in 
treating pre-formed biofilm and not initial attachment. It is possible that the mechanism of action 
or the target sites of these inhibitors played a role in their respective efficacies.  Since efflux 
proteins are up-regulated in the mature biofilm, both NMP and PAβN reduced biofilm formation 
by E. coli and K.pneumoniae (Kvist et al., 2008). These inhibitors had not yet been tested 
previously against Aeromonas spp. isolates, however, Mahamoud et al. (2007) observed that 
NMP was effective in inhibiting biofilm formation of A.baumannii.   
 Percent reduction which measures the efficacy of treatments (Pitts et al., 2003) was also 






isolates. NMP proved to be the most effective EPI in inhibiting the two major stages of biofilm 
development which are initial attachment and mature biofilm. NMP inhibited initial attachment 
of isolates and detached all isolates from biofilms.In the current study, NMP was also more 
effective in inhibiting individual species when compared to CCCP and PAβN. Of the 11 different 
species examined, NMP completely inhibited initial attachment of isolates in 10 species and 
caused detachment of the biofilms of all species.  All three EPIs used in the current studywere 
effective in inhibiting attachment of cells to form biofilms and also in detaching biofilms of both 
Aeromonas spp. and P. shigelloides, however, NMP proved to be the best candidate. PAβN was 
more effective than CCCP in the pre-formed biofilm assays and in the initial attachment assays it 
was vice versa. More detailed studies on the use of EPIs against Aeromonas spp. and the 
mechanisms by which these inhibitors affect this species are required.    
 The effect of DNase I which digests eDNAwas also examined in the present study and it 
was more effective in inhibiting the mature biofilm than initial attachment. Tetz and Tetz (2010) 
suggested that in S.aureus, DNase I was more effective on a matured biofilm where eDNA is 
constantly produced. In the mature biofilm, eDNA joins together with other components to make 
the extracellular polymeric substance (Das et al., 2010). Treatment of P. aeruginosa biofilm with 
DNase I was observed to reduce biofilm formation over the growth period (Andrews et al., 2010; 
Whitchurch et al., 2002). As observed in the present study, Lappann et al. (2010) observed that 
biofilm formed by Neisseria meningitidis was highly sensitive to DNase I treatment. DNase I 
proved to be effective in inhibiting initial attachment of A. bestiarum followed by A. culicicola, 
however, for pre-formed biofilms, DNase I proved to be more effective in inhibiting detachment 
of the same isolates. The same was obtained with P. shigelloides where members of this genus 
were detached from the biofilm rather than their initial attachment being inhibited. The 
effectiveness of DNase I in pre-formed biofilm assays shows that many species were more 
susceptible to DNase I in a mature biofilm where eDNA is highly produced and incorporated in 
the EPS. Using the percent reduction, it was further confirmed that DNase I was more effective 
in detaching biofilms than in inhibiting initial attachment.The results obtained in the current 
study indicate that DNase I ismore useful in treating biofilm thathave already been formed rather 








Inhibition of biofilm formation by aquatic Aeromonas spp. isolates using quorum sensing 
inhibitors 
4.1. Introduction 
During the QS process, bacteria communicate with each other via production of auto-inducers 
molecules that are only produced when a certain cell density is reached (Ponnusamy et al., 
2009). Acyl homoserine lactones (AHLs) in Vibrio fischeri are produced by the LuxI synthase 
and they diffuse out of the cell until the required cell density is achieved (Kirke et al., 2004; 
Chan et al., 2011). AHLs then diffuse inside the cell and bind to their cognate proteins (LuxR) 
followed by induction of gene expression after the complex binds to these genes. In Aeromonas 
spp.,the signal generator and signal receptor are AhyI and AhyR,respectively (Chan et al., 2011). 
The diversity of AHLs have been suggested to result from the N-acyl chains with carbons that 
range from 4-14 and C-3 position on the side chain of the AHL which can either be substituted 
by 3-oxo, 3 hydroxyl or a fully methylene group (Cataldi et al., 2007).  The diversity of these 
molecules aid bacteria of the same species to recognize each other rather than different species 
that are also present within the same community (Taga and Bassler, 2003).   
A.tumefaciens A136 which detects long-chain AHLs (Zhu andWinans, 1998) 
andC.violaceum CV026 which detects short- and medium-chain AHLs (McClean et al., 1997) 
are the two commonly used biosensors. The main signalling molecules that are produced by A. 
hydrophila were observed to be C-4 AHL and C-6 AHL (Chan et al., 2011; Medina-Martínez et 
al., 2006; Morgan-Sagastume et al., 2005). A. hydrophila together with A. salmonicida were 
reportedto produce N-butyryl homoserine lactone as their main signalling molecule (Swift et al., 
1997). Other members of Aeromonas species such as A. salmonicida have been shown to 
produceOHL, d-DHL, t-DHL and N-decanoylhomoserine lactone (Cataldi et al., 2007), while C-
4 AHL has been identified in A. sobria, and C-4 AHL and 3-oxo-C-6 AHL have been identified 
in A. caviaeas its major AHLs (Medina-Martínez et al., 2006).     
 The produced AHLs have been observed toinfluence biofilm formation (Lynch et al., 
2002), C-4 AHL and C-6 AHL in A. hydrophila appeared to be important in biofilm formation 
and for its development after an AHL-mutant strain was compared with its corresponding parent 






production (Labbateet al., 2004). Since AHLs influence biofilm formation (Khajanchi et al., 
2009) and induce production of virulence factors (Khajanchi et al., 2010), targeting QS with 
QSIs provides a promising control strategy.       
 The (2-)(-4-)bromomethylene-2(SH)-furanone was shown to inhibit biofilm formation of 
P. aeruginosa, A. hydrophila (Ponnusamy et al., 2010) and Hafnia alvei (Viana et al., 2009). 
Ponnusamy et al. (2010) observed that halogenated furanones which act as competitive inhibitors 
of AHLs, inhibited the growth of A. hydrophila. This inhibitor has also been shown to inhibit the 
swarming motility ofSerratia liquefaciens by binding to the swrA gene, which is controlled by 
QS (Rasmussen et al., 2000). S-adenosylhomocysteine (SAHC) was shown to have an inhibitory 
effect against P. aeruginosa. This S-adenosyl methionine analog is believed to inhibit AHL 
synthesis, however, the mechanism of action is not fully understood (Hentzer and Givskov, 
2003). Vanillin interacts with AHL receptors and interferes with the binding of AHLs to their 
cognate receptors.Vanillin was shown to inhibit both short and long chain AHLs in A. hydrophila 
resultinginbiofilm formation inhibition of this species (Ponnusamy et al., 2009). 
Cinnamaldehyde reduced the biofilm-forming ability of Burkholderia species by targeting QS 
with an unknown mechanism of action (Brackman et al., 2009). Targeting quorum sensing by 
use of these four quorum sensing inhibitor (QSIs) provides a promising control strategy to treat 
resistant biofilm-associated infections. The aim of this study was thus to detect aeromonad AHL 
production using biosensors and to determine the effect of four QSIs [(2-)(-4-)bromomethylene-
2(SH)-furanone, SAHC, trans-cinnamaldehyde and vanillin] on aeromonad initial attachment 
and mature biofilms. 
 
4.2. Materials and Methods 
4.2.1. Detection of acyl homoserine lactoneproduction using biosensors 
In order to detect AHL production by study isolates, 24 h TSA cultures were cross-streaked 
against the 24 h-grown C. violaceum CV026 biosensor grown on LB agar plates, or against the 
A. tumefaciensA136 biosensor grown on LB agar plates [with 50 µg/ml of 5-bromo-4-chloro-3-
indolyl-beta-D-galactopyranoside (X-gal)being spread on the plate prior to inoculation]. C. 
violaceum ATCC 31532 was used as a positive control in the C. violaceum CV026 bioassay, 






bioassay. Plates were incubated at 30 ºC for 24 h. Positive assays were due to the production of 
the purple pigment, violacein by the C. violaceum CV026 reporter (McClean et al., 1997)and 
AHL induction of β-galactosidase breaking down X-gal by A. tumefaciensA136 resulting in a 
blue color (Swiftet al., 1997). 
 
4.2.2. Effect of quorum sensing inhibitors on biofilm formation 
Quorum sensing inhibitors [(2-)(-4-)bromomethylene-2(SH)-furanone, S-adenosylhomocysteine 
(SAHC), trans-cinnamaldehyde and vanillin] were used to determine their effect on initial 
attachment and biofilm detachment using modified microtiter plate assays (Basson et al., 2008). 
Isolates were grown overnight in TSB, washed three times with sterile distilled water and the 
turbidity of the cell suspensions adjusted to that equivalent to a 0.5 McFarland standard. The first 
assay investigated the effect of QSIs on initial attachment of aeromonad isolates. QSIs at a final 
concentration of 5 µg/ml(2-)(-4-)bromomethylene-2(SH)-furanone, 5 µg/ml SAHC, 100 µM 
trans-cinnamaldehyde and 5 µg/ml vanillin were added to 90 µl TSB and 10 µl of respective cell 
suspensions and incubated for 24 h at 30 ºC with agitation. For the second assay, biofilms were 
grown for 24 h without treatment at 30 ºC, following which pre-formed biofilms were exposed to 
5 µg/ml(2-)(-4-)bromomethylene-2(SH)-furanone, 5 µg/ml SAHC, 100 µM trans-
cinnamaldehyde and 5 µg/ml vanillin in TSB (90 µl) and incubated for a further 24 h at 30 ºC 
with agitation. The negative control contained only broth, while the positive controls contained 
the respective cell suspensions in TSB with no QSIs added.    
 Contents of each well were aspirated, washed three times with 250 µl of sterile distilled 
water and the remaining cells were fixed with 200 µl of methanol for 15 min. After air-drying, 
wells were stained with 150 µl of 2% Hucker’s crystal violet for 5 min. Excess crystal violet was 
removed by gently rinsing plates under running tap water and air dried. Dye bound to the 
adherent cells was resolubilized with 150 µl of 33% (v/v) glacial acetic acid, and the optical 
density (OD) of each well was obtained at 595 nm using the Multiskan RC (Ascent F1, 
Thermolabsystems). Tests were done in triplicate, on two separate occasions and the results 
averaged (Basson et al., 2008). The OD595 nmof the control wells without QSIs were compared to 






reduction was calculated from the blank, control, and treated absorbance values as described 
previously in section 2.2.4. 
 
4.2.3. Statistical analysis 
Differences in adhesion between untreated and treated samples were determined by Paired t-tests 
or Wilcoxon signed rank tests if the homogeneity of variances test failed (SigmaStat V3.5, Systat 
Software, Inc; San Jose, CA, USA).  Differences were considered significant if p< 0.05.  
 
4.3. Results 
4.3.1. Detection of acyl homoserine lactones using biosensors 
Of the 48 Aeromonas and six Plesiomonas spp. isolates that were examined, only a single A. 
hydrophilaisolate (M13) induced the production of the pigment violacein by the C. violaceum 
CV026 biosensor (Fig. 4.1) while all isolates induced the utilization of X-gal to produce a blue 
color when using the A. tumefaciens A136 biosensor. 
 
 
Figure 4.1: Induction of C.violaceumCV026 by anA. hydrophila isolate (M13) isolate to produce 
the purple violacein pigment. 
 
4.3.2. Effect of quorum sensing inhibitorsin the initial attachment 
Cinnamaldehyde inhibited initial attachment of 64.8% (35/54) of isolates including A. caviae 
ATCC 15468
T
, it increased attachment of isolates M31, M32, M38, M41, M49, M65, M92, M77, 
M95 and had no effect against isolates M2, M5, M23, M39, M46, M50, M96, M80, and A. 
hydrophila ATCC 7966
T 






0.013). Furanone inhibited initial attachment of  63% (34/54) of isolates and A. caviae ATCC 
15468
T
, increased attachment of isolates M5, M8, M14, M17, M31, M47, M38, M76, M77, 
M80, M94, M95, M96and A.hydrophila ATCC 7966
T
  and had no effect against isolates M13,  
M41, M46, M49, M57, M66 and M88 (Fig. 4.3). Furanone treatments were not statistically 
significant (p = 0.104). SAHC inhibited initial attachmentof 72.2% (39/54) of isolates and 
increased attachment of isolates M8, M13, M25, M32, M47, M77, M66, M94, M95 and 
A.hydrophila ATCC 7966
T
 (Fig. 4.4). SAHC had no effect on isolates M5, M38,M47, M52, 
M64, M65, M76 and A. caviae ATCC 15468
T 
(Fig. 4.4). SAHC treatments were not statistically 
significant (p = 0.254). Vanillin was observed to inhibit initial attachment of 59.3% (22/54) of 
isolates and A. caviae ATCC 15468
T 
(Fig. 4.5). This QSI increased attachment of isolates 
M8,M50, M53, M62, M72, M76, M77, M88, M94 and A. hydrophila ATCC 7966
T
. Vanillin was 
also observed to have no effect on isolatesM5, M13, M17, M32, M38, M41, M46, M47 M65, 
M80, M90 and M95 (Fig. 4.5). Vanillin treatments were not statistically significant (p = 0.195). 
Initial attachment inhibition was observed to decrease in the following order: SAHC > 







Figure 4.2: Effect of 100 μM cinnamaldehyde on initial attachment of Aeromonas and Plesiomonas spp. isolates following addition at the time of inoculation.A. 
hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M72, M80, M81, 
M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 
15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); A. sobria (M49); Plesiomonas shigelloides 







Figure 4.3: Effect of 5 μg/ml (2-)(-4-)bromomethylene-2(SH)-furanone on initial attachment of Aeromonas and Plesiomonas spp. isolates following addition at 
the time of inoculation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. 
bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); A. sobria 







Figure 4.4: Effect of 5 μg/mlS-adenosylhomocysteine (SAHC) on initial attachment of Aeromonas and Plesiomonas spp. isolates following addition at the time 
of inoculation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, 
M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, 
M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); A. sobria (M49); 








Figure 4.5: Effect of 5 μg/ml vanillin on initial attachment of Aeromonas and Plesiomonas spp. isolates following addition at the time of inoculation.A. hydrophila 
(M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum (M70, M72, M80, M81, M88, M90, 
M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 15468
T
); A. 
veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); A. sobria (M49); Plesiomonas shigelloides (M9, M45, 







SAHC followed by cinnamaldehyde was the most effective QSI in inhibiting initial 
attachment. While furanone was the third most effective in QSI in the initial attachment, vanillin 
was the least effective QSI (Table 4.1).  
 
Table 4.1: Effect of QSIson initial attachment and pre-formed biofilm of Aeromonas spp. 









































































4.3.2.1. Species-specific effect of QSIson initialattachment 
The species-specific effects of all four QSIs on initial attachment are given in Table 4.2. In the 
initial attachment assays, furanone proved to be more effective against A. hydrophilaisolates by 
inhibiting initial attachment of 64.7% (11/17) of these isolates (Table 4.2). Cinnamaldehyde 
inhibited initial attachment of 75% (6/8) of A. bestiarumisolates (Table 4.2). Furanone and 
SAHC inhibited 100% of unspecified Aeromonas spp. isolates. Cinnamaldehyde, vanillin and 
SAHC inhibited 66.7% of A. caviae isolates (Table 4.2). SAHC was the best candidate against P. 











Table 4.2: Species-specific effect of QSIson initial attachment  











A. hydrophila (n=17) 58.8 (10/17) 64.7 (11/17) 47.1 (8/17) 41.2 (7/17) 
A. culicicola (n=8) 25 (2/8) 37.5 (3/8) 37.5 (3/8) 50 (4/8) 
A. bestiarum (n=8) 75 (6/8) 37.5 (3/8) 25 (2/8) 50 (4/8) 
Aeromonas spp. (n=3) 66.7 (2/3) 100 (3/3) 100 (3/3) 66.7 (2/3) 
A. caviae (n=3) 66.7 (2/3) 33.3 (1/3) 66.7 (2/3) 66.7 (2/3) 
A. veronii (n=3) 66.7 (2/3) 33.3 (1/3) 66.7 (2/3) 66.7 (2/3) 
A. allosaccharophila (n=2) 50 (1/2) 50 (1/2) 50 (1/2) 50 (1/2) 
A. salmonicida (n=2) 100 (2/2) 50 (1/2) 50 (1/2) 0 
A. jandaei (n=1) 0 0 0 0 
A. sobria (n=1) 100 (1/1) 0 0 0 
Plesiomonas shigelloides (n=6) 50 (3/6) 33.3 (2/6) 66.7 (4/6) 33.3 (2/6) 
*SAHC = S-adenosylhomocysteine 
 
 
4.3.3. Effect of QSIs on pre-formed biofilm 
In the pre-formed biofilm assays, cinnamaldehyde induced detachment of 64.8% (35/54) of 
isolates and A. caviae ATCC 15468
T
, as well as increasing attachment of isolates M32, M38, 
M39, M41, M49, M65, M67, M76, M77, M92, M95 and it had no effect against isolates M2, 
M5, M17, M31, M50, M62, M80, M96 and A. hydrophila ATCC 7966
T
 (Fig. 4.6). 
Cinnamaldehyde treatments were statistically significant (p = 0.001). Furanone induced 
detachment of 64.8% (35/54) of isolates and A. caviae ATCC 15468
T 
(Fig. 4.7). It increased 
attachment of isolates M5, M8, M14 ,M17, M38, M47, M80, M76, M77, M95, M96, and A. 
hydrophila ATCC 7966
T
 and had no effect against isolates M2, M13, M31, M41, M57, M67, 
M88, M94(Fig. 4.7). Furanone treatments were statistically significant (p ˂ 0.001). SAHC 
induced detachmentof 74.1% (40/54) of isolates and increased attachment of isolates M8, M13, 
M25, M32, M41, M47, M67, M77, M94, M95and A. hydrophila ATCC 7966
T
 (Fig. 4.8). SAHC 
had no effect against isolates M5, M65, M18, M76 and A. caviae ATCC15468
T
(Fig. 4.8). SAHC 
treatments were statistically significant (p ˂ 0.001). Vanillin induced detachmentof 61.1% 






M76, M77, M88, M94, M99 and A. hydrophila ATCC 7966
T
 (Fig. 4.9). Vanillin also induced 
detachment of A. caviae ATCC 15468
T
 and had no effect against isolates M5, M17, M38, M46, 
M47 M51, M65, M80, M95 (Fig. 4.9). Vanillintreatments were statistically significant(p value = 
0.006). An increase in biofilm detachment was observed in the following order: SAHC > 










Figure 4.6: Effect of 100 μM cinnamaldehyde on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates following addition after 24 h biofilm 
formation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum 
(M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); 







Figure 4.7: Effect of 5 μg/ml(2-)(-4-)bromomethylene-2(SH)-furanone on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates following 
addition after 24 h biofilm formation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, 
ATCC 7966
T
); A. bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas 
spp. (M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida 








Figure 4.8: Effect of 5 μg/ml S-adenosylhomocysteine(SAHC) on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates following addition 
after 24 h biofilm formation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 
7966
T
); A. bestiarum (M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. 
(M26, M34, M41); A. caviae  (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, 








Figure 4.9: Effect of 5 μg/ml vanillin on pre-formed biofilm of Aeromonas and Plesiomonas spp. isolates following addition after 24 h biofilm 
formation.A. hydrophila (M2, M5, M6, M13, M14, M17, M50, M51, M52, M53, M60, M62, M64, M65, M86, M94, M95, ATCC 7966
T
); A. bestiarum 
(M70, M72, M80, M81, M88, M90, M96, M99); A. culicicola (M22, M23, M25, M31, M32, M38, M39, M58); Aeromonas spp. (M26, M34, M41); A. 
caviae (M18, M59, M68, ATCC 15468
T
); A. veronii (M55, M57, M63);A. allosaccharophila (M8, M92); A. salmonicida (M76, M77);A. jandaei (M28); 






SAHC was also the most effective inhibitor in increasing detachment of the biofilm. 
While cinnamaldehyde and furanone were both the second most effective QSIs, vanillin was the 
least effective (Table 4.1). 
 
4.3.3.1. Species-specific effect of QSIson mature biofilm 
The species-specific effects of all four QSIs on mature biofilm are given in Table 4.3. In the pre-
formed biofilm assays, SAHC was more effective in increasing detachment of 64.7% (11/54) of 
A. hydrophilaisolates (Table 4.3). Vanillin and SAHC were the best candidates against A. 
culicicola isolates with both increasing biofilm detachment of 62.5% (5/8) of A. culicicola 
isolates (Table 4.3). SAHC was observed to detach biofilm of 100% of A. bestiarum isolates. 
Furanone, SAHC and vanillin increased biofilm detachment of66.7% (2/3) of Aeromonas spp. 
isolates. While furanone and SAHC detached 100% of A. caviaebiofilms, cinnamaldehyde, 
SAHC and vanillin detached 100% of A. veroniibiofilms.  P. shigelloides biofilms were 
effectively detached by cinnamaldehyde and SAHC, with both inhibitors increasing biofilm 
detachment of 83.3% (5/6) of isolates (Table 4.3).  
 
Table 4.3: Species-specific effect of QSIs on pre-formed biofilm  










A. hydrophila (n=17) 58.8 (10/17) 58.8 (10/17) 64.7 (11/17) 29.4 (5/17) 
A. culicicola (n=8) 37.5 (3/8) 50 (4/8) 62.5 (5/8) 62.5 (5/8) 
A. bestiarum (n=8) 87.5 (7/8) 87.5 (7/8) 100 (8/8) 50 (4/8) 
Aeromonas spp. (n=3) 33.3 (1/3) 66.7 (2/3) 66.7 (2/3) 66.7 (2/3) 
A. caviae (n=3) 66.7 (2/3) 100 (3/3) 100 (3/3) 66.7 (2/3) 
A. veronii (n=3) 100 (3/3) 66.7 (2/3) 100 (3/3) 100 (3/3) 
A. allosaccharophila (n=2) 100 (2/2) 50 (1/2) 50 (1/2) 100 (2/2) 
A. salmonicida (n=2) 0 0 0 0 
A. jandaei (n=1) 100 (1/1) 100 (1/1) 100 (1/1) 100 (1/1) 
A. sobria (n=1) 0 0 100 (1/1) 100 (1/1) 
Plesiomonas shigelloides (n=6) 83.3 (5/6) 66.7 (4/6) 50 (3/6) 83.3 (5/6) 






4.3.4. Percentage reduction following QSIs treatments 
The percent reduction following QSI treatments at time of inoculation and on pre-formed 
biofilm, respectively are shown in Table 4.4. For initial attachment assays, cinnamaldehyde 
treatment inhibited initial attachment of 63% (34/54) of isolates. Percent reduction for 
cinnamaldehyde ranged from 2.4 to 101.6% and percent induction ranged from 0.3 to 
118.5%(Table 4.4). Furanone inhibited initial attachment of 59.3% (32/54) of isolates. Its percent 
reduction ranged from 3.0 to 74.8% and percent induction ranged from 3.3 to 158.3%. SAHC 
inhibited intial attachment of 55.6% (30/54) of isolates. Percent reduction for SAHC ranged from 
7.3 to 78.1% and percent induction ranged from 1.6 to 152.8%. Vanillin treatment inhibited 
initial attachment of 63% (34/54) of isolates.Percent reduction for vanillin ranged from 2.4 to 
72.5% and percent induction ranged from 3.1 to 151.5%.     
 In the pre-formed biofilm assays, SAHCinhibited the biofilm of 74.1% (40/54) of 
isolates. Percent reduction for SAHC ranged from 1.5 to 85.4% and percent induction ranged 
from 0.8 to 235.4%. Vanillin inhibited the biofilm of 70.4% (38/54) of isolates. Percent 
reduction for vanillin ranged from 2.6 to 93.4% and percent induction ranged from 1.8 to 
291.1%. Furanone and trans-cinnamaldehyde inhibited the biofilm of 68.5% (37/54) and 66.7% 
(36/54) of isolates, respectively. For furanone, percent reduction ranged from 0.3 to 88.8% and 
percent induction ranged from 1.0 to 120.2%. Percent reduction for cinnamaldehyde ranged from 











Isolates % Reduction 
Initial attachment         Pre-formed biofilm Pre-formed biofilm 
  Cinnamaldehyde Furanone SAHC
# Vanillin SAHC
# Cinnamaldehyde Furanone Vanillin 
A. hydrophila  M2 58 61.4 65.5 70.9 12.5 -3.3 -2.2 8.6 
 M5 24 35.7 15.2 19.7 -10 -1.8 -53.5 9.4 
 M6 30.4 50.5 25.3 -14.6 57.9 -2 20.2 69.1 
 M13 23.4 7.4 27.7 -12.7 -43.2 58.9 0.3 12.5 
 M14 -50.1 -54.7 -119.9 -114.7 57.6 14.6 -28.8 34.5 
 M17 -2.5 -37.5 -19.9 -10.9 35.8 3.5 -120.2 6.6 
 M50 -32.8 -25.4 -37.4 -3.1 40.6 0.4 34.5 -6.5 
 M51 29 4.6 21 38.7 76 20.3 27.9 -8.5 
 M52 -14.2 -139.3 -65.7 8.7 2.6 35 28.5 31.5 
 M53 -118.5 -100.1 -49.1 -52.1 42.4 8.9 37.6 -62.3 
 M60 -20.5 42.4 54 31.6 59.7 20.3 68.8 79.7 
 M62 10 65.7 55.5 58 4.9 -3.7 31.5 -54.8 
 M64 -5.2 15.7 8.8 -66.4 15.8 39.9 59 32.1 
 M65 -4.7 4.4 -6.6 -11.9 -0.8 -183.3 19.6 7.6 
 M86 -3.6 3 -27.1 -16.8 85.4 73.6 88.8 79.2 
 M94 8.1 16.1 7.3 23.4 -235.4 44.3 -46 -219.7 
 M95 9.9 -79.5 -48.1 -74.5 -43 -54.3 -65.2 8.4 
 ATCC 7966
T
 -60.2 -3.4 20.5 43.3 -28.4 3.1 -88.8 -45.8 
A. bestiarum M70 18.1 53.8 34.9 72.5 45.8 47.8 65 68.8 
 M72 23.9 29 11.8 14.9 38.3 11.5 11.4 -12.2 
 M80 47.7 56.1 52 4.8 46.9 -4.2 -16.4 -1.9 
 M81 18.8 16.2 -3.6 19.4 56.7 14.6 74 7.1 
 M88 85.4 27.6 -11.9 -8.3 25.1 54.4 6.2 -14.5 
 M90 -89.4 -3.3 -43.6 -62.2 21.1 29.3 42.9 2.6 
 M96 21.3 25.7 -65.2 18.4 18.6 -1 -46.7 18 
 M99 27.2 -29.4 16.8 2.4 21.7 46.5 28.1 -4.1 
A. culicicola M22 2.8 -8 -22.6 25.1 32.8 79 66.2 40.2 
 M23 2.4 21 25.6 -44.2 39.4 4.8 52.5 78.5 
 M25 -16 -8.9 -5.9 22.5 -121.4 40.4 -39.2 -89.1 
 M31 -23.7 -89.9 22.4 12.9 37.3 -17.7 -18.8 36.2 






 M38 14.9 -17.4 40 22.8 -12.4 -69.6 -51.9 18.3 
 M39 33.6 23.2 43.5 24.1 76.4 -5.3 46.2 40 
 M58 -13.5 17.9 -26 -48.2 60.5 13.2 36.6 47.9 
Aeromonas spp. M26 58.8 -10.4 -1.6 3.5 17 14.2 25.2 52.2 
 M34 -5.3 9.2 14.5 24.1 51 20.8 69 28.8 
 M41 39.9 68.5 10.8 42.1 -86 -26.2 -6.4 -6.7 
A. caviae M18 12.6 55.7 53.8 28.6 24.4 2 46.4 8.7 
 M59 96 59.1 22.8 66 64.8 72.9 18.5 38.2 





-47.3 27.3 42.1 2.4 1.5 16.7 16.7 10.3 
A. veronii M55 101.6 74.8 39.2 29.3 77.3 68.3 57.7 38 
 M57 -57 39 20.5 23.3 62.1 16.6 -1 52.9 
 M63 83.7 -36 -52.8 50.3 33.3 21 41.1 93.4 
A. 
allosaccharophila 
M8 16 58.6 11.8 23.6 -99.6 41.5 -22.7 -34.4 
 M92 -9 -16.9 -83.2 13.8 26.6 -13.8 41.7 66 
A. salmonicida M76 28.9 39.1 32.3 -3.9 -14.4 -70.5 -90.2 -291.1 
 M77 42 -21.1 -22.9 68.2 -154.3 -101.6 -78.7 -223.2 
A. jandaei M28 101.3 -28.5 -97.4 -151.5 83.2 82.6 72.8 65.5 
A. sobria M49 -26.3 -158.3 -132.8 8.3 28.5 -17.6 2.6 15.3 
P. shigelloides M9 85.7 -29 78.1 28.3 84.6 49.6 76.4 59.9 
 M45 23.6 -10.1 36.1 25.4 55.5 44.3 42.5 33 
 M46 20.6 -11.5 -16.7 -8.2 44.5 11.8 20.2 8.1 
 M47 -0.3 -11.4 18.5 -26 -56 24.8 -22.5 -1.8 
 M66 -17.5 10.6 -58.6 -109.3 -159.7 -48.7 15.1 -83.9 
 M67 -6.1 13.4 16.8 31.7 49.4 40.1 11.7 71.5 
*Percent reduction=Percentage reduction =   ((   )   (   )) (   )       , where B=average absorbance per well for blank wells, C=average absorbance per well for 
control wells, T=average absorbance per well for treated wells(Pitts et al., 2003),  
#







Aeromonas spp. are known to produce a diversity of AHLs for bacterial communication (Chan et 
al., 2011). Based on biosensor responses, the Aeromonas spp. isolates in the this study produce 
long-chain AHLs as their major QS molecules. All 54 isolates tested induced the utilization of X-
gal to produce a blue color by A. tumefaciens A136, which detects a wide range of AHLs, 
including long chain AHLs. As observed in the present study Aeromonas spp. have been 
documentedto produce long-chain AHLs such as N-octanoylhomoserine lactone (C-8 AHL), N-
dodecanoylhomoserine lactone (C-12 AHL) and N-tetradecanoylhomoserine lactone (C-14 
AHL) and N-decanoylhomoserine lactone (DHL) (Cataldi et al., 2007) which is in agreement 
with findings of this study. Only isolate M13, which is an A. hydrophila isolate, was observed to 
induce production of the pigment violacein by the C. violaceum CV026 biosensor which detects 
short and medium (C-4 to C-8) AHLs. A. hydrophila have been observed to produce C4-AHL 
and C6-AHL as their two major types of AHLs (Chan et al., 2011; Medina-Martínez et al., 
2006).The majority of Aeromonas spp. isolates appeared to be producing long chain AHLs 
enabling their detection by A. tumefaciens A136.      
 QSIs used in the present study proved to be important candidates to control biofilm 
formation since they inhibited both initial attachment and pre-formed biofilm. However, these 
inhibitors were more effective in treating pre-formed biofilms than initial attachment. SAHC was 
most effective in treating both initial attachment and pre-formed biofilm (Table 4.1). Hentzer and 
Givskov (2003) observed that SAHC displayed activity against P. aeruginosa biofilm. The use 
of the S-adenosylmethionine analogue such as SAHC is suggested since these molecules inhibit 
the synthesis of the signal molecule (Defoirdtet al., 2004). In P. aeruginosa, this S-
adenosylmethionine analogue was shown to inhibit the LuxI homologue, RhlI, by up to 97% 
(Defoirdtet al., 2004). As confirmed by percent reduction, SAHC was the best QSI candidate, in 
inhibiting initial adhesion and detaching mature biofilm.   
 Cinnamaldehyde was the second most effective QSI when treating initial attachment as 
well as mature biofilms. Brackman et al. (2009) observed that cinnamaldehyde inhibited biofilm 
formation of Burkholderia spp. by binding to short chain AHLs, as did Niu and Gilbert (2004) 
who observed that cinnamaldehyde inhibited biofilm formation by E. coli.Amalaradjou et al. 






coli.             
 Other QSIs such as furanones, which are suggested to interfere with AHL synthesis, have 
been shown to interfere with mature biofilm rather than with initial attachment (Rasmussen et 
al., 2000) and this corresponds with results obtained in the this study. Halogenated furanones are 
antagonists to AHLsand by inhibiting both short and long chain AHLs they affect biofilm 
formation (Ponnusamy et al., 2010). Ponnusamy et al. (2010) observed that 0.2 mg/ml of 
furanone reduced the biofilmmass of A. hydrophila to 17% and when used at 1 mg/ml it reduced 
the mass to 32%. In the current study, furanone reduced the biofilm mass of Aeromonas and 
Plesiomonas spp. isolates to 63 and 64.8% in the initial attachment and pre-formed biofilm 
assays (Table 4.1), respectively.         
 Vanillin has been shown to inhibit Aeromonas spp. biofilm formation by inhibiting long 
chain AHLs rather than short chain AHLs. Kappachery et al. (2010) demonstrated that by 
interfering with QS,vanillin reduces biofilm formation of A. hydrophila without inhibiting 
growth of cells within the biofilm. Low concentrations of vanillin such as 0.25 mg/ml reduced 
biofilm formation of A. hydrophila by 43% (Ponnusamy et al., 2009).In present study 5 μg/ml of 
vanillin reduced biofilm formation of Aeromonas and Plesiomonas spp. by 59.3 and 61.1% in the 
initial attachment and pre-formed biofilm assays biofilms (Table 4.1), respectively.  
 When the different species were examined individually, it was foundthat some 
Aeromonas species (A. hydrophila, A. culicicola and A. bestiarum) and P. shigelloides were 
more resistant to the action of QSIs in the initial attachment assay, however, in the pre-formed 
biofilmassays majority of the QSIs were more effective againstthe same species. QSIs are 
effective against Aeromonas and Plesiomonas spp. isolates in the pre-formed biofilm assays 
rather than the initial attachment stage assays and SAHC is the most suitable. This raises 
questions such as: Is the activity of QSIs species-related or is a variable mechanism of inhibition 
being exerted on the different species. QSIs are effective in treating mature biofilm but further 
studies need to be conducted to determine how these molecules work and also to whether they 










General Discussion and Conclusions 
Aeromonas spp. are one of the major fish pathogens in the aquatic environment. Members of this 
species have been isolated in diverse places such as sewage, water systems, food products and 
vegetables(Farmer et al., 2006). These then serve as a source of diseases for humans and other 
different animals. Considering the pathogenicity of Aeromonas spp. in the aquatic environments, 
the current study investigated diverse control strategies to limit biofilm formation and/or quorum 
sensing by Aeromonas spp. isolates.         
 The MICs of different antimicrobial agents (azithromycin, ciprofloxacin, ceftazidime, 
gentamicin, and tetracycline) were observed to range between 0.064-64 μg/ml. Gentamicin 
displayed the lowest MIC range (MIC ranged from 0.0048-32 μg/ml) when compared to other 
antimicrobial agents. As expected, the MBICs were higher than MICs. The MBICs of 
antimicrobial agents against most Aeromonas spp. isolates were observed to be 4096 μg/ml. The 
most effectiveconcentration of antimicrobial agents between sub-MIC, MIC and supra-MIC 
when targeted against biofilms formed by Aeromonas spp. isolates were the MIC exposures.MIC 
exposures of gentamicin inhibited initial attachment of 100% (28/28) of isolates andMIC 
exposures of azithromycin detached biofilms of 82.1% (23/28) of isolates.    
 The combination of EPIs with antimicrobial agents is suspected to provide a synergestic 
effect and to inhibit biofilm formation(Pagès and Amaral, 2009). In the current study, CCCP 
completely inhibited efflux of cefpodoxime in 14.8% of isolatesand proved to be the best 
candidate to be used in combination with antimicrobial agents. However, when EPIs were used 
on their own, NMP proved to be the best candidate. NMP inhibited attachment of 98.1% of 
isolates and detached biofilms of 100% of isolates. DNase I was observed to be more effective in 
the pre-formed biofilm assay where it detached 64.8% (35/54) of isolates rather than in the intial 
attachment where it inhibited initial attachment of 59.2% (32/54) of isolates.   
 The production of AHLs by Aeromonas spp. was detected prior to investigating the effect 
of QSIs against these isolates. While all 54 isolates were observed to produce long chain AHLs, 
only a single A. hydrophilaisolate M13 was observed to produce short chain AHLs. SAHC was 
observed to be the most effectiveQSI as it inhibited initial attachment of 72.2% (39/54) of 






Future studies may focus on applying combinations of antimicrobial agents, EPIs, lytic 
enzymes and QSIs used in the current study in aquatic settings where Aeromonas spp. and other 
related aquatic pathogens cause diseases. In addition, HPLC could be used to identify different 
AHLs that are produced by these South African Aeromonas spp. isolates. The mechanism by 
which EPIs and QSIs inhibitAeromonas spp. isolates is not fully understood, thus, future studies 
might focus on understanding how these inhibitors behave within Aeromonasspp. planktonic 
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APPENDIX B: DATA FOR CHAPTER 3 




















Table 2B: Resistance, Intermediate and susceptibility profile of A. bestiarum isolates 
 







Table 3B: Resistance, Intermediate and susceptibility profile of A. culicicola isolates 
 







Table 4B: Resistance, Intermediate and susceptibility profile of P. shigelloides isolates 
 







Table 5B: Resistance, Intermediate and susceptibility profile of Aeromonas and A. veronii 
 










Table 6B: Resistance, Intermediate and susceptibility profile of A. jandae, A. sobria and A. caviae 
 








Table 7B: Resistance, Intermediate and susceptibility profile of A. allosacharophila and A. salmonicida 
 


























APPENDIX C: DATA FOR CHAPTER 4 








Table 2 C: QSIs treatments absorbance readings after 48 h 
 
 
 
 
189 
 
 
 
